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ABSTRACT
BIOCHEMICAL STUDIES OF THE NORMAL HUMAN BREAST
by
PENG LEE YAP
The age of the mother at the birth of her first full-term
•infant determines the subsequent risk of developing carcinoma of the
breast throughout her life. In this thesis, the hormonal control of
the normal breast was studied so as to achieve a better understanding
of the aetiology of breast carcinoma. Oestrogen receptor concentrations
were studied, and low but detectable levels were found in normal
human breast tissue. However, the assay used was insufficiently
sensitive to detect variations between breast tissue from nulliparous
and parous women.
Large quantities of secretory IgA (11S IgA) are synthesised in
the breast during post-partum lactation, and therefore mammary IgA
production was measured in different reproductive states. Neonatal
milk ('witch's milk'), galactorrhoeic secretions due to hyper-
prolactinaemia, normal breast secretions and cyst fluid from patients
with gross cystic disease of the breast were examined for IgA, the
latter because cyst fluid might reflect IgA synthesis by surrounding
breast tissue. An IgA radioimmunoassay was developed for the small
quantities of secretion available and methods were also developed for
differentiating IIS IgA from serum IgA (7S IgA).
Low but detectable concentrations of 11S IgA were found in
neonatal milk reflecting the immaturity of IgA synthesis in the
neonate. Galactorrhoeic mammary secretions, and normal breast secretions
from non-lactating nulliparous and parous women were found to contain
concentrations of 11S IgA comparable to colostrum and milk, suggesting
that mammary 11S IgA synthesis is not uniquely associated with the end
of a full-term pregnancy. Cyst fluids were found to contain either
7S IgA, IIS IgA or mixtures of both, suggesting that there may be
•different modes of cyst formation.
Finally, because colostral and milk IgA provide immunological
protection to the neonate, experiments were undertaken to discover if
breast feeding altered neonatal serum IgA concentrations. No alterations
were found, suggesting that IgA in the breast fed neonate acts only
in the intestinal lumen.
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CHAPTER 1
GENERAL INTRODUCTION
1
GENERAL INTRODUCTION
The distinguishing feature of all species in the class Mammalia
is the possession of mammary glands. These glands occur in both
sexes, and may be of variable size, shape and number. In the human,
the breast (a term whose usage will be restricted in this thesis to
the mammary gland of Homo sapiens alone) has multiple functions: it
provides immunological protection and nutrition to the neonate in the
form of colostrum and milk (reviewed by Jeliffe and Jeliffe, 1978).
In addition, the breast has a subsidiary function as an organ of
sexual attraction (Ford and Beach, 1952), and the highly innervated
nipple (Robinson and Short, 1977) acts as an important sensory
receptor of suckling by the neonate. This suckling stimulus initiates
a reflex discharge of oxytocin and prolactin from the pituitary gland
(Tyson, Friesen and Anderson, 1972). Oxytocin stimulates the initial
flow of milk and prolactin ensures lactation is sustained. This
suckling stimulus also inhibits maternal pituitary gonadotrophin
secretion (Baird, McNeilly, Sawers and Sharpe, 1979)^ and lactational
amenorrhoea ensures adequate natural spacing between successive births
(Short, 1976).
The Development of the Breast
The development of the breast (Tholen, 191+95 Dabelow, 1957;
Patten, 1968 and Raynaud, 1961) occurs early in embryonic life, and a
mammary band can be discerned in embryos I), mm. in length. This mammary
band develops into a primitive mammary bud by about two months
gestation, but little further growth occurs till about the fifth month
of gestation. At this time, the mammary bud, consisting of a solid,
spheroidal clump of cells, begins to form 15 to 20 secondary buds
which eventually form the basis for the duct system of the mature
mammary gland (Fig. 1 .1). These secondary buds lengthen, and this
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Fig. 1 .1 Developing mammary tissue in a human foetus of 8-10 weeks
gestation (above) and 16-18 weeks gestation (below). Foetal
time was obtained by courtesy of Dr. C. Gosden (x 1000).
3
ingrowth of ectoderm protrudes into the underlying mesenchyme, forming
cylindrical cords. As pregnancy advances, these cylindrical cords
bifurcate successively, and lumina develop surrounded by a wall
composed of two concentric layers of cuboidal cells. The inner layer
of cells eventually forms the secretory epithelium, and the outer
layer the myoepithelium. The ends of the cords develop eventually
into glandular acini.
The factors that control this developmental process are not
known, but may involve some form of epithelial-mesenchymal interaction.
In the mouse, it has been shown that the stromal tissue of the mammary
gland has an important regulatory action on ductal growth (Faulkin
and de Qme, 1960) and the epithelial necrosis that takes place during
the twelfth to fourteenth day of gestation in the male foetus is
secondary to the action of testosterone on the mesenchyme (Kratochwil
and Schwartz, 1976). It should be noted however that in humans, no
such male-specific epithelial necrosis takes place, and hypertrophy of
the breast (see below) takes place in a large proportion of neonates,
regardless of sex (lyons, 1937j Bluestein and Gardner, 1966j Dr. J.
McKiernen, personal communication).
Shortly before parturition, the embryonic mammaiy ducts
undergo a limited degree of proliferation (Dabelow, 1937), which is
thought to be due to the influence of maternal hormones circulating in
the foetal blood at that time (Mayer and Klein, 1961 ). This limited
degree of proliferation manifests itself in the engorged breasts
observed during the immediate post-partum period. In addition, a milk¬
like secretion (occasionally called 'witch's milk') can be expressed
from some neonatal breasts (Bluestein and Gardner, 1966), for a period
lasting up to twenty days (Ponzone and Voglino, 1976).
w*
. % $ I
Fig 1.1 (cont.) Mammary tissue in a non-lactating woman, showing a
duct surrounded by featureless stroma (above, x I4.O)
and in a lactating woman, showing proliferation of
glandular tissue (below). A few IgA plasma cells
are present, and are stained dark brown, (immuno-
peroxidase preparation by courtesy of Dr. R.S.H.
Pumphrey).
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Gradual involution of the neonatal breast occurs after birth,
and from then on till puberty, the breasts of both sexes grow
proportionately with the body as a whole. However, at the beginning
of puberty, enlargement of the breast occurs in the female (Marshall
and Tanner, 1969) which is thought to be due to increased ovarian
oestrogen synthesis (Short and Drife, 1977)- Following puberty, no
further major changes take place in the breasts, but if pregnancy
ensues, additional growth of the breasts and nipples takes place. The
major changes taking place during pregnancy are the development of the
stroma (consisting of fat and connective tissue), and of the alveoli.
Branching of the ducts to form lobules occurs, and these changes are
thought to occur in response to the raised circulating blood levels of
oestrogen, progesterone, prolactin and placental lactogen (reviewed by
McNeilly, 1977). Following the delivery of the baby and the placenta,
a small amount of colostrum may be expressed from the maternal breast and
is followed a day or two later by the secretion of milk. Lactation
continues for a variable period, depending on the persistence of breast
feeding and blood prolactin concentrations, but eventually milk
secretion ceases, involution of the breast occurs, and no further
developments take place till the next pregnancy, or the arrival of the
menopause, when permanent involution takes place.
In nulliparous women, or in parous women following the end of
lactation, but before the next pregnancy, the term "resting breast" is
often used to describe the mammary gland that is not secreting milk.
However, the breast of a non-pregnant woman is capable of responding
to the action of steroid hormones, as shown by the changes in breast
volume during the normal menstrual cycle, that have been ascribed to
increased oestradiol and progesterone secretion in the luteal phase
(Milligan, Drife and Short, 1975) • In addition, cyclic variation of
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DNA synthesis in human breast epithelium (Masters, Drife and Scarisbrick,
1977) and of IgA synthesis in parous (but not nulliparous) women has
been reported (Drife, McClelland, Pryde, Roberts and Smith, 1976)o
Small amounts of secretion can be aspirated from at least 75$ of non-
lactating breasts (Petrakis, Mason, Lee, Sugimoto, Powson and Catchpool,
1975>)j also suggesting that the term "resting" breast may be a
misnomer. In describing the non-lactating breast, it is worth noting
that among mammals, human beings are unique in the relatively large
size of their mammary glands outwith pregnancy and lactation.
Immunological Aspects of the Breast
The immunological protection provided by human milk has been
recognised for decades (Woodbury, 19225 Grulee, 193U)• Numerous
studies have shown that the incidence of gastrointestinal infection is
much lower among breast-fed infants (reviewed by Chandra, 1978) and
one of the major antimicrobial factors in milk is secretory IgA
(11S IgA). This immunoglobulin is found in very high concentrations
in comparison with IgG and IgM (Hanson, 1961 ; McClelland, McGrath and
Samson, 1978) and is synthesised by mammary sub-epithelial plasma
cells (Lamm, 1976) that originate in the Peyer's patches of the gut
(Walker and Isselbacher, 1977). Evidence for the entero-mammary
circulation of lymphocytes in the human is based upon "the observation
of IgA antibodies in milk with a specificity for bacterial antigens
commonly found in the intestine or other antigens deliberately
instilled there (Adinolfi, Glynn, Lindsay and Milne, 1966; Allardyce,
Shearman, McClelland, Marwick, Simpson and Laidlaw, 197U; Montgomery,
Rosner and Cohn, 197b', Goldblum, Ahlstedt, Carlsson, Hanson, Jodal,
Lidin-Janson and Sohl-Akerlund, 1975; Stoliar, Kaniecki-Green,
Pelley, Klaus and Carpenter, 1976). This 11S IgA differs from the
IgA present in serum (7S IgA) in being a dimer with an additional
7
protein component, secretory component, which confers on 11 S IgA
increased resistance to proteolytic digestion in the neonatal gut
(Brown, Newcomb and Ishizaka, 1 970). The exact mechanism by which
11S IgA acts is not known, but it is capable of causing the agglutination
of a wide range of enteric organisms (McClelland, Samson, Parkin and
Shearman, 1972), and thereby reducing the ability of an organism to
colonise the intestine, possibly enhancing its clearance by intestinal
peristalsis. Secretory IgA acts with lysozyme to lyse E. coli
(Adinolfi et ad.., 1966; Burdon, 1973) by activating the complement
sequence, presumably by the alternative pathway (Gotze and Muller-Eberhard,
1971)- Other antimicrobial factors are also present in colostrum and
milk such as lysozyme (Adinolfi et al., 1966), lactoferrin (Bullen,
Rogers and Leigh, 1972), complement (Adinolfi et al.. 1966),
lactoperoxidase (Reiter, Marshall, Bjorck and Rosen, 1976) and Bifidus
factor,which promotes the growth of lactobacilli (Chandra, 1978).
Colostrum and milk also contain various cells, including
lymphocytes which "are capable of blastoid trans¬
formation on exposure to the polyclonal mitogen, phytchaemagglutinin
(Smith and Goldman, 1968) as well as the synthesis of immunoglobulins
and complement (Murillo and Goldman, 1970). However, the role of the
cellular constituents of colostrumand milk in relation to the immuno¬
logical protection of the neonatal gut is not clearly delineated.
Breast Histology and the Menstrual Cycle
From the preceding description of the development of the breast,
it can be seen that the breast is a complex organ composed of different
tissues: namely epithelium (consisting of mammary ducts and glandular
acini) lying within mesenchyme (consisting of connective tissue stroma
containing the vasculature and adipose tissue). In addition there are
various cells types like plasma cells and T lymphocytes that infiltrate
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the breast. The proportion of some of these cells and of the
secretory epithelium, may depend on whether the breast is "resting",
lactating, or in a post-lactational state (Pumphrey, 1977). There
have been a number of studies which have•attempted to correlate
histological changes in the breast to the phase of the menstrual cycle.
Rosenburg (1922) claimed that budding of ductal epithelium occurred in
the pre-menstrual phase, with the subsequent disappearance of the
acini formed from this proliferation after menstruation had occurred.
This was disputed by Dieckmann (1925) who reanalysed Rosenburg's
material and concluded that the differences detected were due to the
patient's age rather than the phase of the menstrual cycle. In another
study, Foote and Stewart (191i5) claimed that the number and size of
the alveoli increased prior to menstruation and that the number of
lobules increased with age. In a comprehensive study by Dabelow (1957),
the changes in the breast during the menstrual cycle were found to
involve different portions of the mammary gland to varying degrees, and
some portions of the mammary gland were not affected at all. Two
recent studies have confirmed the histological heterogeneity of the
breast (Wilson, 1976j Short and Drife, 1977). For instance, in the
same specimen of breast tissue, the proportion of glandular tissue
varied at random from 0.3% to 29.0$ of the area of the section and none
of the histological variables examined showed consistent variations
with the stage of the menstrual cycle in either nulliparous or parous
women (Short and Drife, 1977). Histological studies of the normal
non-lactating breast are therefore fraught with difficulties, and any
conclusions reported must be treated with caution.
Carcinoma of the Breast
In the preceding sections of this chapter, only the normal
lactating or non-lactating breast has been considered. However, the
9
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Fig. 1 .2: The relative risk of developing breast cancer in relation
to the mother's age at the birth of her first child. The
risk in nulliparous women is taken as one. Pregnancy
before the age of 35 reduces the riskj and after 35 increases
it. From MacMahon, Cole & Brown (1973).
Fig. 1 .3: Age-specific incidence rates of breast cancer in five
different areas of the world. From MacMahon, _et _al. (1973).
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major impetus for research into the breast is the occurrence of
carcinoma of the breast. Among Western women, this is the commonest
cancer, and the leading cause of death from malignancy (Registrar
General, Scotland, 1976). It affects approximately one woman in
twenty, and despite extensive research into the aetiology of the
disease, the death rate has remained constant (Myers, 1972). In an
attempt to discover the 'cause' of breast cancer, various risk factors
have been elucidated of which the most important is the age at which
a woman bears her first full-term child (MacMahon, Cole, Lin, Lowe,
Mirra, Ravnihar, Salber, Valaoras and Yuasa, 1970 b; Table 1-1). Figure
1 .2 clearly illustrates the finding that the younger the maternal age
at first pregnancy, the lower the risk of developing breast cancer.
This finding, together with observed increased risk associated with an
early menarche, or a late menopause, led Short and Drife (1977) to
postulate that the nulliparous breast might be stressed by a repeated
succession of menstrual cycles, whereas following the first full term
pregnancy, a structural or functional change in the breast might
occur, protecting the breast from subsequent malignant change.
Lactation itself has little, if any, effect on breast cancer risk
Mirra, Ravnihar, Salber, Trichopoulos, Valaoras & Yuasa(l 970a),
according to MacMahon , Lin, Lowe, / although this was disputed by Ing,
Ho and Petrakis (1977) in their retrospective study of Hong Kong women
who breast fed unilaterally only (see below). The decreased risk
observed with multiparity can be accounted for try the association of
this factor with an early first pregnancy (MacMahon et al., 19706).
The increased risk of developing breast cancer seen in patients with
pre-existing fibrocystic disease of the breast is thought to be due
to an unknown predisposing factor shared by the two diseases, rather
than a Causal association (Haagensen, 1971).
I
Table 1-1 Major risk factors for breast cancer in women
Factor
Geographic/ethnic
Age at first birth
Parity-
Age at menarche
Age at natural
menopause
Ovariectomy
Nutritional
Ionising radiation
Familial
Previous cancer
Prior benign
breast disease
Increased risk
Western European
North American
After age 30
Nulliparity
Before age 13
After age £0
Decreased risk
Japanese, Taiwanese,
South African (blacks)
Indians
Before age 20
Multiparity
After age 16
Before age
None Before age
Obesity None
Ionising radiation None
Positive family history None
of breast cancer
Breast, endometrium, Cervix
colon-rectum,
salivary gland, cancer
Fibrocystic breast None
disease
(From Levin and Thomas, 1977)
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What then might be the mechanism of protection against
developing breast cancer that results from a full term pregnancy?
One possibility is that some substance or cell type is present in the
breast towards the end of pregnancy and that this somehow confers the
decreased risk observed. An attractive candidate for this hypothesis
might be some component of the immune system as it is known that in
rare primary immunodeficiency states, the frequency of malignancy is
approximately 10,000 times greater than that in the general age-matched
population (Gatti& Good, 1971). In patients with common variable
(late onset) acquired hypogammaglobulinemia, malignancy occurs much
/
more frequently than in the normal population (reviewed by Ross and
Asquith, 1979). In secondary immunodeficiency (following immuno¬
suppressive therapy for renal transplantation), de novo cancers occur
at approximately 100 times the frequency observed for the general
age-matched population. In one series (Penn, 197U), epithelial tumours
accounted for 67% of the cancers, an interesting finding in comparison
with cancer of the breast where almost all cancers are epithelial in
origin. As described above, large numbers of lymphocytes enter the
breast towards the end of pregnancy (Pumphrey, 1977), and some of these
lymphocytes secrete IgA, and smaller quantities of IgG and IgM. Other
lymphocytes occur in colostrum and milk, suggesting that the involvement
of the immune system at the end of a full-term pregnancy might provide
a possible explanation for the protective effect observed.
Another possibility that might also explain the protective
effect of an early full term pregnancy might be the removal at the end
of pregnancy of some potentially carcinogenic substance, or the removal
of a clone of cells likely to undergo subsequent malignant transformation.
A variety of ingested and inhaled chemical substances have been
demonstrated in the secretions obtained from non-lactating women, and
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among these substances may be initiating and promoting factors acting
on the epithelium to produce malignant change (Petrakis, 1977) • Ing
et al. (1977) reported the intriguing finding that in a group of
Chinese women in Hong Kong who traditionally only fed their babies
from one breast, cancer developed only in the unsuckled breast of 79$
of such women when postmenopausal, a distribution that was significantly
different from that seen in the normal Chinese population in Hong
Kong. This proposal that the mammary ducts contained potentially
carcinogenic substances would be in accord with the proposal by Short
and Drife (1977) that a repeated succession of menstrual cycles might
be harmful, as each cycle might lead to an increase in the quantity
of carcinogenic substances within the mammary ducts. Alternatively,
the death of ductal and alveolar cells at the end of lactation,
associated with engorgement and milk stasis regression, would reduce
the overall number of potentially malignant cells.
A third possibility is that some change in endogenous hormone
secretion occurs associated with a full term pregnancy, and that this
confers a permanent change in either the breast itself, or in the
subsequent pattern of hormone secretion. Among the endogenous hormones,
it is probable that oestrogens are involved in the genesis of breast
cancer, as it has been shown that ovariectomy prior to the menopause
decreases the risk of developing breast cancer and the earlier
ovariectomy is performed, the greater the decrease in risk (Hirayama
and Wynder, 1962; Feinleib, 1968). The
protection against developing breast cancer conferred by a late
menarche and an early natural or artificial menopause could be linked
with an alteration in oestrogen synthesis by the ovary.
The relationship of oestrogens to breast cancer can also be
studied in women who receive exogenous oestrogens over a long period,
1U
either for contraceptive purposes, or for menopausal symptoms, or
after a hysterectouy. Epidemiological studies in this area are
fraught with difficulties, due to alterations in patterns of oral
contraceptive or hormone replacement usage. In addition, the wide
variety of preparations used, and the requirement for case control
studies of an adequate size or cohort studies of a sufficiently long
period contribute to difficulties of data interpretation. To date, on
the basis of cohort or case-control studies, (reviewed by Vessey,
1977), there appears to be no clear evidence that oral contraceptives
are linked with breast cancer. However, in the case of oestrogens
administered after the menopause, or after hysterectomy, evidence from
two studies (Burch, Byrd and Vaughn, 1976; Hoover, Gray, Cole and
MacMahon, 1976) considered to be carefully performed (Vessey, 1977)
indicates that the risk of breast cancer might be slightly increased
by the administration of oestrogens as hormone replacement therapy.
The problem with all hypotheses linking oestrogen secretion
Cdle and Brown
with breast cancer, as pointed out by MacMahon , / (1973) is that
they fail to explain why the protective effect should only be
restricted to the first pregnancy. Even the oestriol hypothesis,
popularised by Cole and MacMahon (1 969)3 which included in it an
explanation for the protective effect of the first pregnancy^ is no
longer considered to be valid (Kirschner, 1977 ) - When considering
other endogenous hormones (e.g. androgens, progesterone, prolactin and
thyroid hormones) the same problem arises as with oestrogens: that
it is difficult to formulate a hypothesis connecting a particular
hormone with the restriction of the protective effect to the first
pregnancy. It is for instance difficult to reconcile the finding
that breast cancer patients had a higher incidence of anovulatory
cycles than normal women (Grattarola, 196U) and that inadequate corpus
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luteum function may be very common among breast cancer patients
(Sherman and Korenman, 197U) with the restriction of the protective
effect, unless a full-term pregnancy somehow alters the pattern of
pituitary hormone secretion.
Another important epidemiologic observation has been the
striking variation in breast cancer incidence among different areas
of the world. The incidence is five to six times higher in North
America and Northern Europe than in most areas of Asia and Africa.
Striking differences also occur in age incidence patterns (Fig. 1.3) and
it is interesting to note that differences in reproductive practice
are unlikely to be responsible for the major international differences
in breast cancer rates (MacMahon .et al. 1973). Numerous
hypotheses have been advanced to explain this geographical variation,
including diet, histologic type of the tumour and genetic differences
(reviewed by MacMahon et al., 1973) hut at the present time, no
definitive explanation is available.
Animal Models for Breast Cancer
A number of animal models have been used experimentally to
increase our understanding of breast cancer. The species with the
highest spontaneous incidence of mammary cancer are man, the laboratory
rat and mouse, and the domestic dog and cat. However, as pointed out
by Short and Drife (1977), only in the human does mammary development
occur at puberty, whereas in the cat, rat and mouse, mammary develop¬
ment and lactation are dependant upon copulation. In the dog, mammary
development and lactation occurs at puberty, and are independant of
pregnancy. Thus, it is possible that extrapolation of experimental
findings about mammary carcinogenesis in animals to breast cancer in
humans may be unwarranted. However, it is of interest to note that
ovariectomy, or absence of pregnancy is a major aetiological factor
16
cancer
in the development of mammary in the cat (Dorn, Taylor, Schneider,
Hibbard and Klauber, 1968; Weijer, Head, Misdorp and Hampe, 1972),
and in the rat (Howell and Mandl, 1961). In the dog, the evidence is
less conclusive that pregnancy is related-to mammary carcinoma incidence
(reviewed by Hamilton, 197il-) -
Differences also exist between species in immunological function
of the mammary glands. This is probably related to the fact that in
some mammals, for example humans, both the placenta and the mammary
gland are involved in the transfer of immunoglobulin to the foetus and
the neonate. In other mammals, e.g. cows, goats and sheep, only the
mammary gland is involved in the transfer of immunity. A third group
which includes cats, dogs and rodents is intermediate between the two
groups described above. This difference is reflected in the mammary
gland. In cattle, the acinar epithelial cells of the mammary gland
possess specific receptors for the Fc portion of the IgG molecule.
Selective transport occurs of a single subclass, IgG^, from serum to
colostrum, and the IgG^ content in colostrum is Qb% of the total immuno¬
globulin, whereas IgGg is 3% only. IgA and IgM are also present in low
concentrations in cow's colostrum (l% and 3% respectively). By contrast,
in human colostrum, IgA predominates, constituting 98% of the total
immunoglobulin. IgG (0.9%) and IgM (2%) are much lower, reflecting the
fact that most of the immunoglobulin in human colostrum and milk is
synthesised in the breast by plasma cells, the majority of which secrete
IgA (McClelland et al.. 1978; Butler, 1979). The rat occupies an
intermediate position with IgA and IgG constituting'63 and 36% of
colostral immunoglobulin respectively. This data may be of significance
when one considers that mammary cancer is virtually unknown in the
cow, despite the selection for large udder size and high milk yield for
many generations (Short and Drife, 1977)-
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As well as using animal models, many experimental studies
attempting to unravel some of the factors that might be related to
mammary carcinogenesis have utilised human breast tumours or tissue from
patients with existing or previous breast- carcinoma. However, it has
been shown that the period between exposure to a carcinogen, and the
development of tumours of the respiratory tract can range from 10 to
30 years (Hueper, 1966) and it is likely that a latent period of similar
magnitude exists for breast cancer. Furthermore, it has been proposed
(on the basis of tumour size doubling times) that a malignant tumour
of the breast may exist for ten years prior to clinical detection
(Gullino, 1977)• It is therefore important to study normal i.e. non-
malignant breast tissue obtained from female patients who have no
existing or previous breast malignancy if we are to understand why
malignant change occurs in the female breast.
Aims of the thesis
The aim of the experiments described in this thesis was to
study the hormonal control of the normal breast so as to achieve a
better understanding of the aetiology of carcinoma of the breast in
humans. An oestrogen receptor assay was therefore validated, and the
oestrogen receptor concentration in normal human breast measured. In
addition, IgA production was measured in different reproductive states.
Neonatal milk ('witch's milk'), galactorrhoeic secretions due to hyper-
prolactinaemia, and normal breast secretions were examined for IgA.
Cyst fluid obtained from patients with gross cystic disease of the breast
was also examined for IgA, as the fluid might reflect the IgA synthetic
activity of the surrounding breast tissue. A radioimmunoassay for IgA
was developed for the above studies because of the small quantities of
secretion available and methods were developed for differentiating
IIS IgA from 7S IgA. The radioimmunoassay was also used to assess if
18
quantitative changes in IgA synthesis occurred during the menstrual
cycle, as earlier studies by Drife _et al. (1976) had demonstrated that
qualitative changes occurred during the menstrual cycle in IgA synthesis
in parous but not nulliparous women.
Finally, because of the importance of colostral and milk IgA
in the immunological protection of the neonate, experiments were
undertaken to discover if breast feeding produced a detectable effect
on serum IgA concentrations in the neonate.
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CHAPTER 2
OESTROGEN RECEPTOR CONCENTRATIONS IN
RAT AND HUMAN TISSUES
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CHAPTER 2 OESTROGEN RECEPTOR CONCENTRATIONS IN RAT AND
HUMAN TISSUES
2.1 INTRODUCTION
The normal human female breast is a target organ for steroid
and protein hormone action, as described in Chapter 1 (Marshall and
Tanner, 1969; Milligan et al., 1975; Drife- et al., 1976; Masters
et al., 1977; McNeilly, 1977; Short and Drife, 1977)- The initial
event in the mechanism of action of the steroid oestradiol-1 Ijl in
a target organ like the uterus is the binding of the steroid to a
specific, cytoplasmic, soluble protein, the oestrogen receptor (Toft
and Gorski, 1966). Thus the receptor may exist either in a free state
or bound to oestradiol-17^> . Most reports concerning cytoplasmic
oestrogen receptor concentrations in rat and human tissues have examined
only concentrations of free receptor, and it is possible that the
failure of previous attempts to measure oestrogen receptors in normal
breast tissue (Feherty, Farrer-Brown and Kellie, 1971; Leclercq,
Heuson, Deboel and Mattheiem, 1975) was due to this.
The possibility of measuring both free and bound receptor by
exchange assay has recently been demonstrated by Chamness, Huff and
McGuire (1975); "the method involves precipitating the oestrogen
receptor with protamine sulphate (based on Steggles and King, 1970).
In view of the fact that the other target organs for oestrogen action
such as the uterus, vagina and hypothalamus have all been shown to
contain a specific oestrogen receptor protein, an attempt was made to
demonstrate the occurrence of oestrogen receptors in the normal breast
as a preliminary step towards measuring changes in oestrogen receptor
concentrations in response to the menstrual cycle and pregnancy.
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An evaluation of saturation analysis and exchange assay using
protamine sulphate precipitation was therefore undertaken by studying
vacant and occupied receptor concentrations in rat uterus throughout
the oestrous cycle (where fluctuations in plasma levels of oestradiol-1 lp
occur, resulting in possible differences in the proportion of free and
bound cytoplasmic oestrogen receptor sites) and in other rat tissues.
Saturation analysis and exchange assay was then used to study oestrogen
binding in normal human breast tissue, human uterus, muscle and serum.
2.2 MATERIALS AMD METHODS
Animals Vaginal smears were taken daily at 1000h from female
Liverpool Hooded rats (60-90 days old) known to show regular U-day
oestrous cycles (Yoshinaga, Hawkins and Stocker, 1969). Between 1130h
and 1230h on particular days of the cycle rats were killed by
exsanguination through the aorta under ether anaesthesia. Uteri and
samples of sciatic muscle were excised, trimmed free of fat and blood
vessels, washed in Tris buffer (0.01 mol/1 Tris-HCl, 1 .5> mmol/l EDTA,
pH 7.U at U°C) and stored at -70°C. Plasma was separated from, blood
before estimation of the concentration of oestradiol-17^3 . Inguinal
mammary glands were obtained from lactating rats of the same strain which
were killed by cervical dislocation on day 21 post partum. Serum was
obtained from additional non-pregnant female rats for the determination
of the binding of oestradiol-17^3 to serum.
Patients Normal mammary tissue was obtained from 13 pre-menopausal
patients aged 16—1+3 years at the time of reduction mammoplasty or
biopsy for benign breast disease. Representative sections were submitted
to histology and it was demonstrated that the tissue was normal.
Uterine tissue (predominantly myometrium) was obtained from four patients
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undergoing hysterectomy and inferior rectus muscle from U patients under¬
going cholecystectomy. Serum was also obtained from each of 6 female
pre-menopausal subjects.
Radiochemicals 2,U,6,7-(n) H - Oe stradiol-17^> (sp.act.87-115
Ci/mol) was obtained from the Radiochemical Centre, Amersham and
purified at intervals of 2 weeks by the method of Mikhail, Wu, Ferin and
Vande Wiele (1971).
Determination of protein concentration The concentration of soluble
protein in tissue homogenates or blood sera was determined by the method
of Bradford (1976) using a bovine serum albumin standard.
Determination of plasma hormone levels Concentrations of oestradiol-1
in rat sera were determined by Dr. R.A. Hawkins using the method of
Hawkins, Freedman, Marshall and Killen (1975). The assay sensitivity
for plasma oestradiol-17jS (as defined by Hawkins et al., 1975) was
13«5} 9.0 and £.9 pmol/l for 1 .5, 2.0 and 3.0 ml plasma respectively.
Determination of oestrogen binding site concentration:
Preparation of cytosol and sera The assay used was a modification of
the method described by Chamness et al. (1975). Rat uterus, rat muscle,
mammary tissue from lactating rats, human uterus, human muscle or normal
human breast tissue were frozen with liquid Ngj pulverized in a stainless
steel mortar and homogenized at l4°C in Tris-dithiothreitol buffer (0.01
mol/1 Tris-HCl, 1.5 mmol/1 EDTA, 0.5 mmol/1 dithiothreitol, pH 7-U)
using a Silverson homogenizer at maximum speed in two bursts of 10s
each with a 1S>s cooling period between. Tissue homogenates prepared
in this way and blood sera were centrifuged at 105,00Qxg to remove nuclei
and cell debris: the resulting supernatants were incubated with
dextran-coated charcoal, centrifuged and the supernatants were diluted
to a final concentration of 0.8 - 1.5 g soluble protein/litre as described
by Chamness et al. (1975). Larger amounts of normal human breast tissue
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than of human or rat uterus were required for homogenization because
of the lower yield of soluble protein obtained from breast tissue.
Protamine sulphate (Grade II, Sigma) was added to aliquots of
diluted cytosol or serum in glass or plastic tubes (12 x 75 mm) pretreated
as described by Chamness et al. (1975) "to give a final concentration of
0.5 g/1. Vacant oestrogen binding sites in the precipitates (obtained
by centrifugation at 2000 x g for 1 0 min) were then submitted to saturation
analysis at l*°Cq vacant and occupied oestrogen binding sites were
measured by the oestradiol-1 7^3 exchange assay at 30°C.
2.2.1 Saturation analysis for vacant binding sites
Duplicate tubes containing known quantities of the protamine
precipitates from rat or human tissues and 10,20,30,1*0,60 or 80 pg of
2,l*,6,7-(n)"^H - oestradiol-17^5 were incubated at 1|°C overnight in
a total volume of 0.5 ml. Parallel incubations of the protamine con-
with o
taining precipitates/the same concentrations of H - oestradiol-1 "^3
plus 500 nmol/1 non-radioactive oestradiol-17/3 permitted determination
of non-specific binding. The data was plotted according to Scatchard
(191*9) • The concentration of vacant oestrogen binding sites and the
dissociation constant of binding (K^) were calculated from the intercept
and gradient of the graph respectively.
2.2.2 Exchange assay for total binding sites: rat tissues
Triplicate tubes containing the protamine precipitates from
cytosols or sera in Tris-dithiothreitol buffer (0.5 ml) containing
'-oestradiol-17ji (10 nmol/l) were incubated overnight at 1*°C and
subsequently for 3h at 30°C, except where other concentrations or times
were studied (as indicated in the text). Parallel incubations of the
same composition but including oestradiol-1 "^3 (500 nmol/l) were carried
out to measure non-specific binding.
21*
The number of occupied oestrogen binding sites that could be
measured by exchange assay following artificial saturation of a known
number of vacant binding sites was initially determined by saturation
analysis at lj.0C of an unsaturated rat cytosol. This cytosol was then
artificially saturated by incubation with non-radioactive oestradiol-1 7^2
(10 nmol/1) for 2h, followed by treatment with dextran-coated charcoal
to remove excess free oestradiol-1 "^3 . Exchange assay was then carried
out for 1, 2, 3, k and 6h at 1j?°C, 22°C and 30°C by incubation with
3 o
H -oestradiol-17^ (10 nmol/l) after overnight incubation at It C.
2.2.3 Exchange assay for total binding sites: human tissues
The assay conditions for human tissues were slightly modified
from those used for rat tissues in that the overnight incubation at
U°C was omitted. The number of occupied oestrogen binding sites that
could be measured by exchange assay in an artificially saturated human
cytosol was also measured. The concentration of vacant binding sites
was initially determined by saturation analysis of an unsaturated human
uterine cytosol. This cytosol was then artificially saturated by
incubation with non-radioactive oestradiol-1 7^5 (l5 nmol/1) for 2h
followed by treatment with dextran-coated charcoal. Exchange assay
was then carried out, either immediately by heating at 30°C for 1, 2,
\
3 or U h or with an overnight preincubation at l4°C followed by heating
the next morning for 1 , 2, 3 or U h.
Separation of free and bound hormone At the end of the incubation
3
with H_ oestradiol-1the precipitates from saturation analysis and
exchange assay were washed thrice with Tris buffer (2 ml) at It.0C. The
radioactivity bound to washed precipitates was extracted twice with 1 ml
portions of ethanol. Dried extracts were counted after dissolving in
toluene (5 ml containing PPO 0.k% w/v) using a liquid scintillation
counter (isocap A , Searle).
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Tests of statistical significance The statistical significance of
differences was examined by Student's t-test.
2.3 RESULTS
2.3.1 Rat Tissues
3
Saturation analysis High affinity binding of H - oestradiol-1 yl
by vacant binding sites present in cytosol from rat mammary tissue
(Fig. 2.1) and rat uterus (not shown) was evident upon Scatchard
analysis. In contrast, muscle cytosol and rat serum (Fig 2.1) did not
show any high affinity binding.
3
Effect of time, temperature and H - oestradiol-1concentration on
3the binding of H - oestradiol-1to protamine-precipitated rat uterine
cytosol
At 1|°C, linear Scatchard plots were obtained when the protamine
precipitates from rat uterine cytosol was incubated with low con--
centrations of H - oestradiol-17^ (not shown). However, if the
protamine precipitate was incubated at 30°C for 3h instead of U°C
3
overnight, then lower binding of H - oestradiol-17/2 was seen for all
3
concentrations of H - oestradiol-17^2 less than 2 nmol/1 (Fig. 2.2).
This was presumably due to the destruction of vacant receptor by
3
heating at lower concentrations of H- oestradiol-1. In the
3
exchange assay 5 or 10 nmol/1 H- oestradiol-1 "Jji was therefore used.
In 1 2 rat uterine cytosols an exchange assay was carried out
for 3h at 30°C with .either 3 or 10 nmol/1 ^H - oestradiol-1 Ip, j mean
O
non-specific binding was 38 and 33$ of the total bound H - oestradiol-1 Ijl
3
respectively. It was found that incubation with 3 nmol/1 H -
oestradiol-17/2 gave only 93 - 16$ (n=12) of the receptor concentration
3
which was detected when 10 nmol/1 H - oestradiol-1 was used.
3
10 nmol/1 H - oestradiol-1 was therefore used routinely in all
subsequent assays.
*
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Fig. 2.2: The specific binding of H-oestradiol-17ft to the protamine-
precipitate from rat uterine cytosol following (o) non-
exchange incubation at U C overnight, or (t) exchange
incubation (at U°C overnight, then at 30°C for 3h), for
concentrations of 3H-oestradiol-17ft from 0.08 nmol/l to
10 nmol/l- Non-specific binding was subtracted in all
cases.
28
Incubation at higher temperature allowed the exchange of added
3
H- oestradiol-1 7^!> for endogenous oestradiol-1 which was already
3
bound, as well as resulting in the production of bound H -oestradiol-1'
from vacant binding sites. In attempt was-made to determine the optimum
temperature and incubation period for exchange and the fraction of bound
sites that could be detected by saturating a cytosol with excess non-
O
radioactive oestradiol-1 yj followed by incubation with 10 nmol/l H -
3
oestradiol-17p, . It was found that optimum exchange of added H -
oestradiol-17^3 for bound oestradiol-17^2 occurred after 2 - 3 h at 30°C
(Fig. 2.3). However, only 6of the sites detected by saturation
analysis before artificial saturation could be detected by exchange
assay. Thus a correction factor of 100/65 was applied to all subsequent
exchange assay results.
Changes in vacant and occupied uterine binding sites and total binding
site concentration in rat muscle, serum and mammary cytosol during the
oestrous cycle
The total binding site levels in uterine cytosol were measured in 18
rats at various stages of the oestrous cycle, and in six of the experi¬
mental animals vacant and occupied binding sites in muscle cytosol were
also measured. The concentration of occupied binding sites was obtained
by subtracting the vacant binding site value from total binding site
value.
The mean concentration of vacant binding sites was significantly
lower at pro-oestrus than at oestrus (P< 0.001), metoestrus (P< 0.05) or
dioestrus (P< 0.01). No vacant sites were detected in either serum or
muscle.
Mean total binding site levels were significantly higher at
oestrus than at pro-oestrus (P< 0.01) or metoestrus (P< 0.05), and
levels at dioestrus were also significantly higher than those at
pro-oestrus (P<0.01, Fig. 2.U). The variation in mean total and vacant
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Fig. 2.3: The exchange of non-radioactive oestradiol-1and
3H-oestradiol-17/3 in a rat uterine cytosol artificially
saturated by incubation with 10 nmol/l non-radioactive
oestradiol-17/3 for 2 h followed by treatment with charcoal
to.remove excess, free non-radioactive oestradiol-1 7/> .
After treatment with protamine sulphate the precipitates
were incubated at (•) 1£, (^) 22 and (x) 30°C in 10 nmol/l
3H-oestradiol-17/3 for 1, 2, 3, U and 6h. The number of
vacant sites before artificial saturation, determined by
saturation analysis at l4.°C> is shown by the broken line.
Non-specific binding was subtracted in all cases.
30
binding site concentrations was inversely related to concentrations of
plasma oestradiol-1 7p which were highest at pro-oestrus and lowest at
oestrus (Fig. 2.U). It was also observed that in 1lj. out of the 18 rat
uterine cytosols (including all six of the cytosols from animals in
i
oestrus) the concentration of vacant binding sites (determined by-
saturation analysis) exceeded the concentration of vacant binding sites
(determined by exchange assay) before the use of the 100/65 correction
factor described above.
It was found that the mean total binding sites for uterus at all
stages of the oestrous cycle significantly exceeded the value obtained
for muscle or serum (P< 0.001). During the oestrous cycle, the changes
in either occupied binding sites or the degree of occupancy of binding
sites did not attain statistical significance. This may have been caused
by the wide variation in the degree of occupancy of binding sites observed
in individual animals during the same phase of the oestrous cycle or by
continual intra-nuclear translocation of receptor-bound oestradiol-17yfl .
A low concentration of vacant binding sites was found in the
inguinal mammary glands from five lactating rats, the mean level being
significantly lower than the mean values found in rat uterine cytosol
at all phases of the oestrous cycle (P< 0.001 in all cases). The mean
total binding site concentration found by exchange assay was also
significantly lower in rat mammary cytosol from lactating rats than the
mean total uterine receptor concentration at all phases of the oestrous
cycle (P< 0.001 in all cases) and significantly higher than the mean
value for rat muscle (P< 0.001 ) and rat serum (P< 0.001)'. However, the
value of bound sites was nearly eight times greater than the value for
vacant sites (Fig. 2.ii). The mean value in the mammary cytosol from
lactating rats was not significantly different from the mean value seen
during pro-oestrus but was significantly lower than the mean value found
during oestrus (P < 0.005), metoestrus and dioestrus (P< 0.01 in both
cases, Fig. 2.5).
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2.3*2 Human Tissues
Saturation Analysis
Vacant binding sites could be detected in the cytosols from only uterus
of all the human tissues studied. The mean value for the vacant binding
site concentration in uterine cytosols was 1lf! fmol/mg soluble protein
(Fig. 2.6). The dissociation constant (K^) for uterine cytosols ranged
from 0.26 x 10 ^ to 5-62 x 10*"'^. By contrast no vacant sites could
be demonstrated in mammary cytosol, muscle cytosol or diluted serum
(Fig. 2.6).
Exchange Assay
In an artificially-saturated human cytosol, it was found that after
exchange reaction for 3h at 30°C, the number of total binding sites
(measured by exchange assay) exceeded the number of vacant binding sites
(measured by saturation analysis) present before artificial saturation.
This suggested that exchange was also occurring with occupied oestrogen
binding sites that were present before artificial saturation under
these conditions (Fig. 2.7). Pre-incubation at k°C overnight with
3
10 nmol/l H - oestradiol-1 7^. before exchange assay as described above
for rat tissues was omitted since this procedure resulted in a minor
reduction (7-8$) in exchangeable binding sites (not shown). Pre-incubation
at l4°C was therefore omitted from all subsequent exchange assays.
■When mammaiy cytosol from a patient -undergoing reduction mammo-
plasty, muscle cytosol or diluted serum were incubated with 10 nmol/l
O
H - oestradiol-1 7^ for 1, 2, 3 or 6h, maximal binding was found in
mammary cytosol after 3h at 30°C but neither muscle cytosol not diluted
serum showed a clear peak of binding (Fig. 2.7). Furthermore, the maximal
levels of binding in mammary cytosol were higher than those found with
muscle cytosol or diluted serum, suggesting that mammary cytosol, like
uterine cytosol, contained occupied oestrogen binding sites.
33
•40
2*8
i\
i\
i\
I
2-0-
"9
TJ
id
V2 0-4
T
I
-30
>
en
Z > o m
cn
73
>
20§
-10
o o z o
O
(O
■0
,<£>
0> -r0> -A°
MAMMARY CYTOSOL
UTERINECY OSOL
Fig.2.^:. Thevariationinruterincytosolduri gthoes r uscycleandinmammarycytos lfrolact tingr t usingthesamecyto olsades rib dinFig.2.1).Pla maoe tradiol—17^Jlev ls(•w redeterm nedur g pro-oestrus,oestrus,metoe trusanddioestru .ThS.E.M.arthsshownnF g.2.L
In four human uterine cytosols studied using the exchange assay,
total binding sites (vacant and occupied) exceeded the vacant site value,
again suggesting a low concentration of occupied receptors in human
uterine cytosol.
The mean value (- S.E.M.) of total binding sites in llj. mammary
cytosols obtained for 13 pre-menopausal patients was 2k - 3 fmol/mg
soluble protein. This value significantly exceeded the mean values
for muscle cytosol (P< 0.01, Student's t-test) and diluted serum (P< 0.01)
but was eight-fold lower than the mean value of 161). - J4.2 fmol/mg soluble
protein for uterine cytosol (Fig. 2.6).
2.U DISCUSSION
The purpose of the studies described in this chapter was to
develop and validate a receptor assay that would permit detection of
occupied cytoplasmic receptor sites in normal human breast tissue, as
vacant receptor sites in previous studie s (Feherty et al., 1971 j Leclercq
et al., 1975) were below the limit of detection. However, it was found
that the exchange assay, based on protamine sulphate precipitation
resulted in a detectable loss of cytoplasmic receptor sites in rat but
not human uterus. Nuclear receptor sites were not measured as some
doubt exists about their interpretation (e.g. Laing, Smith, Caiman, Smith
and Leake, 19775 Kiang, 1977)J furthermore, the number of nuclear
occupied receptors is partly dependant upon the level of available
vacant cytoplasmic receptors (Sakai and Saez, 1976).
3
The concentration of H - oestradiol-1 7^3 used for exchange assay
has varied from 5 nmol/1 (Nicholson, Golder, Davies and Griffiths, 1976)
to 30 nmol/1 (Katzenelleribogen, Johnson and Carlson, 1973). A concentration
of 10 nmol/1 was chosen since apparent total receptor values were
lower, at 3 nmol/1. This may be due either to receptor breakdown since
Katzenellenbogen et al. (1973) reported that high concentrations of
33
Fig. 2.6:
Vacant and total receptor concentrations in human breast cytosol,
muscle cytosol, diluted serum and uterine cytosol. Mean vacant binding
site concentrations - S.E.M. are indicated by the solid bar and mean
total binding site concentration (vacant and occupied) * S.E.M. are
indicated by the open bars. The number of experiment's for each tissue .
is indicated in parentheses. Non-specific binding was subtracted in
all cases in the exchange assay and was 81, 9h> 91 and 79% on average
of the total 3H-oestradiol-1 7/3 bound for breast cytosol, muscle
cytosol, diluted serum and uterine cytosol respectively.
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Fig. 2.7:
Above: The time course of exchange of non-radioactive oestradiol-17/3
for 3H-oestradiol-1 7/3 in an artificially saturated human uterine
cytosol. A human uterine cytosol was incubated with 15 nmol/l non¬
radioactive oestradiol-1 7/3 for 2h followed by treatment with dextran-
coated charcoal to remove excess, free, non-radioactive oestradiol-1 7ji.
Exchange assay was then carried out for 1 , 2, 3, or I|h at 30°C.
Saturation analysis was also performed on the uterine cytosol at 1; C
before artificial saturation to yield the concentration of vacant
receptor sites before artificial saturation. Non-specific binding was
subtracted in all cases.
Below: the time course of binding of 3H-oestradiol-17/3 in human
mammary cytosol, diluted serum and muscle cytosol when exchange assay
was carried out by incubation at 30°C for 1, 2, 3 and 6h. Non¬
specific binding was subtracted in all cases.
3
H_oestradiol-17^ are necessary to stabilize the receptor, or to the
3
greater dilution of H-oestradiol-17/3 by endogenous hormone. The use
of 30 nmol/1 H - oestradiol-1 7^3 in assays involving protamine-precipitated
receptors would, however, increase the non-specific binding to unacceptably
high levels and thereby diminish sensitivity.
During the oestrous cycle, vacant binding site concentrations
varied considerably, being minimal in pro-oestrus and maximal in
oestrus in agreement with previous observations (Feherty/ .Robertson,
Waynforth and Kellie, 1970; Lee and Jacobson, 19715 Shain and Barnea,
1971) and in inverse relationship to the plasma oestradiol-17y3 concentration.
Similar fluctuations also occur in rat mammary tumours (Hawkins, Hill,
Freedman, Killen, Buchan, Miller and Forrest, 1977). However, in the
study of Hawkins _et al., (1977) using an assay not involving protamine
sulphate, maximal receptor concentrations were detected in metoestrus.
In the studies described in this chapter the concentrations
of occupied binding sites varied to a lesser extent than did the
concentrations of vacant binding sites but the total binding site
concentrations were also significantly increased at oestrus. This may
reflect increased receptor synthesis induced by the oestrogen secreted
in pro-oestrus since several studies have shown that injection of
exogenous oestradiol-17^ initially depletes, but subsequently increases,
the cytoplasmic receptor concentration (Sarff and Gorski, 1971J
Nicholson et al., 1976; Pavlik and Coulson, 1976). The changes in
concentration of occupied sites were not statistically significant,
possibly because, once formed, receptor-bound oestradiol-17^1 is rapidly
translocated out of the cytoplasm into the nucleus to maintain an
equilibrium between the two subcellular compartments (Williams and
Gorski, 1971).
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A low but detectable concentration of vacant oestrogen binding
sites was found in the inguinal mammary glands of 21 day lactating rats,
a result in accord with earlier observations (Shyamala and Nandi, 19725
Witliff et al., 1972). However, an apparently eight-fold greater con¬
centration of occupied sites was demonstrated by exchange assay, an
unexpected result in view of the fact that oestrogen concentrations in
post-partum lactating rats are very low (R«a« Hawlcins and e. Killen,
personal communication). One possible explanation for this finding is
that a steroid-binding component might be present in rat milk.
3
Using the exchange assay, low levels of H - oestradiol-17^3
were bound by rat skeletal muscle cytosol (8-12 fmol/mg soluble protein)
and rat serum (33 - 3 fmol/mg soluble protein) but no vacant binding
sites were detected by saturation analysis. Although oestrogen receptors
are very widely distributed in animal tissues (e.g. Brinkmann, Mulder,
Earners—Stahlhofen, Mechielsen and van der Molen, 1972) and this binding
in muscle might represent occupied sites, it would be preferable to
regard the level observed in muscle as the limit of sensitivity of the
exchange method. The binding seen with serum, presumably caused by
precipitated serum proteins, will also need to be taken into account in
tissues where serum contamination is significant.
During the oestrous cycle, the apparent for the binding of the
vacant receptors changed significantly, being lower in pro-oestrus than
in metoestrus or dioestrus. A similar result was found by Wise, Payne,
Karsch and Jaffe (1975) who showed a reduction in in the pituitary
gland after the administration of oestrogen to sheep. Hawkins et al.
(1977) however found the contrary effect in rat mammary tumours, where
the apparent was probably less accurately determined when receptor
concentrations were low. The reasons far these changes in apparent
and their significance are unclear.
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Among the human tissues studied., a low but detectable level of
occupied oestrogen binding sites was found in normal human breast tissue.
The mean level is approximately eight times lower than the total oestrogen
binding site concentration seen in the human uterus, a finding which
suggests that there may be few oestrogen-sensitive cells present in the
normal breast. Alternatively, if it is assumed that oestrogen receptors
are found in stroma, ductal and glandular tissue, then the number of
oestrogen receptor sites in each cell must be minute. It was not possible
to distinguish between the two alternatives because of the difficulty in
obtaining biopsy samples that consisted of only one type of tissue.
However, oestrogen receptors have been detected in approximately 11 -$0%
of benign breast dysplasias and fibroadenomas (Leclercq et al., 19753
Rosen, Menendez-Botet, Nisselbaum, Urban, Mike, Fracchia and Schwartz,
1975) where the epithelial component of the tissue has a higher cellular
density than that found in normal breast tissue. This suggests that the
low concentrations of oestrogen binding sites seen in normal breast
tissue might be due to the scarcity of epithelial cells. It is likely
that the normal breast also contains a low level of vacant binding sites
but these may be below the limit of detection of the assay method, due
to vacant receptor lability.
The loss of receptor sites that was found on exchange assay is
probably due to the increased thermolability of free receptor in comparison
with bound receptor (Katzenellenbogen et al., 1973). Thus incubation
of cytosol at temperatures which permit exchange to occur is likely to
result in destruction of a proportion of both vacant receptors and
receptors which become vacant transiently by the dissociation of endogenous
oestradiol from occupied receptors. A loss of 35^ of oestrogen binding
sites was observed in an exchange assay performed on a rat uterine
cytosol that was artificially saturated by previous incubation with non¬
radioactive oestradiol-17/3 , and a correction factor of 100/65 was
therefore used to compensate for this loss. This loss of oestrogen
binding sites was also observed in 1l| out of 18 rat uterine cytosols
examined where, in the absence of the application of such a correction
factor, the value for vacant binding sites (determined by saturation
analysis) was greater than the value for total binding sites (determined
by exchange assay). In particular, for all the cytosols from animals in
oestrus, (where the largest number of vacant receptors was detected),
greater binding values were obtained by saturation analysis than
exchange assay„ It should be noted that it was not possible to estimate
occupied receptor sites before artificial saturation, as exchange assay
would have resulted in the receptor losses that this experiment was
attempting to estimate, and that no independant method for checking
occupied site concentration appears to be present in the literature
concerning exchange assays.
The receptor losses observed are similar to those of Nicholson
et al. (1976) who reported a 25$ loss of oestrogen binding sites, and
to those of Richards (1975) who also reported loss of cytoplasmic oestrogen
receptor at temperatures greater than li°C; in both cases an exchange
assay that did not utilise protamine sulphate was used. However, the
originators of the method used, Chamness et al.. (1975) did not report
any such loss. The reason for this apparent discrepancy is not clear
but it may be related to the difference in the method of detection of
vacant sites before artificial saturation, as Chamness et al. (1975) used
an equilibrium time of only three hours, in contrast to the 18 hours
they originally reported (McGuire and de la Garza, 1973). In a more
recent modification of the method involving protamine sulphate by Lippman
and Huff (1976), an intermediate recovery (86$) of receptor sites was
found after artificial saturation of a human breast tumour cytosol.
In an experiment using a human uterine cytosol that had been
artificially saturated, no such loss of binding sites in the exchange
assay was observed. This may have been due to the presence of greater
numbers of occupied receptors before artificial saturation or it may be
a characteristic of the different types of tissue studied. Separate
correction factors were therefore required for rat and human tissues and
exchange assay results should perhaps be regarded as indicating qualit¬
ative rather than quantitative changes.
It is possible that errors in vacant site quantitation may have
occurred due to the use of only a single high concentration of non¬
radioactive oestradiol-1 7^ (500 nmol/l) to determine non-specific binding,
as it has been suggested that errors occur in Scatchard plots based
upon the use of excessive amounts of non-radioactive oestradiol for the
determination of non-specific binding (Chamness and McGuire, 1976).
However, during the routine assay of a large number of human breast
cancers by a dextran-coated charcoal method, it was found that the use
O
of a 100 fold excess of non-radioactive oestradiol-17^2 (over H -
oestradiol-1 ^3) lead to an overcorrection and consequent loss of
linearity of the Scatchard plot compared with the use of a 2000 fold
excess of non-radioactive oestradiol for the determination of non¬
specific binding (R„A. Hawkins, personal communication). It has also
3been suggested that a variation in specific activity of H-oestradiol-1 lp
might affect the determination of occupied sites (Chamness and McGuire,
1976). However, in experiments on rat uterine cytosol, a change in
specific activity by a factor of 20 does not alter the slope and inter¬
cept of the Scatchard plot (R.A. Hawkins, personal communication).
Furthermore, the values that were found for both rat and human
uterine cytosol were of the same order of magnitude as published values
(Hawkins, Hill and Freedman, 1975; Leclercq et al., 1975; Nicholson
et al., 1976). It was therefore felt that the use of a single concen¬
tration of non-radioactive oestradiol did not affect vacant site
quantitation.
h2
In conclusion, three major difficulties were encountered in
studies on human tissues. Firstly, high mean levels of non-specific
binding (79 - 9h%) were encountered in all the tissues studied. This
'specific'
undoubtedly affects the reproducibility of the method. Secondly, /binding
3of H _ oestradiol-1 7yj was observed under exchange assay conditions in
muscle and serum. The binding level in human muscle, like in rat
muscle, could be regarded as the limit of the sensitivity of the exchange
method. The binding level in serum, like in the rat, will need to be
considered in tissues where serum contamination is significant. Thirdly,
it was difficult to obtain reproducible samples of glandular tissue.
In a previous study by Short and Drife (1977)* wide histological
variations were found within a single breast, with the proportion of
glandular tissue varying from 0.3% to 29% of the area of the section;
variations between individuals were very much greater than those within
an individual.
For these reasons, it was felt that the exchange assay based
upon protamine sulphate precipitation, while demonstrating that occupied
cytoplasmic oestrogen binding sites were present in normal human breast,
was not likely to yield useful information about the changes of the
breast in response to the menstrual cycle, nor in response to a full
term pregnancy. No further experiments were therefore undertaken using
this assay.
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CHAPTER 3
RAHI01ODINATION OF IMMUNOGLOBULINS
bh
CHAPTER 3 RADIOIODINATION OF IMMOHOGLOBUIINS
3.1 INTRODUCTION
Radioimmunoassay (RIA) was chosen for the majority of immuno¬
globulin measurements described in this thesis because of the high
degree of sensitivity and specificity associated with the method, and
the requirement of only small volumes of material for assay. This
chapter describes the iodination of immunoglobulins for RIA.
In any RIA, three reagents are required:
(a) a purified preparation of the substance to be measured,
for labelling with the appropriate radioisotope;
(b) a preparation containing known amounts of the substance to
be measured to act as standard; and
(c) a specific antiserum with antibody activity against the
substance to be measured.
It should be noted that in this and subsequent chapters, the
immunoglobulins measured are acting as antigen, and not as antibody
in RIA.
The aim of any radio labelling, procedure is to produce a
stable, radiolabelled antigen (tracer) that is immunologically identical
to the unlabelled substance to be measured. Among the radioisotopes
available for labelling, )f -emitters are preferable to -emitters due
to the higher specific activity of }f -emitters. Radioiodine is
particularly suitable as it is a jf -emitter that can be readily substituted
125into the tyrosine residues of proteins or polypeptides; I is
usually chosen because of its long half-life (60 days) and higher
isotopic abundance (95$) in canmercially available preparations, in
1 31
preference to I with its shorter half-life (8 days) and lower
isotopic abundance (20$).
U5
The preparation of the substance to be radiolabelled should be
as pure as possible as this can lead to problems of specificity in
RIA. For example, if IIS IgA is to be radiolabelled, it should not be
contaminated with 7S IgA, IgG or IgM. Furthermore, no alteration of
the substance to be radiolabelled should have occurred during purification,
as occasionally happens during the extraction and purification of
pituitary hormones.
Three methods are commonly used for the radiolabelling of
proteins: the method of Hunter and Greenwood (1962) which involves
12E>
oxidising I using Chloramine T, with subsequent incorporation of
12^
I into tyrosyl groups of the protein; the method of Marchalonis
(1969) using the en2yme, lactoperoxidase; and the conjugation method
of Bolton and Hunter (1972) which utilizes N-succinimidyl-3-(^-hydroxy,
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5- I-iodophenyl) propionate. Of the three methods, that of Hunter
and Greenwood (1962) using Chloramine T results in the best yield of
tracer and is technically the singlest, and was therefore chosen.
During the radiolabelling procedure, conditions are optimised to ensure
that the specific activity of the tracer (defined as the number of
125
I atoms incorporated per molecule of protein) is not excessive, as
damage to protein molecules becomes increasingly worse with increasing
specific activity (Hunter, 1973). It is now widely accepted that the
incorporation of one iodine atom per molecule of protein is the most
desirable specific activity, and this was confirmed at each iodination.
A loss of affinity of antiserum for tracer results in a'loss
of RIA sensitivity (Ekins, 1975). The tracer should therefore be
assessed for the degree of immunological identity with the native,
unlabelled protein and this can be achieved in three different ways:
by physico-chemical methods e.g. gel filtration; by the binding of
tracer to excess antibody; and by a direct comparison in RIA of the
h6
immunoreactivity of the labelled and unlabelled material. These methods
1 25
were used to assess the j_ immunoglobulin that was prepared for use
in RIA.
3.2 MATERIALS AND METHODS
The following were used:
Reagents and Buffers
Sodium phosphate buffer (Na^POU; O.O^M, pH 7.5 at room
temperature) containing sodium azide (NaN3;0.01 % w/v)
Na^POij. (0.05M or 0.25M, pH 7.5), containing no NaN^.
Chloramine Tj Sodium metabisulphite (NagSgOf?)} Potassium
iodide (Kl).
Crystallised Bovine Plasma Albumin (CBPj Armour Pharmaceuticals).
12E>
Na I (Amersham) as the carrier-free solution in NaOH,
specific activity 100 mCi/ml.
Sephadex G3>0, Sepharose i|B (Pharmacia).
Sera and Antisera
Specific rabbit antisera (for antigenic specificities and
sources, see Table 3-3).
Donkey anti-rabbit IgG serum (DARSj Wellcome or Scottish
Antibody Production Unit).
Non-Immune Rabbit serum (NIRSj Wellcome).
Horse serum (HSj heat inactivated^ Wellcome).
Immunoglobull ns
The following purified Immunoglobulins were iodinated:
Secretory IgA (IIS IgA), purified by the method of Newcomb,
Normansell and Stanworth (1968) and given by Mr. R.R. Samson.
Serum. IgA (7S IgA), purified by ZnSO^ and (NE^^SO^ precipitation
and Sephadex G200 gel filtration as described by Schuurman
(1977), and given by Dr. H.J. Schuurman.
bl
Serum IgG, purified by polyethylene glycol precipitation and
DEAE ion exchange chromatography, and given by Dr. S. Moore.
All Immunoglobulins were stored in 63 x 11 mm stoppered polystyrene
tubes at -20°C. IIS IgA and IgG were stored in 80 ug amounts at a
concentration of 2mg/ml and 7S IgA. was stored in 50 ug amounts at a
concentration of 2.5 mg/ml.
Radioiodination
The following method was used for all iodinations:
To 300-1+50 uCi of Na 12^I (for IIS IgA)
or
500-600 uCi of Na 12^I (for 7S IgA or IgG)
in 75 x 12 mm polystyrene tubes, the following additions were made
sequentially at room temperature:
1 . 20 ul Na^PO^ (0.25 M, no NaN^)
2. 20 ul Chloramine T (2.5 mg/ml in 0.05 M Na2P0^, no NaN^)
3. 20 ul 11S IgA (containing lj.0 ug IIS IgA)
or
10 ul 7S IgA (containing 25 ug 7S IgA)
or
20 ul IgG (containing 1+0 ug IgG).
The mixture was allowed to react for 10 seconds, then
1+. 900 ul Na2S20.£ (0.133 mg/ml in 0.05 M Na^O^, no NaN^) was added
to stop the reaction, followed by
5. 50 ul HS (to reduce non-specific binding).
The reaction mixture was mixed immediately after the addition of
Na2S20^ and HS, and immediately transferred to a Sephadex G50 column
(11S IgA, 7S IgA, IgG) and then to a Sepharose I4B column (11S IgA,
7S IgA) for additional purification of tracer.
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Gel filtration
The eluting buffer in all gel filtration studies was Na^ PO^
(O.O^M containing 2% HS).
(a) Sephadex G50: 1 g. of Sephadex G50 was equilibrated, overnight
in an excess of Na^PO^ (0.05 M containing NaU^ and 2% HS). The
swollen gel was then decanted into a glass column (250 x 10 mm)
containing a fixed porous plate. The column was then washed with at
least 50 ml of Na^PO^ (containing 2% HS) and then run nearly dry once
the gel was compacted. Immediately prior to use, 20 mg CBP in a volume
of 1 ml buffer was run through the column to coat the Sephadex, and.
thus minimise adsorption of iodinated immunoglobulin to the column.
Exqess CBP was washed out of the column with a further 20-30 ml
NagPOi . Each Sephadex G50 column was only used once for the purification
of iodinated immunoglobulins.
Following Chloramine T radioiodination, the reaction mixture
was applied to the top of the Sephadex column and allowed to percolate
into the gel. The column was then topped up with Na^PO^ and 20
fractions of 1 ml volume were collected in 75 x 12 mm polystyrene
tubesj each fraction was counted on a )f - counter.
(b) Sepharose liB: A degassed preparation of Sepharose I4B was
decanted into a 900 x 22 mm glass column containing a fixed porous
plate (Wright Scientific Ltd.) until the column was completely filled.
The gel was then washed thoroughly with at least 1 1 Na^PO^ buffer
prior to use. Following Sephadex G50 gel filtration, the fraction
containing the highest radioactivity from the iodinated protein peak
was placed on the top of the Sepharose I4B column, and allowed to
percolate dompletely into the gel. The column was then topped up
with NagPO^ and 120 fractions of 3 ml volume were collected at room
h9
temperature in 100 x 13 ram polystyrene tubes; each fraction was
counted on a )§ -counter. The column was then washed successively with
1 1 of Na£P0^ containing 2% HS followed by 1 1 of Na^PO^ with NaN^
and then stored till the next iodination.
Confirmation of Immunological Identity of Tracer with unlabelled
Immunoglobulin
(a) Gel filtration
The elution profile of radioactivity for each preparation of
iodinated immunoglobulin was determined by gel filtration on Sepharose
JL|B.
(b) Binding of tracer to excess antibody
A pool was made from the fractions comprising each peak of
radioactivity seen in the elution profile of iodinated IIS IgA on
Sepharose IjB gel filtration.
A portion of each pool was tested with rabbit antisera each
with different antigenic specificities at a range of final dilutions
1 1
from /3>000 to /2,560,000 using a six hour incubation period at room
temperature. Antibody bound counts were then determined using a
second antibody (DARS) and a carrier (NIRS) as described for routine
immunoglobulin RIA ("Chapter k ). The antigenic specificity of each
rabbit antiserum used is described in Table 3-3J Peak I (Fig. 3 -2)
material was only tested with anti-7S IgA due to the limited amount
of material available.
(c) Direct measurement of labelled and unlabelled immunoglobulins
by RIA
Purified 12%-11S IgA, 12^I-7S IgA and 12%-IgG obtained by
gel filtration using Sephadex G50 (all immunoglobulins) and Sepharose
IjB (^2^I-11S IgA, ^ 2^I-7S IgA) were assayed directly by RIA by setting
50
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up a standard curve containing known amounts of I-immunoglobulin.
A similar set of tubes were prepared containing known amounts of
unlabelled immunoglobulin. A fixed mass of labelled immunoglobulin
was added to all the tubes (as in the routine RIA, Chapter Ij. )
followed by the specific antiserum, and the mixture incubated for six
hours at room temperature. At the end of the incubation period,
antibody bound counts were determined using a second antibody (DARS),
and a carrier (NIRS), as described for routine RIA .
The percentage of the original amount of iodinated immunoglobulin in
each tube which was bound to antiserum was calculated, and plotted as
a percentage bound, against the mass of immunoglobulin. The resultant
curves for labelled and unlabelled immunoglobulin were then assessed
by seeing if the two curves were superimposable (Fig. 3.-ii).
3.3 RESULTS
Calculation of percentage yield and specific activity of
radioiodinated immunoglobulin
To enable a calculation of the specific activity of a radio¬
iodinated immunoglobulin to be made, the following three factors must
be known:
(a) the weight of immunoglobulin used.
(b) the amount of radioactivity used.
(c) the proportion of (b) that is incorporated into (a) as
a result of radioiodination.
A calculation of the specific activity and concentration of a preparation
of iodinated immunoglobulin is required for two reasons. Firstly, the
degree of iodination of the immunoglobulin preparation has a direct
bearing on the quality of the tracer. Secondly, the RIA in this thesis
depends upon the addition of a specific quantity of labelled
Table 3-1 . The calculation of the percentage yield and specific
1 25
activity of 1—11S IgA following Chloramine T
radioiodination
UP ug 11S IgA. iodinated with
Elution from Sephadex G30
Fraction no. Counts/IOs
12*.
1 25
2 26
3 100
1+ 1+521
5 23000*
6 1111+5
7 3281+
8 1972
9 2366
10 2868
11 1+603
12 731+9
13 6035
11+ 2661+
15 1118
16 61+6
17 1+53
18 232
19 160
20 25
Total 8107U
12%-11S
IgA
UU022cts
free 12%
28529cts
fraction kept for use
on Sepharose I4B column
Total radioactivity added =830l|6cts/
10S (equivalent to 377 uCi)
Total counts associated with protein
(US IgA)
= total counts added - eluted
free 1
= 8301+6 - 28529
= 51+517
% yield = X 100 = 65-6$
Specific activity = 0.656 x 377
1+0
= 6.2 uCi/ug
Of 51+51 7 cts associated with 11S Igfl.,
23000 are in fraction 5
.". fraction 5 contains 23000 1 n
51+517 x h°
= 16.87 ug
Total radioactivity added = 8301+6 cts
Radioactivity remaining in reaction
vessel = 8523cts j
Radioactivity eluted from column =
81071+cts
Radioactivity remaining on column
= 8301+6 - (8523 + 81071+)
= 1972.
one I atom per molecule of
11S IgA is represented by a
specific activity of 5.5 uCi/ug.
52
immunoglobulin, rather than the addition of a specific amount of
radioactivity (in the form of labelled immunoglobulin).
Specific activity and concentration of tracer were determined
by the following method (based on Greenwood, Hunter and Glover, 1963),
and is illustrated with an example in Table 3-1 .
12^(a) The total used for radioiodination is assessed just
prior to the addition of the various reactants to the reaction vessel.
(b) The radioactivity associated with protein (immunoglobulin)
is calculated as being that in (a) minus the counts eluted as
•free 12^I» (see Fig. 3.1).
125>
This figure is then used to calculate the % yield of I-
labelled immunoglobulin and hence the notional specific activity
(Table 3-1 ).
12C>
(c) The counts in each fraction containing I-labelled
immunoglobulin (e.g. fractions 3-8, Table 3-1) are then expressed as
a percentage of (b), and it is assumed that this percentage of the
total immunoglobulin used (1;0 ug) is present in the respective fractions
(e.g. see calculation for fraction 3, Table 3-1).
This method assumes that all the radioactivity that is not
12!?
eluted as free I is immunoglobulin associated, and may result in
an overestimation. However, the error is likely to be small, as free
125
I (as iodide) does not readily adsorb to the reaction tube or the
Sephadex column (Greenwood et al., 1963) and is therefore readily
eluted. Binding of iodinated protein is minimised by prior adsorption
of the Sephadex with CBP, and the use of an eluting buffer containing
2% HS.
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Table 3-2. The calculation of the concentration of 1-11S IgA
following purification on a Sepharose IiB column
Purification of 16.87 ug protein from the iodination of 11 S IgA
(see Table 2-1).
Total number of fractions collected = 120.
Total counts in all fractions = 53*528 cts/10 sees*
Total counts in peak II fractions pooled for use in RIA
= 13759 cts/10 sees
% of counts in peak II fractions pooled for use in RIA
= 1375? , 100
53528 x 100
= 25.7$
volume of peak II fractions pooled = 21 ml.
As the amount of protein used initially was 16.87 ug,
Concentration of ^ I-11S IgA = 16.87 x 0.257
21
= 0.216 ug/ml
* The fractions from Sepharose I4B gel filtration were counted with a
different geometry from the fractions from Sephadex G50 gel filtration
(Table 2-1).
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Calculation of the concentration of iodinated Immunoglobulin following
Sepharose IlB purification
12£>
Sepharose IpB was routinely used for the purification of I-
11S IgA and ^ I-7S IgA from Sephadex Gf>0 gel filtration. After the
determination of the radioactivity present in each fraction arising
from Sepharose ipB gel filtration, the following calculation was made
to determine the concentration of iodinated immunoglobulin present in
the fractions containing tracer for use in RIA, and is illustrated
in Table 2-2.
(a) The total radioactivity was determined in all the
Sepharose JfB gel filtration fractions.
(b) The radioactivity present in the seven fractions with the
maximal amounts of radioactivity was calculated.
(c) The value for (b) was then divided by (a) to calculate
the concentration of iodinated immunoglobulin in the pool of seven
fractions collected.
In this calculation, no allowance is made for the quantity of
radioactivity left in the column, or in test tubes, but the losses
are again minimised by the use of the eluting buffer containing 2% HS.
Properties of Iodinated Immunoglobulins
Gel Filtration: Sephadex G5>0
An elution profile of the reaction mixture following Chloramine
T iodination showed two peaks of radioactivity: a first peak, eluting
at the void volume, containing iodinated proteins (Peak I, Fig. 3 .1 )
1
and a second peak (Peak II) containing free I. The data from the
Sephadex G^O elution profile was used to calculate the specific activity
of iodinated immunoglobulin, and the yield of the iodination reaction,
as described above.
FRACTION No.
Fig. 3.1:
Elution profile of iodinated protein mixture following reaction of
Na^5>i with 11 S IgA, when purified on a Sephadex G50 column. Two peaks
of radioactivity were observed: ^ 25i-protein (Peak I) and Na125l
(Peak II). Procedural details are described in the text.
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Sepharose IiB
> 4 The use of Sepharose I4B for gel filtration permits the
separation! of proteins with molecular weights less than 20 x 10^
daltons, and is therefore suitable for studying protein mixtures
likely to contain immunoglobulin aggregates or small peptide fragments
resulting from the iodination method.
(a) 11S IgA: a typical radioactivity elution profile from
Sepharose I4B gel filtration of the fraction from Sephadex G5>0
purification containing the maximal radioactivity in the iodinated
protein peak (e.g. fraction no 5, Table 2-1) is shown in Fig. 3.2.
Three peaks were observed: a small peak, eluting at the void volume
(Peak I), and presumably consisting of aggregated iodinated immuno¬
globulin; a large peak (Peak II), eluting at a volume consistent with
the molecular weight of unlabelled 11S IgA.; and a slightly smaller
peak (Peak III), eluting at a volume consistent with a molecular
weight of approximately 20,000 daltons (on the basis of marker proteins
consisting of thyroglobulin, bovine serum albumin and cytochrome C
analysed on the same column). Peak III varied in size from iodination
to iodination but never exceeded 20$ of the total radioactivity eluting
from the column.
(b) 7S IgA: A typical radioactivity elution profile on
Sepharose I4B gel filtration of the fraction resulting from Sephadex
G50 purification containing maximal radioactivity in the iodinated
protein peak is shown in Fig. 3.3. A peak was observed at an
elution volume consistent with the molecular weight of unlabelled
7S IgA, and some radioactive protein eluted before the major peak.
(c) IgG: The radioactive elution profile corresponding to
that described in (b) above, but for IgG is shown in Fig. 3.3. Only
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FRACTION No.
Fig. 3.2:
1 2<
Elution profile of I-protein (from Sephadex G$0 purification, see Fig.
3.1) when further purified on a Sepharose I4B column. Three peaks of
radioactivity were observed: aggregated ^5>I-IgA at the void volume
(Peak I), 123l-11S IgA (Peak II) and low molecular weight iodinated
protein (MW=-20,000 daltons, Peak III). Procedural details are
described in the text.
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one peak was observed at an elution volume consistent with the
molecular weight of unlabelled IgG and no other radioactive protein
eluted before or after the major peak.
Binding of Iodinated Proteins to Excess Specific Antibody
The appearance of three peaks of radioactivity (Fig. 3.2) in
the radioactive elution pattern for 11S IgA indicated further experi¬
ments using specific antisera, particularly for Peak III (Fig. 3-2).
It was found that Peak I radioactivity was bound poorly by rabbit
anti-7S IgA. indicating that Peak I material was probably aggregated
IgA.. With Peak II, radioactivity was bound with anti-7S IgA, anti-
light chain antisera (/C and X ) ^ anti-secretory component,
indicating that Peak II contained the complete IIS IgA molecule.
However, Peak III radioactivity was not bound by any of the antisera
used, indicating that Peak III probably represented some unknown
peptide fragment without any antigenic determinant known to be present
on the intact IIS IgA or 7S IgA molecule (Table 3-3).
These studies were not carried out with 7S IgA or IgG as only
one major peak of radioactivity was observed in both cases.
Direct measurement of labelled and unlabelled immunoglobulins by RIA
125
1-11S IgA • Complete superimposability was seen for the respective
curves for unlabelled 11S IgA and ^^1-11S IgA (Fig. 3»U) indicating
1
that the Peak II material (representing purified 1-11S IgA) from
Sepharose IjB gel filtration was not detectably damaged by the
iodination procedure.
125I-7S IgA: When a graph corresponding to Figure 3-h was plotted for
125
I-7S IgA and unlabelled rjs IgA, it was found that the graph for
125
I-7S IgA was parallel but slightly to the left of the graph for
unlabelled 7S IgA (not shown). This was due to the fact that the
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FRACTION No.
Fig. 3.3:
Elation profile for 12%-7S IgA (• • ) and 12^I-IgG (o o) (from Sephadex
G5>0 purification) when further purified on a Sepharose IjB column. In
both cases, only one major peak of radioactivity was observed.
Procedural details are given in the text.
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5 20 80 320 1280
IgA or 1251->IqA ng/ml
(ADDITIONAL TO 10nglml TRACER)
Fig. 3.U:
125Assessment of the immunological activity of purified 1-11S IgA.
A standard curve consisting of increasing amounts of unlabelled 11S IgA
(• • ) was compared with a curve of increasing calculated amounts of
12^I-11S IgA (o—-o). After separation of bound from free protein, the
percentage of original added counts bound to antibody was calculated,
and the two curves tested for superimposability.
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protein concentration value for the labelled 7S IgA was obtained by-
direct 'protein measurement (Schuurman, 1977) whereas the concentration
value for the unlabelled 7S IgA. was based upon the W.H.Oo International
Standard (see Chapter!;. ). It was therefore considered unlikely
that damage had occurred during iodination of 7S IgA.
123
I-IgG: When a graph corresponding to Figure 3»U was plotted for
123
7S IgG and I-7S IgG, complete superimposability was found (not
shown) indicating that no immunologically detectable damage had
occurred to 7S IgG during the iodination procedure.
3.k DISCUSSION
The purpose of the experiments described in this chapter was
to assess the use of the Chloramine T method for producing iodinated
immunoglobulins for RIA. The quality of iodinated Immunoglobulins
can be affected in three different ways: firstly, the insertion of a
123
Iodine atom into the immunoglobulin molecule, or the chemical
reagents used in iodination can damage the immunoglobulin molecule by
altering the protein structure. Primary radiation damage can also
12^
occur from |f -emission by the I incorporated into the immuno¬
globulin molecule. Secondly, variations in the stability of the
123
protein to be iodinated can affect the quality of the I -labelled
123
product. Thirdly, the method of purifying I-labelled protein can
affect the quality of the tracer.
The Chloramine T method was found to be convenient and satis¬
factory; once the optimum quantities of radioiodine to be used had
been ascertained, high yields (63-83$) of iodinated immunoglobulins
were produced with specific activities representing the incorporation
of about one atom of ^ ^1 per molecule of immunoglobulin. However, of
62
Table 3-3 Analysis of Peaks I, II and III from Senharose liB
gel filtration of iodinated protein from 11S IgA
iodination
Antiserum Binding %
Peak I Peak II Peak III
Anti-7S IgA 19 97
Anti-secretory component
Anti-K. light chain
Anti- "X light chain
89
96
less than
UO
2#*
Anti-lactoferrin
Anti-whole colostrum
Anti-whole serum
All antisera were obtained from Dakopatts except for anti-7S IgA,
anti-lactoferrin and anti-whole serum, which were obtained from
T.A.E. Platts-Mills, R.R. Samson and the Dutch Red Cross Blood
Transfusion Service respectively.
Non-specific binding averaged 2% in this experiment.
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the three immunoglobulins that were iodinated, problems were encountered
with 11S IgA, which required further purification by gel filtration
using Sepharose ]fB. As can be seen in the elution profile of radio¬
activity from Sepharose I4B gel filtration of iodinated IIS IgA (Fig.
3.2); three types of iodinated proteins were produced, only one of
which was bound completely by specific antisera directed against
antigenic determinant present in the complete unlabelled IIS IgA
molecule. This material (Peak II, Fig. 3.2) was used as tracer for
11S IgA RIA. The iodinated protein eluting at the void volume
probably represented aggregated IIS IgA, as iodination of prolactin
also results in the formation of high molecular weight' aggregates
(Sharpe, 1979). It was not possible to identify the low molecular
weight material (Peak III, Fig. 3 .2 ) and it is probable that this
peak consists of a portion of the IIS IgA molecule cleaved during
iodination, losing all antigenic determinants in the process. It
was therefore decided that for IIS IgA RIA, purification of the
iodinated protein material required both Sephadex G50 and Sepharose
I4B gel filtration. The quality of the tracer purified by this method
is shown by the complete superimposability of the standard curve for
labelled and unlabelled 11S IgA (Fig. 3.U ) •
A similar purification using Sepharose I4B for the labelled
protein resulting from iodination of 7S IgA was undertaken as some
slight impurities were present (Fig. 3«3). By contrast, as the labelled
protein resulting from iodination of IgG was considered to be pure
(Fig. 3-3) and immunologically undamaged, purification with Sepharose
IjB was not -undertaken.
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CHAPTER U RADIOIMMUNOASSAY AND STATISTICAL METHODS
U.1 INTRODUCTION
In Radioimmunoassay (RIA), a fixed concentration of labelled
antigen (tracer) is incubated with a constant dilution of specific
antiserum such that the concentration of antigen binding sites on the
antibody is limiting. If unlabelled antigen is added, competition
occurs between tracer and unlabelled antigen for the limited
and constant number of antibody binding sites, and the amount of
tracer bound to antibody will decrease as the concentration of unlabelled
antigen increases. This can be measured by the appropriate separation
procedure (e.g. the double antibody method used in this thesis). A
standard curve is therefore set up with increasing concentrations of
standard unlabelled antigen, and from this curve the amount of antigen
in unknown samples can be calculated. In a number of studies
described in this thesis, concentrations of IIS IgA, 7S IgA and IgG
(acting as antigen not antibody) have been determined using specific
RIA. The following is an account of the reagents and methodology-
used.
U-2 MATERIALS AND METHODS
I4..2.I Materials
All antisera, standards, second antibody precipitating sera,
quality control samples and non-immune rabbit carrier sera were stored
in separate aliquots in stoppered 63 x 11 mm polystyrene tubes at
-20°C till use, to avoid freezing and thawing each solution more than
once.
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(a) Standards
All standards were kept at three concentrations varying
eight-fold in concentration.
11S IgA: As no International Reference Preparation for this protein
exists, the purified IIS IgA preparation described previously (Chapter
3) was used as a standard. The protein value for this standard was
obtained by a determination of dry weight by Mr. R.R. Samson.
7S IgA and IgG A commercial standard (Hyland) that had previously
been standardised against the W.H.O. Standard (Rowe, Anderson and
Grab, 1970) was used.
(b) Antisera
Anti-human 7S IgA and anti-human IgG specific for heavy
chain antigenic determinants (Platts-Mills and Ishizaka, 1975) were
used for IIS IgA, 7S IgA and IgG RIA. These antisera were kindly
given by Dr. T.A»E. Platts-Mills.
An antiserum specific for the conformational determinant of
IIS IgA ('C', shown diagramatically in Fig U-10) and for the
accessible determinant present on free secretory component ('A') was
prepared by two further adsorptions of rabbit anti-1lS IgA/FSC
(IGMSP, Dakopatts) with 7S IgA coupled to Sepharose ipB.
(c) Sera for precipitation of first antibody
Donkey anti-rabbit serum (Wellcome $ Scottish Antibody Production
Unit) and non-immune rabbit serum (Wellcome) acting as carrier, were
used for precipitation in all RIA. For the IgG RIA only, donkey anti-
rabbit serum that had previously been adsorbed with human IgG coupled
to Sepharose was used. The adsorbtion procedure was used to remove
all donkey antibodies that reacted with antigenic determinants that
were common to human IgG and rabbit IgG, thus allowing separation of
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human IgG (antigen) bound to rabbit IgG (antibody), from free human
IgG.
Each batch of donkey anti-rabbit -serum was optimised prior to
use with normal rabbit carrier serum, to ensure maximal precipitation
of (rabbit) antibody bound immunoglobulin as well as economical use
of precipitating sera.
(d) Assay buffer
The assay buffer used in all instances was 0.05 M Na^Po^
buffer at pH 7-5, containing 2% horse serum. In assays with longer
incubation periods, or where sucrose was present (from ultracentri-
4
fugation studies),0.01 % (w/v) NaN^ was included in the buffer.
14..2.2. Methods
(a) Preparation of immunoadsorbents
Sepharose JfB (37.5 gm; Pharmacia), washed thoroughly with
distilled water, was activated using the method of Axen, Porath and
Ernbeck (1967) by addition of cyanogen bromide (Ugj CNBr$ Aldridge)
at pH 10.5 in a well ventilated fume cupboard. The activated CNBr
was then washed with 0.1 M NaHCO^ (2 1) and 0.1 M sodium citrate
solution pH 6.0 (2 l)Jthen mixed with human IgG (750 mgj Protein
Fractionation Centre, Edinburgh), or undiluted serum (2 ml, from three
patients with IgA myelomas, courtesy of Dr. D.B.L. McClelland), and
the mixture diluted in citrate buffer to 50 ml total volume. Coupling
of protein to activated CNBr occurred over 18 h at i|°C. The coupled
protein was then washed thoroughly (2 1 each of 0.1 M NaHCO^, 0.05 M
N^PO^ pH 7.5j and 0.05 M Na^PO^ pH 7-5 containing 2$ horse serum),
prior to use as an immunoadsorbent. The Sepharose-IgG preparation
was sufficient to adsorb 80-100 ml DARS; the Sepharose-serum IgA
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preparation was sufficient to adsorb 2 ml of rabbit anti-11S IgA/
FSC.
(b) RIA procedure
The standard double antibody technique was used in all RIA.
Known volumes of mammary secretions, sera, culture fluids or fractions
from gel filtration and ultracentrifugation, or the appropriate
immunoglobulin standard (using a X2 concentration interval) were
diluted to a total volume of 0.2 ml in assay buffer. The specific
antiserum (first antibody) was added in a volume of 0.1 ml, and the
mixture incubated for three hours in 63 x 11 mm polystyrene tubes at
room temperature. Labelled immunoglobulin was then added in a
volume of 0.1 ml, and incubation allowed to proceed for a further
three hours, following which donkey anti-rabbit serum (0.0f> ml) and
normal rabbit serum (0.0£ ml) were added at the appropriate dilutions.
Precipitation of (rabbit) antibody bound immunoglobulin occurred
over 12 - 16 h at 1|°C, following which bound tracer was separated from
free tracer by centrifugation (1,^00 x g for 30 min., 1|°C) after
addition of 1 .5 ml assay buffer to all assay tubes (except total
count tubes). The radioactivity in the precipitate was then counted
in a ft - spectrometer (LKBj Nuclear Enterprises).
' 12^
In the IgG-RIA only, antiserum and I-IgG tracer were added
in a volume of 0.05 ml instead of 0.1 ml to reduce the amount of
antiserum used. Assays which required a higher degree of sensitivity
than could be attained by the usual procedure were performed using a
16 and 8 hour incubation period before and after addition of tracer
respectively instead of two incubation periods of 3 hours duration.
Incorporated into the above procedure were tubes which
contained either:
69
10,000 7SIgAR.IA 17-10-78
E
Q.
U
V—*
Q
Z
3
o
CO
< 5,000
o
Nl
\
T 1 | 1 I 1 I I I I ■ ■ 1 1 1 I
80 240 400 560
7S IgA CONC. ng/ml
100i 7SIgA R.LA. 17-10-78
o
m
? 80
Q
Z
3
o
m
i/)
60-
§ 40
O
U
<
2 20
»o
20 80 320
7SIgA CONC.ng/ml
Fig. U.I s
Analysis of RXA Standard Curve Data.
Above: Raw counts vs. IgA concentration
Below: % B/Bo vs log IgA concentration.
70
1 25
(a) assay buffer + I-labelled immunoglobulin
125
(b) assay buffer + I-labelled immunoglobulin + first
antibody (specific antiserum)
1
(c) I-labelled immunoglobulin only.
These tubes were used to assess
125
(a) Non-specific binding (NSB) i.e. the binding of I-
labelled immunoglobulin in the absence of first antibody (specific
antiserum).
(b) the zero binding or Bo i.e. the maximal binding of
125
-I labelled immunoglobulin to the particular concentration of
first antibody used in the assay
(c) the amount of radioactivity (i.e. labelled immunoglobulin)
added per tube = total counts.
All experimental sauqples, standards and tubes for the
assessment of total counts, NSB and B^were run in duplicate.
An automatic diluting and dispensing system (Compupet, General
Diagnostics) or precision dispensing pipettes (Eppendorf; Finnpipette)
were used for the addition of test fluids, standards and diluent
buffers. Additions of first antibody, labelled immunoglobulin,
second antibody and rabbit carrier serum were made with the Compupet,
or a 2.5 or 5 ml graduated glass syringe with an attached repeating
dispenser (PB 600-1, Hamilton). The 1.5 ml volume assay buffer used
to dilute incubates prior to centrifugation was added with an adjustable
dispenser (Lumomix ).
(c) Assay Analysis
The analysis of RIA data was performed automatically using a
programme written by Dr. R.M. Sharpe for a Hewlett-Packard desk-top
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Analysis of RIA Standard Curve Data
Logit B/Bo vs log IgA concentration.
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calculator (model 9821A). This programme subtracted the mean cpm
radioactivity in the NSB tubes from the cpm in all other tubes
(excluding total counts) and the remaining radioactivity was considered
as specifically bound to the first antibody. For each point on the
standard curve, the cpm bound in duplicate tubes was expressed as a
$ of that bound in the Bo tubes (i.e. B/Bo), and a standard curve
constructed (e.g. Fig. J+.l). In order to allow a straight line
equation to be fitted to the results, the percentages were transformed
to logits. Using the method of least squares, the straight (regression)
line of best fit was then calculated using data for standards that
were within the range 10-90$ B/Bo; this restriction was imposed due
to the variability of the results approaching the asymptotes.
The programme then ascertained that the straight, line fitted
to the data was in fact the 'best' line: the mean cpm for each
point on the standard curve was re-entered, and, using the 'best-fit'
lines the amount of immunoglobulin present calculated. This value was
then compared with the amount of immunoglobulin added. If the known
and calculated amount of immunoglobulin differed by 30$ or more, then
that particular point on the standard curve was omitted, the 'best-
fit' straight line recalculated, and the above procedure repeated.
Subsequently, the same procedure was used to locate (and discard)
points with errors of 20$, then of 10$. Once the final 'best fit' line
was achieved, the transformed data for all samples was substituted
into the equation for this line, and the immunoglobulin present in the
sample calculated and printed out. Values for samples outwith the
10-90$ B/Bo range were not calculated and the samples were subsequently
re-assayed at a different dilution. Visual confirmation that the above
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procedures were accurate was provided in every instance by a simul¬
taneous plot of the standard curve data by an automatic X-Y graph
plotter (Hewlett-Packard) attached to the calculator.
(d) Validation of RIA
Validation of the specificity of each RIA used was required
because of the common antigenic determinants that appear in the
immunoglobulins measured e.g. 11S IgA, 7S IgA and IgG share common
light chain antigens; IIS IgA and 7S IgA share common heavy o£ -chain
antigens.
Validation was performed in the following manner:
(i) The possibility of IgG interfering in IgA RIA, and IgA interfering
in IgQ RIA was determined.
(ii) The use of ^^1-11S IgA instead of ^%-7S IgA tracer in measuring
IgA in serum was examined. IgA concentrations in the sera of each of
12E>55 normal subjects were determined by RIA using either 1-11S IgA
125
or I-7S IgA as tracer, with the same 7S IgA standard and anti-
7S IgA antiserum.
(iii) RIA was compared with two widely used methods for the
measurement of immunoglobulins: single radial immunodiffusion (SRID;
Fahey and McKelvey, 1965) and laser nephelometry. Using the same
7S IgA and IgG standards, serum IgA and IgG concentrations were
determined in 53 and 60 normal sera respectively by either RIA,
commercial immunodiffusion plates (Hyland, or Behring LC-Partigen) or
a Hyland laser nephelometer with sheep anti-7S IgA or sheep anti-IgG
(Seward) as specific antiserum.
Using the same IIS IgA standard, 11S IgA concentrations were
determined in I4.8 colostrum and milk samples by either RIA or single
radial immunodiffusion plates prepared in the Department of Therapeutics
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using goat anti-7S IgA (Hyland). The correlation coefficient was
determined for a comparison of values obtained by RIA with those
obtained by either SRID or nephelometry. A paired Student's t-test
was used to determine if the value for each serum was significantly
different from the value for the same serum obtained by SRID and
nephelometry.
(iv) Gel filtration using a Sepharose IjB column (900 x 22 mm) was
carried out on samples of colostrum, milk and normal adult serum;
120 fractions of 3 ml volume were collected using downward flow of
eluate (RIA buffer) and stored at -20°C till immunoassay for IIS IgA,
7S IgA or IgG without concentration.
(v) The precision and reproducibility (as defined by Whitehead,
1977) of the RIA was determined in the following manner: for the
determination of intra-assay CV, the same sample was analysed at
different concentrations 20 times in RIA; for the determination of
inter-assay CV, the sample was assayed at different concentrations in
10 assays in duplicate (7 assays for IgG RIA and 7S IgA RIA using
12£
I-7S IgA), by placing the sample tubes at the 'end' of the assay.
In both cases, the sample used was derived from aliquots of the
appropriate standard (7S IgA, 11S IgA or IgG) and stored at -20°C
till assay.
U-3 RESULTS
In assessing the use of RIA for the measurement of immunoglobulins,
the parallelism of inhibition of binding by the immunoglobulin standard,
and various samples was first determined. It was found that the
binding of ^^I-11S IgA to rabbit anti-human 7S IgA was displaced in
a parallel manner by the 11S IgA standard, and by various samples of
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colostrum or milk, in which 11S IgA is the predominant form of IgA
present (not shown). Similarly, parallel inhibition curves were
observed when the 7S IgA standard was compared with various sera
(where 7S IgA is the predominant form of IgA present) in an RIA using
12^
I-7S IgA tracer and rabbit anti-human 7S IgA (Fig. I4..2). Parallel
12£inhibition curves were also observed when the binding of I-7S IgG
to rabbit anti-human IgG, in the presence of the 7S IgG standard or
of various serum samples, was studied (not shown).
Interference in RIA by other immunoglobulins
(i) In an 11S IgA RIA, £0,000 ng purified IgG produced the
same inhibition of binding of ^^1-11S IgA as 32.9 ng of purified
11S IgA. Similarly", in an Ig G RIA, 2£60 ng of purified 11S IgA
12^
produced the same inhibition of binding of I-IgG as 1U ng of
purified Ig G.
(ii) Comparison of ^^1-1 IS IgA and "*^I-7S IgA tracer for
measuring 7S IgA
12£
A validation of the use of 1-11S IgA tracer for measuring
7S IgA, in combination with a 7S IgA standard and an anti-7S IgA
antiserum, was undertaken as it was considered that it would be : _
1 2£
more convenient if -\E-11S IgA could be used as tracer for both
7S IgA and 11S IgA RIA. As a first step in the validation process, it
was confirmed that the binding of ^^I-11S IgA by rabbit anti-7S IgA
was inhibited in a parallel manner by the 7S IgA standard and .five
normal sera (Fig. lj..3).
The 7S IgA concentration in £3 normal sera was then determined
by RIA using either a I-7SIgA tracer or a 1-11S IgA tracer with
a 7S IgA standard and rabbit anti-7S IgA. A highly significant
correlation of serum 7S IgA concentrations determined using the two
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Fig. ii.Us
12^ 12^
A comparison of the use of 1-11S IgA with I-7S IgA as tracer
in the measurement of serum IgA by RIA (n=55) •
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different IgA tracers was found, (r = 0.876, p^O.OOIj Fig. Ij-.lj.),
suggesting that the use of ^-^1-11 S IgA. tracer might be valid. However,
it was found that the mean 7S IgA. value for the sera determined
125
using 1-11S IgA tracer was higher than the mean value found
12£
using I-7S IgA tracer, a difference that was statistically
significant (paired t-test: t = 6.0l|., p<L0.00l).
It should be noted that the IIS IgA standard and the 7S IgA
standard are not interchangeable as they do not inhibit the binding
12£of 1-11S IgA in a parallel manner. This non-parallelism is more
clearly seen when the B/Bo values undergo a logit transformation
(Fig. 1;.]?).
(iii) Comparison of RIA. SRID and nephelometry for the measurement
of immunoglobulins
(a) 11S IgA 11S IgA RIA (using 1^I-11S IgA tracer and rabbit
anti-7S IgA) was compared with single radial immunodiffusion for
measuring 11S IgA in J4.8 samples of human milk. "The same 11S IgA
standard was used for both methods and a highly significant correlation
was found between the two methods (Table I4.-I). The 11S IgA value
obtained for each sample by RIA was not significantly different from
the 11S IgA value obtained for the same sample by SRID (paired t-test,
t = 1 .95, p< 0.05). A correlation of nephelometry with RIA was not
performed for the measurement of IIS IgA.
(b) 7S IgA
125
Initial experiments using 1-11S IgA tracer together with a
7S IgA standard indicated that it might be possible to measure 7S IgA
in serum with this 'heterologous' tracer. Sera from each of $3 normal
125
subjects was therefore measured by either RIA (using 1-1 IS IgA
tracer and rabbit anti-7S IgA), SRID or laser nephelometry. The same
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AComparisonfRIA.SRIDandnenhelometrvfthmeasuremenf 11SIeA.7SIandgG
ImmunoglobulinTracerStandardmpl .RIAvsRIDnephelometry- USIgA12^I-11SI1colostrumij.80.?U< .001n tdone milk 7SIgA12^ -7SInormal530.8?<0.001U<0 sera
co
ro
IgG12%-IgI normal600.80<0. 015. sera r=correlationc efficient
7S IgA standard was used in all three methods and a highly significant
correlation was found when the RIA was compared with nephelometry
or SRID (Fig. U-6, Fig. b-l> Table ii-1 ). No significant difference
(paired t-test) was found when values for each individual serum
measured by the three different methods was compared.
(c) IgG
A comparison similar to that described above for 7S IgA was
carried out, and again a highly significant correlation was found
between all three methods (Table 1|-1). However, the values obtained
by RIA for each individual serum sample were significantly higher
than the respective values obtained by SRID or nephelometry (Paired
t-testj for RIA vs SRID, t = £.36, p<0.001 j for RIA vs nephelometry,
t = 6.17, p<0.001 ).
(iv) Gel filtration studies
In the gel filtration studies described in this section, the
characteristics of the particular Sepharose I4B column used were defined
by the use of three marker proteins of known molecular weight:
thyreoglobulin, bovine serum albumin and cytochrome C. In all cases,
the elution volume (Ve) and void volume (Vo) were determined (using
a Blue Dextran marker) and a linear plot made of Ve/Vo against log
molecular weight. This calibration graph was used to determine the
approximate molecular weight of the peaks of immunoreactivity described
below.
(a) Colostrum and milk
When fractions from Sepharose I4B gel filtration of colostrum
and milk were subjected to 11S IgA RIA, only single peaks of immuno¬
reactivity were seen. The two peaks overlapped, and the elution volume
was consistent with a protein of molecular weight I4.OO,000, thus
confirming that 11S IgA was being measured by RIA (Fig. U«8).
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Fig. i±.6:
A comparison of RIA (using 1-11S IgA tracer) with nephelometry
for the measurement of serum IgA (n=£3).
8U
SERUM IgA CONC. by S.R.I.D. (g/l)
Fig. U-7s
125
A comparison of RIA (using 1-11S IgA tracer) with single radial
immunodiffusion (S.R.I.D.) for the measurement of serum IgA
(n=53).
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(b) Normal serum
When fractions from Sepharose IfB gel filtration of normal
125
adult serum were subjected to 7S IgA RIA (using 1-11S IgA tracer,
7S IgA standard and rabbit anti-7S IgA) ,again only one peak of
immunoreactivity was seen. However, the elution volume of this peak
was consistent with a protein of molecular weight 150,000, confirming
that 7S IgA was being measured by the RIA (Fig. h-9).
In contrast, when the same fractions were assayed by IgG RIA,
another peak of immunoreactivity was seen eluting slightly after the
7S IgA peak described above (not shown). The elution volume of this
peak is consistent with the finding that the molecular weight of
IgG is slightly less than that of 7S IgA and therefore validating
the IgG RIA.
Finally, when the same fractions from Sepharose IpB gel fil¬
tration of adult serum were immunoassayed using rabbit anti-US IgA/
FSC (following extensive adsorbtion with serum IgA) in combination
125
with 1-11S IgA tracer and an IIS IgA standard, no peaks of immuno¬
reactivity were observed (not shown for Sepharose hB but see Fig.
1 6. h), particularly in the 7S IgA position, indicating that the
antiserum no longer possessed any antibody activity against 7S IgA.
Traces of immunoreactive material were seen before the elution volume
of 11S IgA, possibly indicating the presence of high molecular weight
material with 11S IgA antigenic determinants.
(v) Precision and Reproducibility of RIA
(a) For the determination of 11S IgA, the intra-assay CV for samples
with mean 11S IgA concentrations of 18.6, 36.1, 77.8 and 171.8 ng/ml
was 15.6, 6.2, 6.9 and 5.8$ respectively. The inter-assay CV for
samples with mean IIS IgA concentrations of 12.5, 21 .hj 1|2.3, 83.3 and
175.2 ng/ml was 13.h, 7.6, 9-7, 6.9 and 5«3$ respectively.
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(b) For the determination of 7S IgA using 1-11S IgA as tracer,
the intra-assay CV for samples with mean 7S IgA concentrations of
10.0, 20.5, 1*2.6, 86.5 and 151-7 ng/ml was 10.9, 11.5* 8.2, 6.3 and
5-5$ respectively. The inter-assay CV for samples with mean 7S IgA
concentrations of 5«3, 10.2, 20.2, 1*2.2, 87-5 and 156.7 ng/ml was
21.6, 12+ .6, 11.2, 11.6, 12.It and 10.1$ respectively.
125(c) For the determination of 7S IgA using I-7S IgA as tracer,
the intra-assay CV for samples with mean 7S IgA concentrations of
5.9, 11.1, 19.3, 1*0.1 and 90.9 ng/ml was 19.2, 8.2, 7-8, 6.8 and 9-0$
respectively. The inter-assay CV for samples with mean 7S IgA
concentrations of l*.9, 10.0, 19>3, 1*1 .6 and 88.5 ng/ml was 19-5, 1 b-9>
9.1, 9.1 and 18.5$ respectively.
(d) For the determination of IgG by RIA, the intra-assay CV for samples
with mean IgG concentrations of 11 .6, 21 .5, 1*2.7 and 82.9 ng/ml was
7.0, 7.1*, 5-7 and 6.1$ respectively. The inter-assay CV for samples
with mean IgG concentrations of 9»5j 18.6, 38.8, 79.0 and 161 .9 ng/ml
was 18.8, 13.0, 9.1*, 10.1 and 8.9$ respectively.
l*.l* DISCUSSION
In this chapter, radioimmunoassays for IIS IgA, 7S IgA and
IgG are described together with an antiserum anti-11S IgA/FSC for
detecting the conformational determinant of IIS IgA and the accessible
determinant of free secretory component. When considering the
measurement of the different forms of IgA, a description of the anti¬
genic determinants and the in vivo synthesis of 11S IgA is necessary.
In serum, IgA is present in the monomeric, 7S form possessing
light and heavy ot -chain antigenic determinants. This IgA originates
in spleen, lymph nodes and bone marrow in addition to gut (Hijmans,
Schuit and Hulsing-Hesselink, 1971 J Radl, Schuit, Mestecliy and
89
SECRETORY
IgA
(10S IgA+SC)
EPITHELIAL CELLS
BASEMENT MEMBRANE
7SIgA
—\
H + L )
Free Secretory
Component
11SIgA 10SIgA
Fig. Ij.. 10s
The synthesis and transport of IIS IgA.
Above: IgA monomer (IgA mon) is converted into the IgA dimer (IgA dim)
with the addition of J chain in the sub-epithelial IgA plasma cells;
10S IgA is secreted and converted into 11S IgA by the addition of
secretory component (SC) in the epithelial cell, and then secreted
into the lumen (from Hauptman and Tomasi, 1978).
Below: Antigenic determinants present on the different forms of IgA
and on free secretory component (H, L: heavy and light chain deter¬
minants; A, I and C: accessible, inaccessible and conformational
determinants respectively).
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Hijmans, 197U). In contrast, in external secretions,IgA is present
as 11S IgA -which is synthesised by epithelial cells from 10S IgA
and secretory component (Lamm, 1976). 10S IgA is synthesized by
sub-epithelial plasma cells and this synthetic pathway, and the
difference in antigenic structure between the different forms of IgA
is shown in Fig. 1+.10. Secretory component can exist in the free
form, with two antigenic determinants: an accessible determinant ('A')
and an inaccessible ('I') one. However, when secretory component
combines with 10S IgA to form IIS IgA, one of the determinants (i)
becomes inaccessible (Brandtzaeg, 1971). In addition, this combination
with 10S IgA results in the appearance of a new antigenic determinant,
the configurational or conformational determinant ('C') a characteristic
of bound secretory component (Brandtzaeg, Fjellanger and Gjeruldsen,
1970).
Thus, when all the different antigenic determinants are
considered (Fig. I4..IO), it is clear that considerable cross-reaction
exists between 7S, 10S and 11S IgA. The following procedure was
therefore adopted in many of the studies described in this thesis for
the measurement of IgA. The experimental sample was first analysed
by constructing binding inhibition curves to assess if the B/Bo curve
for the experimental sample was parallel to the appropriate immuno¬
globulin standard. Then an aliquot of the sample was analysed by
Sepharose I4B gel filtration (or latterly by sucrose density gradient
ultracentrifugation). The elution pattern from gel filtration (or
density profile from ultracentrifugation) indicated if predominant
IgA immunoreactivity was in the 1+00,000 dalton (10—1 IS) or in the
1^0,000 dalton (7S) position. If the IgA immunoreactivity was in the
1+00,000 dalton position, then gel filtration fractions, and other
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experimental samples of the same type were analysed by RIA using
1 25
1-11S IgA tracer, an 11S IgA standard, and anti-7S IgA antiserum.
If the predominant immunoreactivity was in the 1^0,000 dalton position,
1 25then RIA using "\E-11S IgA tracer but a 7S IgA standard, and anti-
7S IgA antiserum were used instead.
In addition, in some analyses of gel filtration fractions or
ultracentrifugation fractions, the peak of immunoreactivity in the
lj.00,000 dalton position was assayed using the antiserum (anti-11S
IgA/FSC) that had been adsorbed with serum IgA. With reference to
Fig. l+.IO, it can be seen that antibody activity was originally
present against heavy -chain, light chain, A and C antigenic
determinants. Adsorption with 7S IgA (present in large quantities in
the myeloma serum) removed antibody activity against heavy 06 -chain
and light chain determinants. Thus, this antiserum, anti-1lS IgA/FSC,
no longer reacted with 10S IgA and was used to ensure that the peaks
of immunoreactivity detected in the ij.00,000 dalton (or 10—1 IS)
position were solely due to the complete, native IIS IgA molecule, and
not a 10S IgA molecule. It should be noted that in RIA using anti-
US IgA/FSC (with an 11S IgA standard and ^^1-11S IgA tracer), the
presence of free secretory component would also be detected, since
125this molecule would also compete with 1-11S IgA tracer for binding
by anti-US IgA/FSC. Unfortunately, because of the lack of a purified
standard for free secretory component, no quantitation of this protein
(seen for instance in Fig. 6J4. ) was possible. If an immunoadsorbent
consisting of only free secretory component had been available, an
antiserum specific for 11S IgA, reacting only with the conformational
determinant could have been prepared and would have been of great
value in the study of external secretions.
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The inhibition of binding of ^ ^1-11S IgA by the 11S IgA
standard was not parallel with the inhibition of binding by the 7S IgA
standard, reflecting differences in affinity between the IIS and 7S
IgA molecule for the anti-7S IgA antibody, and emphasising the need
for the correct IgA standard when analysing experimental samples.
The inhibition of the binding of ^^1-11S IgA caused by
purified IgG in an 11S IgA RIA was very small but the inhibition of
123
binding of I-IgG caused by purified 11S IgA in an IgG RIA was
higher. 183 ng of 11S IgA was equivalent to 1ng IgG but it was not
clear whether this was due to incomplete adsorbtion of the rabbit
anti-IgG or contamination of the purified IIS IgA preparation with
IgG. It was not possible to investigate this problem further due to
the difficulty of obtaining preparations of IgA free of IgG impurities.
The reproducibility of the assay was satisfactory except for
samples with values at the 'lower' end (i.e. B/Bo greater than 63$)
of the standard curve. This was avoided in analysis of experimental
samples where possible by assaying the sample at a dilution which
would result in a B/Bo value of 2j.O-30$. .The limit of detection was
not routinely determined since it was found to correspond to the immuno¬
globulin concentration resulting.in 10$ binding inhibition in prelimin¬
ary experiments. 12^
The comparison of RIA using 1-11S IgA tracer, a 7S IgA
123
standard and anti-7S IgA antiserum with RIA using I-7S IgA tracer
and the same standard and antiserum demonstrated that a good
correlation between the two methods existed when 7S IgA in serum was
being measured^thus validating the procedure. Although the use of
123
1-11S IgA tracer resulted in a slightly higher value than when
123
I-7S IgA tracer was used, the value obtained with the former tracer
was not significantly different and correlated well with the value
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obtained by SRID or nephelometry confirming the validity of the
method.
Similarly, a good correlation existed between IIS IgA RIA
and SRID with no significant difference between the values obtained
milk samples
for individual / by the two different methods. A good correlation
was also obtained between RIA, SRID and nephelometry for the measure¬
ment of IgG in serum. However, a significant difference existed for
the IgG values for individual sera when RIA was compared with SRID
and nephelometry. The reason for this was not clear but may have
been due to some factor related to IgG heterogeneity (e.g. subclass
composition) affecting RIA differently from SRID and nephelometry.
9k
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CHAPTER 5 IgA SYNTHESIS IN VITRO BY NORMAL HUMAN BREAST TISSUE
5.1 INTRODUCTION
The high concentrations of 11S IgA present in colostrum and
milk (Hanson, 1961 j McClelland et al.. 1978) are the result of local
synthesis by sub-epithelial plasma cells in the mammary gland (Lamm,
1976). These plasma cells, many of which stain for IgA, are most
numerous in the lactating breast (Pumphrey, 1977) and originate from
gut-associated lymphoid tissues, consisting mainly of Peyer's patches
(for references, see Chapter 1). Some plasma cells staining for IgA
are also present in the non-lactating breast (Drife et al., 1976) and
are presumably responsible for the high IgA concentrations detected
in breast secretions from non-lactating women (see Section 6.i|).
The studies described in this chapter were stimulated by the
A |
demonstration by Drife et al. (1976) that C-amino acid precursors
could be incorporated in vitro into IgA by normal breast tissue obtained
1 )
from non-lactating women. A qualitative difference in C-amino-acid
incorporation was found between the two phases of the menstrual cycle
in parous but not nul 1 iparous women. This finding was interpreted
as suggesting that a change in breast sensitivity to progesterone had
occurred following the first pregnancy, affecting IgA synthesis. A
further investigation of this finding was therefore made by attempting
to quantify the observations of Drife et al. (1976), using the IgA
RIA. The ability of the RIA to detect IgA secreted by lymphocytes or
plasma cells was first tested on peripheral blood lymphocytes. Mammary
tissue fragments cultured in roller tubes (Van Furth, Schuit and
Hijmans, 1966), or on metal grids (Baker and Neal, 1973) were then studied.
96
5.2 MATERIALS AND METHODS
Subjects
Peripheral venous blood was obtained from three healthy male
volunteers aged 2I4.-3I4. years; peripheral blood lymphocytes were purified
from the blood using Triosil (Nygard)/Ficoll (Pharmacia) gradients
and washed thrice with Ham's F10 medium (Flow Labs.) containing 2.5$
foetal calf serum (Flow Labs.) prior to culture.
Normal mammary tissue from seven female patients aged 23-36
years were studied by roller tube culture. They had been admitted to
hospital for reduction mammoplasty (patient 1 ) or diagnostic biopsy of
a breast lump (patients 2 to 7) that was subsequently found to be
benign. In patient 1, mammary tissue was obtained from different areas
of the breast, and in patient 7, mammary tissue was obtained from
opposite ends of the biopsy specimen. The biopsy technique was similar
to that described by Drife et al. (1976).
Normal mammary tissue from three additional female patients
aged 19-35 years who had been admitted to hospital for reduction
mammoplasty was also studied by the organ culture technique of Baker
and Neal (1973).
Lymphocyte culture
Peripheral blood lymphocytes were cultured in Hams F10 medium
and 10$ foetal calf serum by the method of Waldmann, Durm, Broder,
Blackmann, Blaese and Strober (197U). Duplicate cultures of 1 ml
volume containing 2x10^ lymphocytes and 0$, 0.5$, 1 .0$ and 2.0$
Pokeweed mitogen (v/vj Gibco) were incubated for 1, 2, 3, U, 5, 6 and
7 days at 37°C in air. Culture supernatants were then removed, stored
at -20°C till analysis for IgA by RIA using a 7S IgA standard.
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Roller tube culture and demonstration of protein synthesis in vitro
The method used was that of van Furth, Schuit and Hijman (1966).
Briefly, the method was as follows: tissue specimens were placed in
a sterile Petri dish containing Hank's solution, and finely chopped
with scalpels; after rinsing, tissue fragments were randomly divided
into two separate roller tubes (so that each roller tube contained
60-150 mg wet weight of tissue) and either immediately frozen to -20°C
to arrest IgA synthesis, or incubated for I48 hr in 1 ml modified
Eagle's medium (Flow Laboratories) containing 1 uCi/ml ^C-L-lysine
(specific activity 3I4.2 Ci/mol) and 1 uCi/ml ^C-L-isoleucine (specific
activity 3ij.8 Ci/mol; Radiochemical Centre, Amersham), gentamicin
(25 ug/ml) and nystatin (75> units/ml). After incubation, the tissue
fragments that had been either stored at -20°C without culture, or
cultured I4.8 hours, were frozen and thawed successively five times to
disintegrate and extract the IgA present in the tissue fragments. The
culture supernatants were then removed, and the tissue fragments washed
twice with 1 ml buffer; the supernatants and washings for each respective
culture were then pooled and an aliquot withdrawn for measurement of
IgA concentrations by RIA using an 11S IgA standard. The remainder was
dialysed against phosphate buffer (0.1j? mo1/1 j pH 7.6) to remove the
excess radioactive amino acids. Next the culture fluid was concentrated
by lyophilization and dissolved in 0.1 ml of distilled water.
The culture fluids were analysed by micro-immunoelectrophoresis.
Because the concentrated fluids contained insufficient protein to
produce a well-defined precipitation line, carriers were used (Lai A Fat,
McClelland and Van Furth, 1976). The newly synthesized proteins were
detected and identified by autoradiography of the immunoelectrophoretic
pattern or Ouchterlony plate. Plates were exposed to Kodak Royal X
Pan film (ASA 1200) for 21 days and developed with 10$ Rodinal solution.
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Fig. 5.1 :
IgA synthesis by 2 x 10^ lymphocytes in vitro.
Subjects 1 (D.B.L. McC) and 2 (P.L.Y.) responded to 0.5$, 1.0$ and
2$ of Pokeweed mitogen (PWM) with increased IgA synthesis but
subject 3 (R.S.; overleaf) by contrast did not show a similar
response.
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Protein synthesis occurring in vitro was evaluated from the
intensity of the respective autoradiographic lines, which indicates
the amount of protein synthesised (Van Furth et al., 1966). The
intensity was classified according to a scale ranging from - = negative
- = just visible; + = clearly visible, to a maximum of ++++.
Organ culture by the method of Baker and Neal (1973)
The biopsy material was treated in the same way as described
above, but instead of being placed in roller tubes, tissue fragments
were incubated for 2k, lj.8 or 96 hours on moist filter paper (Whatman)
raised by metal grids just above the level of the culture medium
(HEFES buffered Eagle's medium containing 20% newborn calf serum;
Flow labs) in an atmosphere consisting of 5$ C Q, in 95$ air (10 lb/sq.
in.)at 37°C. Some cultures contained glucose (9 mg/ml) or insulin
(up to 200 ug/ml; Sigma) in an attempt to improve tissue survival.
Other cultures contained colcemid (8 ug/culture; from Dr. T.G. Baker)
added 8 hours prior to the termination of the culture, to assess the
number of mitoses occurring in culture. Culture media were changed
regularly at 2k hour intervals.
At the end of the culture period, tissue fragments were fixed
in Bouin's fluid, and processed by standard dehydration and embedding
procedures. Serial sections cut at 9 am were stained with haematoxylin
and eosin.
5.3 RESULTS
Lymphocyte culture
In all three subjects studied, increasing IgA concentrations
of similar magnitude were observed in culture supernatants from the
first to the fifth or sixth day of culture, reaching a value of
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IgA synthesis by 2 x 10^ lymphocytes in vitro; subject 3,
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approximately 100 ng/ml. This suggested that the net IgA secretion
from 2x10^ peripheral blood lymphocytes in 1 ml was 20 ng of IgA
per day.
When the lymphocyte cultures were stimulated with varying
doses of Pokeweed mitogen, large increments of IgA secretion were seen
in subjects no 1 and 2, but not in subject no 3 after the fifth day
of culture, presumably due to suppressor T cell activity (Fig. 5*1 )•
Roller Tube Culture: Correlation of autoradiography with RIA in the
measurement of IgA synthesis
In 11 culture experiments using normal breast tissue from
seven patients, IgA synthesis measured qualitatively by autoradio¬
graphy ranged from - to ++++ and did not correlate with the weight of
tissue cultured.
Measurement of IgA concentrations by RIA in the 3 ml pool of
culture supernatants and washings permitted a calculation to be made
of the total extractable IgA from the tissue fragments in each culture
tube. As the weight of tissue fragments was different in each roller
tube, the amount of IgA extracted per mg wet weight of mammary tissue
was calculated. IgA concentrations ranged from lj.8-600 ng/mg wet
weight in the mammary tissue fragments that had been frozen immediately
to arrest IgA synthesis, suggesting that the normal human breast
contained substantial amounts of IgA normally or that some contamination
with IgA from blood had occurred. IgA concentrations in the mammary
tissue fragments that had been cultured lj.8 hours were similarly
calculated, and it was found that only in four cultures did IgA
concentrations (on a ng/mg wet weight basis) in tissue fragments
cultured lj.8 hours exceed IgA concentrations in tissue fragments
originating from the same biopsy specimen, but frozen immediately
(Table £-1 ).
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Table5-1
IgAextractable fromtissuefragments
PatientCulturfrozenimmediat ly no.AgeParityno.(ng/mgtissuewei ht) 129Parous610 611 612 613
1UU.0 116.1; 228.5 165.7
2
31
Parous
618
2U8.9
3
28
Parous
619
251i.2
k
36
Parous
620
U67.5
5
28
Nulliparous
621
U7.8
6
29
Parous
622
109.7
7
23
Nulli.parous
623 621;
U67.0 599.6
IgAextractable fromtissuefragmentsIgAsynth sis culturedlj.8hrIgAassessedby (ng/mgtissueweight)i crementautoradiography 153.99.9
++
76.2
0
+
209.1;
0
-
107.9
0
±
261;.1
15.2
++++
230.3
0
+++
509.1
1;1.6
+++
155.2
107.1;
+
76.9
0
+
3U0.3
0
++
596.1
0
+++
In one patient (no 1), multiple biopsy specimens were analysed,
and it was found that IgA concentrations were similar in biopsy specimens
excised from different parts of the breast (Table 5-1 ).
When the degree of IgA synthesis detected by autoradiography
was compared with the 'increment' in IgA concentrations between tissue
fragments cultured lj.8 hours over the corresponding tissue fragments
(from the same biopsy specimen) frozen immediately, no correlation
was seen (Table 5-1)•
Organ culture by the method of Baker and Neal (1973)
Three specimens of normal breast tissue were studied in an
attempt to obtain a long term (up to six days) culture system. In
an assessment undertaken with Dr. T.G. Baker, it was found that "the
microscopic appearance of the tissue fragments in haematoxylin and
eosin stained sections was only satisfactory in mammary tissue
cultured for lj.8 hr. In tissue fragments that had been cultured 96
or 1 2jjU hrs, pyknotic cells were present, and there was a breakdown in
the orderly appearance of the ductal and alveolar epithelium. In
addition, increasing cell debris was observed in the lumen of the ducts.
The mitotic index (number of cells in division per 1000 cells
counted) was generally low in explants cultured for J4.8 hours and was
not increased in an experiment where insulin concentrations in the
culture medium were 0, 1, 2, 5j 10 or 50 ug/ml, and glucose concen¬
trations were either 0 or 5 mg/ml. Tissue fragments were found to
vary in their content of glandular or ductal tissue and some tissue
fragments did not contain any epithelial tissue at all, when serial
sections were studied.
10I4.
$.k DISCUSSION
The studies in this chapter have demonstrated that it is not
possible to measure IgA synthesis by using RIA to measure the amount
of IgA extractable from tissue fragments cultured for I4.8 hoars, and
comparing it with the amount of IgA extractable from fragments that
have not been cultured. Substantial quantities of IgA could be
extracted from fragments frozen immediately, and is in accord with the
finding by Drife et al. (1976) of IgA deposits in the lumina of
ductules in 88$ of specimens of normal breast tissue. Alternatively,
some contamination with IgA originating from blood could have occurred
at the time of biopsy.
The RIA itself could detect as little as 10 ng synthesised
by 2 x 10^ peripheral blood lymphocytes (PEL) in 2l| hours. About 15$
of PBL are B (antibody secreting) lymphocytes, and k% of PEL are class-
specific for IgA (Ammann, Borg, Kondo and Wara, 1977) - This suggests
that about 80,000 PBL are capable of secreting 10 ng of IgA per 2k
hours. In the normal, non-lactating breast, a calculation can be made
for the number of plasma cells present, most of which will stain for
IgA (Drife et al., 1976) based upon a mean value of 2.72 plasma cells
per lobule (n = lj.0, J.O. Drife, personal communication) and a lobular
density of 67 lobules per cm in the third decade of life (Wilson, 1976)
If one assumes that no shrinkage of the specimen occurs on fixation
and processing of the tissue, and that sections of 5 u are made with
a plasma cell appearing in only one section, then the number of plasma
cells in cube of breast tissue measuring 1 cm x 1 cm x 1 cm will be
2.72 x 67 1 2 x 10^ = 3.6 x k/. If it is further assumed that a 1 crn^
of breast tissue weighs 1 gm, then a 200 mg fragment of breast tissue
will contain about 0.7 x 10^ plasma cells.
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Although PBL differ from plasma cells in the mammary gland in
their state of differentiation, organ of origin (Lamm, 1976), control
of IgA synthesis (Elson, Heck and Strober-, 1979), type of IgA
synthesised (Lamm, 1976) and possibly in their rate of synthesis,
nevertheless, as a crude estimation, it can be calculated that the plasma
cells present in the tissue fragments in a roller tube may secrete 10 ng
of IgA (or a value similar in order of magnitude) in 2l\. hr. Because
of the high IgA concentration in the tissue fragments prior to culture
(mean value = 2^0 ng/mg tissue weight), it is unlikely that synthesis
of IgA would be detected, without an improved method of removing IgA
already present, in the biopsy, but trapped in the ductules. The
failure to detect an increment of IgA during a U8 hr. culture period
is therefore in accord with the calculation based on PBL IgA secretion
rate.
Long term organ culture on metal grids was attempted because
this method is mechanically less damaging than roller tube culture
(D.B.L. McClelland, personal communication). The method of Baker and
Neal (1973) has been used successfully for organ culture for up to
16 days (0 and Baker, 1976) but it was found that mammary tissue
fragments could only be cultured successfully for lj.8 hr. The failure
to culture mammary tissue for longer periods may have been due to the
wrong choice of culture medium or additives, as other workers have
managed to culture normal breast tissue for longer periods (Barker,
Fanger and Farnes, 196Uj Ceriani, Contesso and Nataf, 19725 Flaxman,
197Uj Dilley and Kister, 1975) but it was felt that a long culture
the
period would be required for / synthesis of IgA}sufficient to be
distinguished from the IgA present in tissue fragments that had not
106
been cultured, and from the experimental variation in the tissue
fragments themselves due to the histological heterogeneity of the
breast (Short and Drife, 1977) • No further experiments were therefore
undertaken to optimize culture conditions or to study IgA. synthesis
in vitro using RIA.
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CHAPTER 6 STUDIES ON BREAST SECRETIONS
6.1 GENERAL INTRODUCTION
In this chapter, various secretions from the breast were
studied with the aim of elucidating the functional state of the
secretory" immune system within the human breast at periods of life
other than post-partum lactation. It is known that lactation some¬
times takes place in the neonate, the secretion being known as
'witch's milk' . Lactation also occurs in some women with hyper-
prolactinaemia due to causes other than pregnancy (galactorrhoea),
and secretions from the nipple can sometimes be expressed in response
to manual compression (Laurie, 1975) or negative pressure exerted via
a suction cup (Sartorius ,1 973) in healthy nulliparous or parous women
who are not hyperprolactinaemic. Finally, the breast also 'secretes'
fluid into cysts in gross cystic disease of the breast. This cyst
fluid might be considered to be a 'static' secretion.
The concept of a distinct secretory immune system arose as a
result of studies indicating that IgA was the predominant immunoglobulin
in several external fluids and originated from sub-epithelial plasma
cells (for review, see Lamm, 1976) . Secretions may also contain other
immunoglobulins, some of which, such as I$i and IgE, may in large
part be produced locally. Thus, the concept of the secretory system
extends to other immunoglobulins in addition to IgA.
the
There are two common characteristics foi/majority of external
secretions: firstly, the proportion of the different classes of '
immunoglobulins in secretions varies significantly from the proportions
in serum, and secondly, independant regulation of serum and secretory
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antibody content occurs, either through local synthesis and/or
selective transport. Biologically, these phenomena are of considerable
importance since they may lead to a dissociation between systemic
and local mucous membrane immunity. Furthermore, these phenomena .
would suggest that for diseases occurring in the epithelial surfaces
of organs which are part of the secretory immune system (e.g. the
breast), the appropriate type of immunity to study might be secretory
rather than humoral (Roberts, Bathgate and Stevenson, 1975$
Pettingale, Merrett and Tee, 1977; Wang, Goodwin, Bulbrook and
Hayward, 1977).
The plasma cells in the lactating breast arise from gut-
associated lymphoid tissue, as demonstrated by studies of antibodies
present in milk (Adinolfi et al., 19665 Allardyce et al., 197U$
Goldblum et al., 1975) but the factors that control the migration to., and
maturation of IgA precursor lymphocytes within the human breast are
unknown.
In this chapter, IgA. concentrations were measured in all
secretions and fluids studied. In addition, the molecular size and
sedimentation coefficient of the IgA. detected was measured to confirm
that it was IIS. Further confirmation of the molecular form of IgA.
detected was obtained in some cases, using the antiserum (anti-11S
IgA/FSC) specific for the conformational determinant of IIS IgA and
the accessible determinant of free secretory component (Brandtzaeg,
1971). This was to ensure that it was not 10S IgA that was being
detected, as its occurrence would have indicated a possible abnormality
of the secretory immune system.
IgG and albumin concentrations were studied, because the
presence of these proteins in external secretions indicates passive
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transfer from serum (Brandtzaeg, Fjellanger and Gjeruldsen, 1970).
The concentrations of lactoferrin and lysozyme were also studied as
these proteins might act as 'markers' of epithelial cell responses
to hormonal stimulation (Masson, Heremans, Priguot and Wanters, 1966',
Kraus and Mestecky, 1971). IgM concentrations were not studied
because concentrations in milk are much lower than the concentrations
observed in serum (McClelland _et al., 1978) and because there was no
obvious way of distinguishing IgM in secretions originating from
serum, from IgM originating from local synthesis.
6.2 STUDIES ON NEONATAL MILK
6.2.1 Materials and Methods
Neonatal milk
Five samples of neonatal milk of O.Oj? to 0.25 ml volume were
collected by manual expression from four neonates (Table 6-1 ) from
6-28 days post-partum by Dr. Ann Harvie. Additional secretions were
obtained from a further nine neonates (whose results are shown in
Table 6-2) by Dr. John McKiernen. In one neonate, the neonatal milk
was diluted twenty-fold with sodium phosphate buffer to provide a
sufficient volume of material for analysis. All sanples were stored
at -20°C. Blood sanples were not obtained as these were healthy
infants, other than neonates 6, 7, 8 and 13 who were ill.
Quantitation of IgA
IgA was measured by RIA using an 11S IgA standard.
Quantitation of IgG. lactoferrin. lysozyme and albumin
Single radial immunodiffusion was used to measure the con¬
centration of IgG, lactoferrin, lysozyme and albumin using the reagents
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NEONATAL MILK ADDED (/JI)
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11SIgA CONCENTRATION (jjg/ml)
Fig. 6.1:
12f>
Binding curves demonstrating parallel inhibition of 1-11S IgA
binding: from left to right, inhibition curve for IIS IgA standard,
and inhibition curves for samples of neonatal milk from each of
four neonates.
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and standards described by McClelland et al. (1978). In neonates
5-13 IgG was measured by RIA instead.
Sedimentation Coefficient Determination
A 25$ to \6% sucrose density gradient (236,000 x g for 3
hours, Sorva.11 OTD-50) was used to determine the sedimentation
coefficient of IgA in a sample of neonatal milk. Fractions of 0.1 ml
were collected and stored at -20°C prior to immunoassay of the
125 125
unconcentrated fractions. I-7S IgA and I-7S IgG were prepared
125
in the same way as 1-11S IgA. and used as markers.
6.2.2 Results
Standard inhibition curve for IgA
The binding of ^ ^1-11S IgA to rabbit anti~7S IgA was
j
displaced in a parallel manner by the IIS IgA standard and three of
the four samples of neonatal milk, suggesting that immunoassayable
11S IgA was present (Fig. 6.1 ). Due to the small volume, it was not
possible to plot a complete binding inhibition curve for the remaining
sample of neonatal milk.
Sedimentation coefficient determination of IgA in neonatal milk
A single peak of immunoassayable IgA was found on density
gradient ultracentrifugation. The peak of immunoassayable IgA was
125
very close to the peak of radioactivity observed for 1-11S IgAj
the difference in position is within the limits of experimental error.
In contrast, the peak of IgA immunoreactivity in necnatal milk differed
in position by eight fractions from the peak of radioactivity seen
for ^^I-7S IgA and ^^I-7S IgG (Fig. 6.2 ). It was therefore confirmed
that 11S IgA was present in neonatal milk and that 11S IgA was the
correct standard to use for quantitation of IgA by double antibody
radioimmunoassay (Table 6-1 and 6-2). It was not possible to study
113
501
^40- O) 3. z O <
cr:
i—
.z
Id
O Z O
u
<
v—* (/)
30
20- 10-
0J
5000 ■4000 3000 -2000
i—
0
10
-1000
20 FRACTIONNo.
30
40
L0
N>
<-r»
(O
>
O
;o
Nj
On
CO
o o o c
cn
Fig.6.2: Sedimentationcoefficientdeterm nationfsamplefeo atalilk(#•bysucrosed n ityg adientultracentrifugation.Markersconsi tingf125>I-7SI A(•—•),12£l-11SgA(•)a d,^'I-7SIgG(•-»-•)werealsosimultaneouslyanalysedadditionalid nticalsucrose.gradients;0.1mlfractionwerec l cteddassayedbRIA(neonatalmilk)orcountediny-counter(-^I-labi-labelledprot ins).
the fractions collected from ultracentrifugation using anti-US
IgA/FSC as described for galactorrhoeic mammary secretions in the
next section. This was due to the large peak of immunoreactivity
caused by free secretory component obscuring the smaller IIS IgA
peak (not shown).
Quantitation of IgG. lactoferrin, lysozyme and albumin
In neonatal milk, IgGr, lactoferrin, lysozyme and albumin
were detected: the concentrations were similar to those in maternal
milk collected on the sixth day post-partum (McClelland et ad., 1978).
The concentrations of IgG in neonatal secretion were very much lower
than serum IgG concentrations at birth ( Tables 6-1 and 6-2) 0
6.2.3 Discussion
The concentrations of proteins present in normal maternal
milk were measured in neonatal milk so as to gain insight into the
early development of the secretory immune system. The visible mammary
hypertrophy with milk-like secretion (sometimes called witch's milk
from the historical belief that it was supernatural in origin, Forbes,
19^0) have been attributed to hormonal changes in the neonate that
parallel the changes which occur in the mother during the immediate
post-partum period (Lyons, 19373 Hiba, del Pozo, Genazzani, Pusterla,
Lancranjan, Sidiripoulos and Gunti, 1977) • As IgA can usually be
found in external secretions, before it is found in serum (Haworth
and Dilldng, 19665 McKay and Thorn, 1969), and as IgA is detectable
in low concentrations in serum on the sixth day of life (see Chapter 7),
it was surprising that an earlier study had indicated that IgA was
absent in neonatal milk ■_ (Hanson, 1961).
The purpose of this study was to ascertain the concentration
and form of IgA present in neonatal milk. In addition, concentrations
of lactoferrin and lysozyme were determined as 'markers' of epithelial
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Table6-1:Milk:proteinconcentratio sineo a almilk,t lserum. maternalilkandrnalserum
Dayof11SIgANeon talI Gat lLact ferrlnysozymeAlbumi
NeonateCollection.(mg/l)MilkIgA/l)iG( g lAlbum n SerumIgArGAlbumin 1Day60430.161000.0107,050
32
330
0.008
Day8
046
0.18
N.D.
N.D.
N.D.
N.D.
-
2
Day16
.3.25
1.25
20
0.002
11,200
380
360
0.009
3
Day19
118.17
U545
NoD.
-
900
N.D.
N.D.
-
h
Day28
17.57
6.76
80
0.008
7,000
51*
290
0.007
Neonatal Serum
2.6-
1 .1*5*
101*20- 592**-
NoD.**
N.D**
1*0110- 11*21***
Maternal*** Milk
Day6
3,680
2.97
39
0.007
l*,95o
115
360
0.010
Maternal** Serum
1,239
5690
N.D.
6.0
31*860
*Mean-SEM(n=1*8)fromChapter7ft ishesi .
**Mean-SEM(n=19)bycClella dandSamsounpub i heobserv tionsncorl ate nall ). ***MeanvaluesfromcClella dt.(1978) NoDootdetectedutil tionfs cretion(neonate3),rinsuffi ie ts cre ionf analysis (neonate1,d y8).
cell responses to hormonal stimulation (Masson et al., 1966;
Kraus and Mesteely 1971). The concentrations of IgG and albumin
were also determined as an indication of the transit of blood proteins
into milk (Brandtzaeg et al.. 1970).
19%
The results of the 1-11S IgA binding inhibition curves and
sucrose density gradient ultracentrifugation indicate that the IgA.
in neonatal milk; is of the IIS type. No 7S IgA was detected in
neonatal milk. Furthermore, the ratio of neonatal milk IgA levels
to neonatal serum IgA levels is very much higher than the ratio of
neonatal milk IgG and albumin levels to serum IgG and albumin levels
at birth respectively (McClelland and Samson, unpublished observations
on cord blood). This difference is particularly marked for neonates
3 and 1|.
This indicates that the presence of IIS IgA in neonatal milk
is not due to passive diffusion, and that there must be either
selective transport of IgA from serum to milk or local production of
11S IgA. In the analysis by gel filtration of both cord blood and
neonatal serum, described in Chapter 7 of this thesis, it was found
that less than 2.%% of the IgA present has an elution volume similar
to that of 11S IgA. The data in this section therefore provides
strong evidence for the local synthesis of 11S IgA in the neonatal
mammary gland, probably in a similar manner to that occurring in the
maternal mammary gland.
Absolute levels of IIS IgA in neonatal milk are approximately
a thousand-fold lower than the levels seen in maternal milk. However,
this finding closely parallels the observation that neonatal serum
IgA concentrations are also a thousand-fold lower than maternal serum
IgA concentrations (Chapter 7, "this thesis), and presumably reflects
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Table 6-2: Sequential milk protein concentrations in
neonatal milk
Gestation Day of IIS IgA IgG Lactoferrin Iysozyme Albumin
Neonate (weeks) Collection (mg/l) (mg/l) ( g/1) C -g/i) C,«/D
5 l+o day 9 0.7U 20.3 17 0.1 0.65
15 20.1+0 29.7 IS IS is
6 ui day 10 0.96 13.6 11 ND 0.20
11 2.30 18.7 IS IS IS
12 3.01 12.5 16.2 ND 0.18
13 h'72 10.1+ llj-.O ND 0 ..18
7 l+o day 28 3U1 .0 76.0 IS IS IS
29 576.3 68.1 13.8 0.38 0.83
31 608.0 89.3 23.6 • 0.50 0.83
8 l+o day 9 3.97 28.3 11+.0 ND 1.07
10 6.69 17.1 8.6 ND 0.62
9 1+0 day 1l+ 3.80 55 .h 18.0 0.1+8 0.82
28 8.10 1+3-8 11+.0 0.80 0.69
10 ho day 11+ 3.9U 29.9 11+.1 0.11+ 0.57
28 97.96 110.3 26.1+ 0.17 0.1+2
11 ho day 9 1.39 25.9 36.1+ ND 0.58
13 9.19 15.1 20.8 0.09 o.i+6
12 37 day 6 2.67 25.5 13.6 ND 0.29
18 h03.$ 63.2 U3-2 0.10 0.57 .
13 ho day h 3.30 28.3 28.0 0.09 0.56 f
6 9.39 23 .U 10.2 ND 0.32
ND = not detected
IS = insufficient secretion for analysis.
Neonates 6, 7, 8 and 13 were ill.
the immaturity of IgA synthesis in the neonate. The presence of
relatively high 11S IgA concentrations in the mammary secretions of
neonates 12 and 13 indicates that soon after birth, IgA secreting
plasma cells are present in the neonatal mammary gland.
In contrast to 11S IgA, the concentrations of lactoferrin and
lysozyme are similar to those found in maternal milk. As these two
proteins originate in the glandular acini (Masson et al., 1966)
and intralobular ducts (Kraus and Mestecky, 1971) respectively, this
finding suggests that neonatal mammary epithelium responds to the
hormonal changes of pregnancy and the immediate post partum period in
the same way as maternal mammary epithelium. It is not known whether
the high concentrations of lactoferrin and lysozyme are due to
epithelial proliferation, increased synthesis by epithelial cells, or
both, but the histological appearance of the mammary gland of a full
term foetus consists of swollen glandular acini with extensive
epithelium, suggesting that epithelial proliferation is occurring
(Dabelow, 1957).
In ten neonates, it was possible to study more than one sample
of breast secretion from each neonate, and it is clear from the data
in Table 6-2 that IIS IgA concentrations increase with the day of
collection post-parturn, ;'for each neonate as well as between neonates
(e.g. neonate 8 and 13 compared with neonate 7* 10 and 12). IgG,
lactoferrin, lysozyme and albumin concentrations do not behave in
the same way suggesting that these results are not due to volume
changes of secretion, and that it is the age of the neonate that
influences the 'maturity' of the mammary secretory immune system.
This hypothesis is strengthened by the data for neonate 12, who was
born premature, and yet on day 18 post partum (equal to a gestational
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age of UO weeks) had IIS IgA concentrations in neonatal milk far
higher than the concentrations observed in neonates 1 and 13 in the
first week of life.
In the mouse, it has been suggested that the migration to
and maturation within the mammary gland of precursor IgA. plasma cells
is due to some undefined influence of the mammary epithelium following
stimulation by the hormones of pregnancy (Weisz-Carrington, Roux,
McWilliams, Phillips-Quagliata and Lamm, 1978) • The data on
lactoferrin and lysozyme concentrations suggests that the initially
low absolute concentrations of IgA. in neonatal milk may be due to
a relative lack of precursor IgA. lymphocytes rather than to a lack of
"attraction" by mammary epithelium. However, it is possible that
antigenic stimulation of the gut post-partum causes division of IgA
precursor lymphocytes in the Peyer's patches, resulting in an influx
of lymphocytes into glandular sites throughout the body including
the neonatal mammary gland. This would explain the rise in 11S IgA
concentrations in neonatal milk with the age of the neonate.
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Table 6-3: Clinical Data of Patients Studied
Patient Age Duration of Serum prolactin
no. (years) galactorrhoea Diagnosis (mLF/l) *
1 35 16 years Pituitary tumour 11,900
2 28 9 months Idiopathic 650
3 23 22 months Post-partum 2,291
k 27 10 months Drug-induced 6I4.I
121
6.3 STUDIES ON GALACTORRHOEIC MAMMARY SECRETIONS
6.3.1 Materials and Methods
Mammary Secretions
Four amenorrhoeic female patients with proven hyperprolactin-
aemia consented to, manual expression of mammary secretions; the
secretions (0.2 to 1.0 ml volume) were collected by Drs. A. Brooks,
C. Martin and C. Vaughan-Williams and stored at -20°C. The clinical
information and serum prolactin concentrations for these patients
is tabulated in Table 6-3; all patients were parous except for one
(no. b)> in all cases, the prolactin levels were previously determined
by a specific double antibody RIA (Hwang, Guyda and Friesen, 1971).
Quantitation of IeA
IgA was measured by a double antibody RIA using an IIS IgA
standard and the antiserum (rabbit anti-7S IgA.) raised in rabbits
immunised with serum IgA (Platts-Mills and Ishizaka, 1975>). In
addition sucrose fractions from sedimentation coefficient determinations
were further analysed using anti-11S IgA/FSC.
Quantitation of IgG. lactoferrin, lysozyme and albumin
IgG, lactoferrin, lysozyme and albumin were determined by
single radial immunodiffusion (Fahey and McKelvey, 1965) using
reagents and standards described previously (McClelland _et al., 1978).
Sedimentation Coefficient Determinations
Sedimentation coefficient determinations were performed as
described in the previous section for neonatal milk. However, immuno¬
assay was carried out using either rabbit anti-7S IgA., or rabbit
anti-11S IgA/FSC. Two different standards were used: a serum IgA
standard that had been standardised against the WHO standard (Rowe et al.,
1972) for a sedimentation coefficient determination of the IgA in normal
adult serum, and an 11S IgA standard, for IgA sedimentation coefficient
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determinations for colostrum, milk and a sample of galactorrhoeic
secretion. Three marker proteins were used; two non-radioactive
markers consisting of 7S human IgG and a lj..5S Bovine serum albumin
marker, prepared by the method of Stanworth, James and Squire (1961)
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by Mr. B. Freedman, and a radioactive 1-11S IgA marker prepared
as described in Chapter 3.
Gel filtration
Gel filtration was carried out using Sepharose UB (Pharmacia)
in a 2.2 x 90 cm column with downward flow of eluate (Na^PO^,
0.05 mol/1 at pH 7»U). Fractions of 3 ml volume were collected and
stored unconcentrated at -20°C till immunoassay using rabbit anti-
7S IgA.
6.3-2 Results
Standard inhibition curve for IgA
125
The binding of -n 1S IgA was displaced in a similar manner
by the 11S IgA standard and samples of mammary secretion from each of
three galactorrhoeic patients. The binding was not entirely parallel,
suggesting that there might be slight antigenic differences between
the IgA present in galactorrhoeic secretions and the IgA present in
the IIS IgA standard (Fig. 6.3). Galactorrhoeic secretion from the
fourth patient was not analysed in this way as it was not available
at the beginning of this study.
Sedimentation Coefficient Determination
When the sucrose fractions obtained from ultracentrifugal
analysis of colostrum, milk, galactorrhoeic secretion and normal
serum were immunoassayed using the rabbit anti-7S IgA, single peaks
of immunoreactivity were seen in all instances. The peak of immuno-
reactivity. for the galactorrhoeic secretion studied was identical
in position to the peak of immunoreactivity for colostrum,
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milk and 12^X-11S IgA marker, but differed in position from the
immunoreactivity peak for normal serum, which coincided with the
position of the 7S marker. This suggested that the IgA present in
galactorrhoeic secretions is IIS (Fig. 6.U).
Further immunoassay of the same fractions, but with the rabbit
anti-US IgA/FSC, demonstrated a single peak of immunoreactivity for
the same galactorrhoeic secretion at the IIS position, confirming
that the IgA present in galactorrhoeic secretions was a dimer combined
with secretory component and not simply a 10S dimer. In the case of
colostrum and milk, two peaks of immunoreactivity were seen, one
12£
coinciding with the 1-11S IgA marker, and the other coinciding with
the non-radioactive 1;.5S marker. This more slowly sedimenting peak
of immunoreactivity had a sedimentation coefficient value similar to
that of free secretory component (Tomasi and Bienenstock, 1968) but
accurate quantitation was not possible due to the lack of a suitable
free secretory component standard. No peaks of immunoreactivity
were detected with the fractions from ultracentrifugal analysis of
normal adult serum, indicating no detectable 11S IgA or free
secretory component in this particular assay (Fig. 6.$) and the complete
adsorbtion of the antiserum with 7S IgA.
Gel Filtration
—————————
/
Gel filtration of two different samples of galactorrhoeic
secretions resulted in a single peak of immunoassayable IgA (Fig. 6.6)
This IgA eluted at the same volume as the IgA peak in colostrum or
milk (Fig. 1|.8) but at a different volume from the IgA peak of normal
adult serum (Fig.li.9), confirming' once again that the IgA present in
galactorrhoeic secretions was 11S. The IIS IgA standard was therefore
used in IgA assays of galactorrhoeic secretions.
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Concentrations of Milk Proteins in Galactorrhoeic secretions
The concentrations of the various milk proteins found in the
four samples of galactorrhoeic secretions were compared with con¬
centrations of rd.Uk proteins in colostrum and day 6 milk determined
previously by McClelland et al.(l978) and are shown in Table 6—1+.
In all four patients studied, the milk protein concentrations observed
were comparable with those found in colostrum. The ratio of IgA.
present in galactorrhoeic secretions to IgA. present in serum was very
much greater than the corresponding ratios for IgG and albumin (Table
640.
6.3.3 Discussion
Previous studies of the composition of the mammary secretions
of patients with galactorrhoea have mainly concentrated on measuring
total fat, carbohydrate and protein concentrations (Levine et al..
1962; Brown et al., 1965; Vorherr, 1975). In addition, same studies
have indicated that casein (Brown et al., 1965) and oi -lactalbumin
(Kleiriberg et al., 1977) are present$ the concentration of lysozyme
(Brown et al.. 1965) has also been measured in galactorrhoeic
secretions. Unfortunately, in tliese earlier studies, the serum
prolactin concentrations in the patients studied were not specified
nor were .highly specific methods of assay used.
In this study, mammary secretions from hyperprolactinaemic
patients with galactorrhoea were compared with normal post-parturn
colostrum or milk, so as to study prolactin-induced secretory changes
in the breast in isolation from changes due to human placental lactogen
or placental steroids. In three patients, (nos. 1,2 and it) prolactin
was acting alone, unlike in patient no. 3 where galactorrhoea had
persisted post-partum, and the breast had undergone various steroid
hormone, placental lactogen and prolactin induced changes.
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Table6-k:Milknrotelnconcentratiarisigalactorrho csecretions,Post-p tumcolos r . milkandmaternalserum PatientIISIgA. g/1Breast secretionIeA serumIgA.IgG g/1Breast secretionIeG serumIgGLactoferrin
g/1
Iysozyme g/1
Albumin g/1
Breast secretion albumin serumalbumin
1
55.10
kk.kk
3.20
0.56
25.00
0.k2
1 .86
0.05
2
69-57
56.10
1 .60
0.28
k6.5o
2.k0
9.20
0.26
3
Jj.0.6I4.
32.77
1.25
0.22
18.50
0.k8
5.62
0.16
h „
32.36
26.07
0.05
0.01
2.19
0.80
2.k7
0.07
colostrum*
120.i4.7- 26.9
97.15
0.3k- 0.07
0.06
1k.82^ 1.9k
0.k6- 0.1k
1 .93- 0.3k
0.06
milk*
3.68- 0.39
2.97
o.ok- 0.02
0.01
k.95- 0.26
0.12- 0.02
0.36- 0.02
0.01
serum**
1 ,2k
5.69
N.D.
0.008
3k.86
*DatafromMcClellandeal.0978).Colostrumajjidmi ks mpleswecoll ctend ys1and6post-p r u respectivelyandthd taisexpressedm an-S.E.M.(n=53and31)•
■**UnpublishedobservationsbyMcClel andandSam oovenousl ooll ctefr mm thersp trtum(=19). IgAwasdeterminedusinga7SI stand rd.
The predominant form of IgA present in galactorrhoeic secre¬
tions has a sedimentation coefficient and a molecular size similar
to 11S IgA. in normal colostrum and milk, us demonstrated by density
gradient ultracentrifugation and gel filtration. In addition, by
using anti-US IgA/FSC, the IgA detected in galactorrhoeic secretions
is a combination of IgA with secretory component rather than a dimer
(1 OS) of serum IgA. It is not possible to explain the lack of complete
1
parallelism in the inhibition of 1-11S IgA binding between galac¬
torrhoeic secretions and the 11S IgA standard. It may be due to the
presence of higher molecular weight polmers of IgA, similar to those
described in early colostrum by Wadsworth (1978) using the more
sensitive technique of immuno-gel filtration.
The IgA in galactorrhoeic secretions could be derived from
either selective or passive transfer from serum, or from local synthesis
In external secretions, the majority of IgG and albumin molecules
are derived from serum by passive transfer (Brandtzaeg et al., 1970).
Furthermore, only small quantities of 11S IgA are present in human
-Stella and Rowe,
serum (Waldman, Mach,/1970). As the ratio of IgA present in
galactorrhoeic secretion to IgA present in serum is so much greater
than the corresponding ratios for IgG and albumin, it is likely that
the high concentrations of IIS IgA that were detected were due to
local synthesis as in the normal post-partum lactating breast.
The reason for the apparent absence of free secretory component
from galactorrhoeic secretions is not clear. However, as it is not
feasible to quantify free secretory component at the present time
(due to a lack of the purified protein standard) no further comment
on this result is possible.
The lactoferrin and lysozyme present in external secretions
originates from glandular acini (Masson et al.. 1966) and epithelium
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(Kraus and Mestecky, 1971) respectively. The demonstration of high
concentrations of lactoferrin and lysozyme, similar in magnitude to
the concentrations observed in colostrum-and milk (McClelland et al..
1978) indicates that the effect of hyperprolactinaemia is to cause
either epithelial proliferation, increased synthesis by epithelial
cells or both. This may be of importance in understanding the transit
of IgA precursor plasma cells to the human breast, as Wei sa-Carrington
et al., (1978) suggest that the migration to, and maturation in the
mammary gland of the plasma cells of the mouse may be due to some
factor produced by epithelial cells following stimulation by the
hormones of pregnancy. These workers found that prolactin was the
most important of the hormones of pregnancy in causing an elevation
of IgA plasma cells in the mammary gland and of intra-epithelial IgA.
However, to obtain a maximal elevation of IgA plasma cells, progesterone
and oestrogen were also required.
One of the patients studied (no. h) was nulliparous and
amenorrhoeic, and therefore it was likely that in this patient,
ovarian steroids played a minor role, if at all, in 'attracting' IgA
plasma cells to the breast. In "the two patients who were parous (no.
1 and 2), involution of the breast had occurred before the onset of
galactorrhoea, again suggesting that ovarian steroids have a minor
role in IgA precursor cell 'attraction' since it is known that in
the human, post-lactation involution of the breast is accompanied by
a decrease in the number of plasma cells (Pumphrey, 1977). In
addition, in patient no. 1, the long duration of the galactorrhoea
suggests that there must have been further migration of IgA precursor
plasma cells to the breast since it is known that in the mouse, the
maximal life span of an intestinal IgA plasma cell is eight weeks
132
(Mattioli and Tomasi, 1973) • In the remaining patient (no. 3) the
galactorrhoea persisted post-partum, and it is therefore possible
that in her case, the migration of IgA. precursor lymphocytes might
have been initially influenced by ovarian and placental steroids and
placental lactogen.
In conclusion, the data shows that in the human, as in the
mouse, prolactin, possibly acting via the mammary epithelium causes a
rise in 11S IgA. secretion by the breast. The actual factor that
accounts for the migration and maturation of plasma cells in the
breast remains unidentified (Lainm, 1976) but may be related to some
property of the mammary epithelium (Wiman, Curman, Forsum, Klareskog,
Malmnas-Tjennlund, Rask, TrSgardh and Peterson, 1978).,,
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6.U STUDIES ON NORMAL BREAST SECRETIONS
6-U.I Patients and Methods
Breast secretions; Breast secretions were collected by nipple
aspiration by Dr. R.J. Crael, Mr. V. Humerduk and members of the
University Department of Clinical Surgery using a suction cup as
described by Sartorius (1973)» Details of subjects and clinical data
(where known) are described in Table 6-5. The volume of secretions
ranged from 15 to 215 ul and were stored diluted in phosphate buffer
at -20°C until assay. In three subjects (nos. 3, 5 and 10),
secretions were obtained from different ducts within the same breast.
Quantitation of IgA and IgG
IgA was measured by RIA using a purified 11S IgA standard.
IgG was also measured by RIA using a serum IgG standard that had been
standardised against the W.H.O. standard (Rowe et al., 1972).
Quantitation of lactoferrin
Lactoferrin was measured by single radial immunodiffusion as
described in the previous section (Section 6.3.1).
Gel filtration
Gel filtration was carried out in an identical manner to the
method described in the previous section (Section 6.3.1 ). The
fractions that were collected were immunoassayed using either rabbit
anti-7S IgA or anti-1lS IgA/FSC.
6.U.2 Results
Standard inhibition curve for IgA
1 2^
The binding of 1-11S IgA was displaced in a parallel
manner by the IIS IgA standard and breast secretions from each of four
subjects, suggesting that immunoassayable IIS IgA was present (Fig. 6.7)
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Gel filtration
Gel filtration of the breast secretion from subject no. 3
resulted in a major peak of IgA immunoreactivity (Fig. 6.8 ) with an
elution volume identical to the elution volume of the IgA. peak in
colostrum and milk (Fig. 1*.8 ) but different to the elution volume of
the IgA. peak of normal adult serum (Figi;.? ), confirming that IgA
in normal breast secretions was predominantly 11S. Higher molecular
weight forms of IgA were present also, as demonstrated by the immuno-
reactive material eluting after the void volume, but before the major
peak (Fig. 6.8).
To confirm that iramunoreactive material detected was immuno¬
logically identical to 11S IgA, the same fractions were also assayed
using anti-US IgA/FSC. An identical elution profile was found,
indicating that all the immunoreactive material eluting before fraction
83 was probably 11S IgA in an aggregated form, and confirming again
that the major peak of IgA immunoreactivity was due to IIS IgA and
not 7S IgA (Fig. 6.8).
Concentrations of 11S IgA and IgG in Normal Breast Secretions
11S IgA and IgG were detected in all the breast secretions
obtained from normal subjects: values ranged from I4..3 to 237.6 g/1
and 1 ,U to 67-1 g/1 respectively. The mean (- S.E., n = 18) 11S
IgA concentration of 117-2 - 13*3 g/1 was significantly higher than
the mean IgG concentration of 7.3 - 3-7 g/1 (p< 0.001j paired t-test),
but no significant correlation existed between IIS IgA and IgG
values for each individual secretion (Table 6t3).
In an attempt to assess the validity of the immunoglobulin
concentrations observed in breast secretions, the value for the right
breast was compared with the value obtained for the left breast, where
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Table 6-5: IgA and IgG in normal breast secretions
IgA IgG
Menstrual Secretion concen- concen-
Subject Age status Parity no- tration tration Comments
(g/l) (g/1)
1 50 Menopausal Not
known
15R 1*5.58 0.75
2 1*2 Pre¬
menopausal
Not
known
19R 111*.73 2.50
3 52 Post¬
menopausal
Parous 20L1
20L2
20R
122.78
116.98
125.80
2.81
2.89
3.26
1* 25 Pre¬
menopausal Parous 22L
22R
10.28
119.25
2.11
6.1*5
5 h9 Meno¬
pausal
Parous 231^
23L2
23R
6.00
li.52
10.82
1 .28
1.1*5
1.91
6 Not
known
Post¬
menopausal
Not
known
2l*L 160.50 67.08
7 21* Pre¬
menopausal
Not
known
■ 2%
29R
33L
33R
188.25
108.50
330.50
21*3-25
5.59
2.52
9.10
3.08
8 39 Pre¬
menopausal
Parous 30R l*l*-3 0.96
9 1*1 Pre¬
menopausal
Parous 31L 300.0 2.51
10 1*5 Pre¬
menopausal
Parous 32L
32R
37Ll
37L2
37R
11*1*.15
11*1*. 20
108.10
237.60
108.80
25.90
1.08
1 .26
2.02
1.05
11 30 Pre¬
menopausal
Nul1i -
parous
3bL
3ltR
38
101*.90
126.60
181 .70
1.11
1 .01*
1 .22
12 35 Pre¬
menopausal
Not
known
35
39R
57.80
23I*.20
6.15
7.91
other
breast
Mastalgia
Normal
Normal
Galactor¬
rhea
disease,
right
breast
Normal
Normal
Normal
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Table 6-1? - continued
Menstrual
Subject Age status
13 U7 Pre¬
menopausal
Not
known
227 70.08 1 .91; Benign
breast
disease
114. it.9 Pre¬
menopausal
Not
known
283L 8.62 1 .lit Cystic
disease
15 53 Menopausal Parous 2l;5R I78.J4.O 2.20 Benign
breast
disease
The secretion number indicates the way in which the secretion
was obtained e.g. for patient no 10, 32L and 32R were taken from left
and right breasts respectively on the same occasion; on another
occasion, 37L1, 37L2 and 37R were obtained, but the secretion within
two separate ducts ending in the left nipple (Li, L2) were collected
individually.
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secretions were obtained from both breasts on the same occasion.
■Where more than one secretion was obtained from a breast on a particular
occasion (e.g. subject 10, secretions 371^ , 37I>2)j mean value for
the breast was used for the comparison. IgA values for the right
breast ranged from 63 to 206$ of the values seen for the left breast
+ +
(mean - S.E. = 119 n = 5) while corresponding IgG values
showed a greater degree of variation (due to the IgG value for
l!4 + ^ +
secretion 32L) ranging from h to 3<39$ (mean - S.E. = .85 -v7$) • In
three subjects (nos.3> and 10), the secretion obtained from each of
two different ducts within the same breast was assayed separately.
11S IgA and IgG concentrations were very similar in two subjects
(nos.3 and 5) but showed a two fold variation in the third (subject
no.10) suggesting that a variation in the immunoglobulin concentration
of secretions might occur between ducts in the same breast.
In view of the small number of subjects studied, and the
incomplete clinical data, it was not possible to assess the relation¬
ship of age, menstrual status or parity to immunoglobulin concen¬
trations of breast secretions. However, high concentrations of IIS
IgA were found in the secretions obtained from postmenopausal or .j
nulliparous subjects (nos.3 and 6; no 11). In addition, concen¬
trations of IIS IgA were in general very similar to the range of
concentrations seen in colostrum and milk (McClelland et al., 1978j
Table 6-1;) • The reason for the high concentrations of IgG detected
♦
in the secretions of subjects 6 and 10 is not clear.
Among the small number of secretions studied obtained from
subjects with breast disease, all but two of the secretions (31L,
33L) were within the range of IIS IgA concentrations found for .
secretions from normal subjects. Similarly, all but two secretions
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Scatter histogram comparing lactoferrin concentrations in (a) the
normal breast secretions of 5 subjects (in whom lactoferrin was
detectable), (b) the mammary secretions of four subjects with
galactorrhoea (described in the preceding section), and (c) normal
post partum colostrum and milk (data from McClelland et al., 1978).
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(15R, 30R) were within the range of IgG concentrations seen in the
secretions of normal subjects. This suggests that no major differences
are likely to be present between breast secretions obtained from
normal subjects and those obtained from patients with breast disease.
Concentrations of lactoferrin in Normal Breast Secretions
Concentrations of lactoferrin similar to the concentrations
found in colostrum and milk were detected in 5 out of 10 breast
secretions obtained from three normal subjects (nos. 10, 11 and 12).
The failure to detect lactoferrin in the remaining secretions was
probably due to the dilution (1/200 to 1/500) of the secretion before
assay (Fig. 6.9).,
6.I4..3 Discussion
Small amounts of secretion can be aspirated from at least
75$ of non-lactating breasts (Petrakis et al., 1975) and previous
studies on breast volume (Milligan et al., 1975), IgA synthesis (Drife
et al., 1976) and DNA synthesis (Masters et al-, 1977) suggest that
the non-lactating breast responds to fluctuating levels of ovarian
hormones. IgA concentrations were determined in secretions obtained
from normal non-lactating breasts ('normal breast secretions') to
gain insight into the influence of hormones associated with the
menstrual cycle on the secretory immune system of the breast. In
addition, lactoferrin concentrations were determined as an indicator
of epithelial synthetic activity (Masson et al.. 1966) and IgG
concentrations as an indicator of the passive diffusion of serum
proteins into external secretions (Brandtzaeg et al.. 1970).
1 ?5
The results of the -\E-11S IgA binding inhibition curves
and gel filtration experiment indicate that the IgA in normal breast
secretions is IIS. This was confirmed using anti-11S IgA/FSC which
1l;2
indicated, that it was the complete IIS IgA molecule that was detected,
and not the 10S form. Interestingly, high molecular weight forms of
11S IgA. (> U00,000 M.W.) were also detected by gel filtration,
possibly representing aggregation of IIS IgA. or the synthesis of high
molecular weight IgA, as occurs in early colostrum (Wadsworth, 1978).
Very little IgA immunoreactive material eluted at the same volume as
7S IgA.
Absolute concentrations of IgA and IgG in normal breast
secretions are very similar to the values found in colostrum and milk
(McClelland et al., 1978; Table 6-I4.). As in the two previous studies
described in this chapter, the ratio of IgA in normal breast
secretions to IgA in serum was much higher than the ratio of IgG in
normal breast secretions to IgG in serum, indicating that the IIS
IgA found in normal breast secretions was due to selective transport
or local synthesis. As there is little 11S IgA in adult serum
(Waldman et al.. 1970), the IIS IgA detected must be a product of
local synthesis. This confirms the earlier report of Drife at al.
(1976) who detected IgA synthesis in 81^ of cultures of normal human
breast tissue.
A wide range of 11S IgA and IgG concentrations in normal ,
breast secretions were observed and the mean value of IIS IgA and
IgG concentrations was seventeen and three times higher respectively
I
than the IgA and IgG concentrations reported in a similar study by
Petrakis, Doherty, Lee, Mason, Pawson, Hunt and Schweitzer (1977).
These differences may have been due to the different analytical methods
used, as Petrakis et al., used rocket Immunoelectrophoresis instead
of RIA. Furthermore, Petrakis et al. (1977) did not report the use of
an 11S IgA standard, an omission that might give rise to a three to
1ll3
six-fold difference in IgA values (Schuurman, 19775 Greenberg, Rossen,
Six, Baxter and Couch, 1978), and their assays were performed on
undiluted samples, with possible loss of immunoglobulin by non¬
specific adsorption to the storage vessel.
In this study, IgA and IgG was detected in all samples of
breast secretion (whether from normal or diseased breasts). In
contrast, PetraJdLs et al. (1977) reported the absence of IgA. and
IgG in a number of normal breast secretions and secretions from
cancerous breasts. This difference may be attributed to the use of a
less sensitive method of detection of immunoglobulins (rocket immuno-
electrophoresis) and it is clear that if a deficiency exists, it is
a relative rather than absolute one.
Although high concentrations of 11S IgA were detected in the
normal breast secretions, because the volume of the secretions was
very small, the total 11S IgA synthesis by the non-lactating breast is
veiy much less than that of the lactating breast. Only a fraction
of the total secretion lying within the mammary ducts of the non-
lactating breast is obtained by aspiration with the suction cup, and
the values for IgA, IgG and lactoferrin observed should therefore be
considered as being representative of the ductal secretion nearest
the nipple, rather than of the entire breast.
For the secretions obtained from normal subjects on a particular
occasion (whether from left or right breast), IgA and IgG concentrations
within each patient vary up to two fold, with the exception of secretion
32L. This suggests that measurements of immunoglobulin concentrations
in breast secretions may be a valid procedure despite the problem of
obtaining uniform volumes of secretion.
lilil
It is thought that the basal activity of the epithelial cells
in the normal human breast during the menstrual cycle may be due to
prolactin, insulin and possibly oestrogen and progesterone (McNeilly,
1977). The high concentrations of lactoferrin observed are indicative
of this basal activity, and in the mouse, it has been proposed that
some unknown factor originating from epithelial cells may be responsible
for the 'attraction' of IgA. precursor lymphocytes into the mammary
gland (Weisz-Carrington et al., 1978). The finding of high 11S IgA.
concentrations in the breast secretions of nulliparous (subject no. 11)
or parous premenopausal subjects suggests that one or more of the
hormones of the normal menstrual cycle may be influencing the
secretory immune system of the normal breast. In two postmenopausal
subjects (no. 3 and 6), high IIS IgA. concentrations in the breast
secretions were also observed, suggesting that the hormone influencing
the influx of IgA. precursor lymphocytes may still be secreted after
the cessation of menstrual periods. As serum prolactin concentrations
in postmenopausal women are only slightly less than those in eugonadal
women (Reuter, Kennes, Gavaert and Franchimont, 1976), prolactin
might be the hormone involved.
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Fig. 6.10:
Age Distribution of patients studied with gross cystic disease
of the breast. The cyst fluids of Group I patients were assayed
within 2 years of collection while cyst fluids of Group II .
patients were assayed within 3 months of collection.
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6.5 STUDIES ON CYST FLUIDS
66« 1 Materials and Methods
Cyst fluids: Cyst fluids were, obtained by needle aspiration
from female patients presenting with cystic disease by Drs. M.M. Roberts,
R.J. Crael, Mr. Vlad Hemeniuk and members of the University Department
of Clinical Surgery. Two groups of patients were studied: an initial
series of 71 cyst fluids from 59 patients aged 32 to 55 years whose
cyst fluids were stored for up to two years at -20°C prior to assay
(Group I), and a second series of 26 cyst fluids from 21 patients
aged 31 to 5U years whose cysts were stored for a maximum of three months
at -20°C prior to assay. Group II cyst fluids were collected because
it was thought that Group I cyst fluids might have been adversely
affected by the long storage period.
The age distribution of patients in the two groups was very
similar, with the maximum number of cyst fluids collected from
patients aged i|.6 - 50 years, and the smallest number of cyst fluids
collected from patients aged 31 - 35 (Fig- 6.10). Reliable clinical
data was available for Group II patients, but unfortunately clinical
data for Group I patients was incomplete.
Quantitation of IgA
IgA was measured by RIA using an IIS IgA standard.
Quantitation of IgG. lactoferrin, lysozyme and albumin
Single radial immunodiffusion was used to quantify IgG, lacto¬
ferrin, lysozyme and albumin using reagents and standards described
previously (McClelland et al., 1978).
Quantitation of Dehydroepiandrosterone sulphate (DHAS)
A double antibody RIA was performed by Dr. W.R. Miller using
the method of Buster and Abrahams (1972).
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Gel filtration
Gel filtration was carried out on a single sample of cyst
fluid in an identical manner to the gel filtration studies described
in the previous section (Section 6.3.1).
Sedimentation Coefficient Determination
This was performed in a manner identical to the procedure
described for the ultracentrifugal analysis of breast secretions from
a patient with hyperprolactinaemic galactorrhoea (Section 6.3.1).
A 7S IgA standard was used for the quantitation of IgA in ultra-
centrifugation fractions when the IgA detected was predominantly 7S,
and the IIS IgA standard when the IgA detected was predominantly of
11S. In a few cyst fluids, fractions from ultracentrifugal analysis
were also assayed using anti-11S IgA/FSC .
6.5-2 Results
IgA, IgG, lactoferrin, lysozyme and albumin concentration in
cyst fluids
A wide range of concentrations of IgA (using an IIS IgA
standard), IgG, lactoferrin and albumin were observed in cyst fluids
(Fig.6.11 ).Lysozyme was only detected in 1; cyst fluids from among 95
examined, and concentrations ranged from 0.13 to 0.5U g/1. When the
mean value for the concentrations of IgA, IgG, lactoferrin and albumin
in Group I cyst fluids were compared with the corresponding mean
values in Group II cyst fluids, no significant difference was found
(Student's t-test), suggesting that the longer storage period for
Group I cyst fluids had not adversely affected milk protein
concentrations. The data for Group I and II cyst fluids was therefore
pooled: mean (3S.E.) values for IgA, IgG, lactoferrin and albumin
were 0.18 - 0.03 g/1, 0.5U - 0.09 g/1, 1 -02 - 0.29 and 2.29 - 0.U8
1 h9
cn
c
O
u
c
O
u
CO
<
X
O
Ol-
OOI-
OOOl
Fig. 6.12:
Scatter histogram illustrating DHAS concentrations in the cyst
fluids of Group I (left histogram) and Group II patients (right
histogram). The horizontal bar indicates the arithmetic mean.
1£0
respectively. The detection rate of these proteins was 100$, 68.1$,
88.1|$ and 9h-7% respectively.
Three different cyst fluids were also examined from an
additional patient with galactocoeles following a recent pregnancy.
Mean (^S.E.) IgA, IgG, lactoferrin, lysozyme, albumin and DHAS
concentrations were 2.99 - 1 .73 , 0.010 - 0.003 , 2.02 - 0.^7, 0.22 - 0,17,
0.60 - 0.01 and 0.000,181 - 0.000,069
DHAS concentrations in cyst fluids
A wide range of concentrations of DHAS-like material was
detected in all cyst fluids (Fig. 6.12) Xn contrast to the data for the
milk protein concentrations above, the mean (-S.E.) values for DHAS
concentrations in Group I and II cyst fluids was 0.0f>1 - 0.006 and
0.128 - 0.131 g/1 respectively, a difference that was highly significant
(p< 0.001, Student's t-test). This suggested that the longer period
of storage of Group I cyst fluids might have adversely affected DHAS
concentrations.
Effect of Reaspiration of Cyst on concentrations of milk proteins
and DHAS
Four cysts were aspirated at 21 day intervals in Group II
patients to study the effect of successive aspirations on IgA, IgG,
albumin and DHAS concentrations. It was found that in three of the
patients, in particular patient no Ij., marked changes in either IgG
or albumin concentrations occurred. The data for the cyst fluids of
three of the patients (nos 1,2 and U) on the second aspiration
indicated that the aspiration procedure itself did not result in an
increased albumin or IgG concentration at the second aspiration
(Table 6-6).
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Table 6-6: Effect of Reaspiration of Cyst after 21 days on cyst fluid
Patient Cyst
no.
Vol.
(ml)
IgA
concen¬
tration
(mg/1)
IgG
concen¬
tration
(mg/1)
Albumin
concen¬
tration
(mg/1)
DHAS
concen¬
tration
(mg/1)
1 5 8.0 266 390 1100 93-00
10 8.0 111* 120 360 50.00
2 12 N.K. 1*2 130 #0 269.00
13 N.K. 32 <100 300 31*8.00
3 18 N.K. 61* <100 200 102.50
19 N.K. 88 1*80 2500 115.00
1* 22 5.0 275 11*00 61*00 1 .51
25 3.0 7 <100 21*0 11*0.00
■- ?£■
The second cyst fluid for each subject was aspirated 21 days after
the initial aspiration of the cyst.
N.K. = not known.
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Relationship of milk protein and DHAS concentrations to parity.
menstrual status and, cyst volume
The parity of the patients studied in Group I and II (where
known) ranged from parity 0 to parity 6. However, no obvious relation¬
ship was seen between milk proteins and DHAS concentrations, and parity.
Unfortunately, no conclusion could be drawn about the relationship
of menstrual status to cyst fluid concentrations of any of the
substances studied because the majority of patients studied (approx¬
imately 90%) were premenopausal and there were insufficient numbers
of menopausal and post-menopausal patients.
In the Group II patients, a record was made of the volume of
the cyst fluids aspirated, but no obvious relationship was observed
between the volume of the cyst fluid aspirated and the age, parity,
menstrual status of the patient, or milk protein and DHAS cyst fluid
coneentratians.
Variation in IgA concentration in cysts from the same patient
Two cysts from each of two patients in Group II were aspirated
on the same occasion. IgA concentrations in each pair of cyst fluids
were 1 Of? and 269 mg/1, and 75 and 169 mg/1. Unfortunately, it was
not possible to measure other milk proteins or DHAS because of the
small volume of cyst fluid available.
Gel filtration
A sample of cyst fluid with high IgA concentrations (no 26,
Table 6-7) was analysed to ensure that the IIS IgA standard had been
the correct one to use. It was found that the peak of IgA immuno-
reactivity in this particular cyst fluid coincided with the peak of
immunoreactivity in a sample of normal adult serum analysed under the
same experimental conditions. This suggested that cyst fluid no 26
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contained mainly 7S IgA, and that the appropriate IgA standard to
this
use for/cyst fluid was 7S rather than 11S (Fig. 6.13).
Sedimentation Coefficient Determination of IgA in Cyst Fluids
Sedimentation coefficient determinations were performed on the
IgA present in the 19 cyst fluids with the highest IgA levels (from
both Group I and Group II patients) where there was sufficient material
for analysis. This was to confirm the finding of 7S IgA in a single
cyst fluid (by gel filtration) and to ensure that the correct standard
was being used for the measurement of IgA by RIA in the cyst fluids.
It was found that the peak of IgA immunoreactivity in nine of
the cyst fluids studied was in the same position in the sucrose
gradient as the 7S marker, while in the remaining ten, it was in the
same position as the 11S marker. The IgA in fluid from the galacto-
coele was, as expected, in the IIS position (Fig. 6.1l±). Mixtures
of 7S and 11S IgA immunoreactivity were seen in some cyst fluids
(Fig. 6.15).
To confirm that the imiminoreactive IgA in the same position
as the 11S marker was truly IIS IgA, and not 10S IgA, some fractions
were reanalysed, but using anti-US IgA/FSC. It was found that a
cyst fluid that had previously been found to have a peak of IgA
immunoreactivity in the IIS position again showed a peak of immuno¬
reactivity in the IIS position using anti-11S IgA/FSC. The fluid
from the galactocoele also showed a peak of IgA immunoreactivity in
the IIS position using anti-11S IgA/FSC, confirming that in these
two fluids it was the complete 11S IgA.molecule that was being detected.
Interestingly, in these two fluids, small amounts of imraunoreactive
material were detected near fraction 35, a position on
the sucrose gradient with a sedimentation coefficient value
corresponding to free secretory component. However, precise
quantitation of the free secretory component in these two cyst fluids
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was not possible due to the lack of the purified protein standard.
Although no peaks of IgA immunoreactivity were detected in the 7S
position using this antiserum, it was observed that two of the cyst
fluids with the peak of IgA immunoreactivity in the 7S position, also
contained some immunoreactive material that suggested the presence
of IIS IgA (Fig. 6.16).
The 19 cyst fluids that were analysed by sucrose density
gradient ultracentrifugation were therefore divided into cyst fluids
where the IgA was wholly or predominantly 7S or IIS. When the two
categories of cyst fluids were compared, it was found that mean IgG
and albumin concentrations were significantly greater in the cyst
fluids where IgA was of the 7S form than in the cyst fluids where IgA
was of the IIS form. In contrast, mean DHAS concentrations were
significantly lower in the cyst fluids where IgA was of the 7S form
(p< 0.001 in all cases, t-test; Table 6-7). When the clinical
data for the two types of cyst fluids were compared, all the cyst
fluids with IgA in the 11S form were noted to have been aspirated
from premenopausal patients (Table 6-8).
6.^.3 Discussion
In this section, fluid obtained from the cysts of patients with
gross cystic disease of the breast were studied because of the pos¬
sibility that the fluid within the cyst might reflect the synthetic
activity of the surrounding breast tissue, and therefore allow the
study of the influence of various clinical factors on the secretory
immune system of the breast. In addition, it was thought that a study
of milk proteins and DHAS in cyst fluid might lead to an understanding
of the mechanism of cyst formation.
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Table 6-7: Classification of cyst fluids by the sedimentation
coefficient of the major IgA peak
IgA Peak in 7S Position
Lactoferrin
concen¬
tration
(mg/l)
Cyst IgA. IgG Albumin DHAS
fluid concen- concen- concen- concen-
no. tration tration tration tration
(mg/l) (mg/1) (mg/1) (mg/l)
1* 796 71*0 61*00 0.95 1*1*0
26 669 2900 61*00 11 .00 25000
31 .639 1600 12200 3.50 61*0
37 661* 1500 13950 10.30 1*00
1*2 867 720 1820 3.00 230
1*8 286 1350 8900 2.30 690
57 676 3100 17050 18.00 1010
61 939 2750 13050 1*.22 300
26* 331* 2150 61*00 0.57 1320
mean 652 1868 9571* 5.98 3330
S.E. 73 300 1602 1 .95 271
IgA Peak in IIS position
5 (2) 390 N.D. 200 1*8.00 1080
8 (1) 780 N.D. 200 80.00 121*0
8 (2) 1*75 N.D. 200 53.50 121*0
10 (1) 1*99 N.D. 70 57.50 181*0
10 (2) 1*07 100 270 56.00 1730
13 (2) 776 100 120 23.50 720
18 1*32 N.D. 50 120.00 350
38 (1) 308 760 1170 3.15 ' /. 580
1*1* 1*22 110 1*70 1*2.50 11*00
*
CM 1*93 N.D. 21*0 325.00 1200
mean 1*98 16.7 299 80.91 1138
S.E. 50 66 103 28.85 151
P N.S. < 0.001 < 0.001 < 0.001 N.S.
Cyst fluids were all obtained from Group I patients except for two fluids
marked with an asterisk, which were obtained from Group II patients.
The figure in brackets indicates cyst fluid obtained from a different
cyst, or on a different occasion^ but from the same patient.
N.D. = Below the limit of detection (<100 mg/l). For statistical
purposes, this was calculated as 100 mg/l.
N.S. = Not significant. 160
Table 6-8: Clinical data of patients -with cyst fluids classified by
the sedimentation coefficient of the ma.ior IgA peak
IgA Peak in 7S position
fluid no. Age Menstrual status Parity
b bb Not known Not known
26 b7 Postmenopausal 0
31 h6 Hysterectony 0
37 b9 Postmenopausal 1
h2 33 Not known 3
U8 U3 Premenopausal 3
37 38 Premenopausal 2
61 3U Not known 3
26* 3U Premenopausal 3
IgA Peak in 11S position
3 (2) b7 Premenopausal 3
8 (1)
8 (2)
Not known Not known Not
10 (1) bs Premenopausal 0
10 (2)
13 (2) hP Premenopausal 2
18 b9 Premenopausal 1
38 (1) bO Premenopausal 0
bb 32 Premenopausal 0
23* b2 Prernenopausal 3
•Jfr
Asterisks indicate cyst fluids obtained from Group II patients.
an other cyst fluids were obtained from Group I patients. ,
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The study of gross cystic disease of the breast is of
particular importance because of the higher than expected incidence
of breast carcinoma in patients with gross cystic disease (Warren,
1I9U0; Lewison and Lyons, 19!?3j Veronesi and Pizzocara, 1968$
Haagensen, 1971). However, the location of the malignant tumour is
rarely related to the site of previous cysts, and it has been suggested
that gross cystic disease and carcinoma of the breast share a common
aetiologic factor (Haagensen, 1971). Histologically, gross cystic
disease appears to be characterised by hyperplasia of acinar epi¬
thelium associated with dilatation of the terminal ducts (Schnug and
Cavanagh, 1966), and it has been proposed that breast cyst fluid is
a unique secretion from breast epithelial cells, possibly in response
to abnormal hormone stimulation (Haagensen, Mazoujian, Dilley, Pedersen,
Kister and Wells, 1979), with an intracellular-like ionic consistency
(Fleisher, Robbins, Breed, Fracchia, Urban and Schwartz, 1973).
Biochemical analysis of cyst fluid is at present incomplete; CEA
(Fleisher, Oettgen, Breed, Robins, Pinsky and Schwartz, 197k), various
enzymes (Schwartz, Fleisher, Breed, Ashilcari, de Palo, Kinne and Urban,
1976), various steroid hormones (Bradlow, Fukushima, Rosenfeld, Boyer,
Kream, Fleischer and Schwartz, 1976), protein hormones (Srivastava,
Pescoritz, Singh, Perisutti and Knowles, 1977), oestriol conjugates
(Raju, Ganguly and Levitz, 1977), a progesterone binding component
(Pearlman, Gueriguian and Sawyer, 1973), albumin (Fleisher et al..
1973), haemosiderin (Haagensen, 1971) and other proteins (Haagensen
et al., 1979) have all been found in cyst fluids, but the origin of the
fluid within the cyst is still unresolved.
The results of this study show that a wide range of IgA, IgG,
lysozyme, lactoferrin, albumin and DHAS concentrations can be detected
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in cyst fluids. Only DHAS concentrations seemed to be affected by
the prolonged storage period of up to two years at -20°C, as judged
by mean levels of DHAS in Group I and Group II patients using Student's
t-test. However, it is possible that this may not be the appropriate
statistical test to use since protein and DHAS values may not be
normally distributed (see below).
The rate of detection was probably a reflection of the
sensitivity of the assay method used being 100$ for the substances
detected by RIA (IgA, DHAS) and less for the substances detected by
radial immunodiffusion. The high detection rate for lactoferrin,
which is not normally detectable in serum, suggests that the cyst fluid
probably does indicate the synthetic activity of the surrounding breast
tissue.
Density gradient ultracentrifugation was used to discover the
cause of the large variations of IgA, IgG and albumin concentrations
observed. Of nineteen cyst fluids analysed, half contained IgA that
was wholly or predominantly of the 11S type, and the remaining half
contained IgA of the 7S type. The latter cyst fluids also contained
high concentrations of two other serum proteins: IgG and albumin. This
suggested that components of serum were entering the cyst by some
unknown route. Interestingly, these cyst fluids also contained low
concentrations of DHAS, similar to concentrations in serum, suggesting
that fluid was also possibly entering the cyst from the vascular
compartment. The appearance of serum proteins in cyst fluid was not
due to the method of aspiration as shown by repeated analysis of fluid
from the same cyst after a 21 day interval.
The high concentrations of IIS IgA present in some cyst fluids
suggested that local synthesis of 11S IgA was occurring. In these cyst
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fluids, very high concentrations of DHAS were observed. These values
were similar to the concentrations found in normal breast secretions
(Miller, Humeniuk and Kelly, 1980). Unfortunately the occurrence of
mixtures of 11S and 7S IgA in some cyst fluids indicated that no single
IgA standard was suitable for IgA measurement.
Insufficient clinical data was present to draw any firm
conclusions about the relationship between milk protein and DHAS con¬
centrations, and the various clinical parameters recorded. The difference
in menstrual status between patients whose cyst fluids contained
mainly 7S IgA, and those whose cyst fluids contained mainly 11S IgA
was intriguing. It may have been due to reduced synthesis of IIS IgA
in the postmenopausal breast, so that the only way in which a cyst fluid
from a postmenopausal patient could contain high IgA levels would be
by entry of 7S IgA from the vascular compartment. Unfortunately, it
was not possible to analyse a larger number of cyst fluids by ultra-
centrifugation for practical reasons, and this explanation therefore
remains unproven.
The results of this study indicate that breast cysts may be
more heterogenous than previously thought, and that two or more "types
of cysts may occur in gross cystic disease of the breast. .It is
unlikely that cyst fluid only reflects the synthetic activity of the
surrounding breast tissue and further studies are required to discover
if the determination of milk protein or DHAS concentrations for a
particular cyst fluid is of any clinical importance to the patient.
It is conceivable that the high concentrations of DHAS in some cyst
fluids might act as a precursor reservoir for the synthesis of more
powerful hormones such as testosterone as suggested by Miller et al. (1980).
Alternatively, high 11S IgA concentrations in cyst fluid might indicate
16U
that the particular breast from which the cyst fluid originates is
functioning 'normally' and therefore less at risk of subsequent
malignant change, than a breast with cyst's containing fluid with high
7S IgA concentrations.
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CHAPTER 7
BREAST FEEDING AND SERUM IGA
IN THE NEONATE
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CHAPTER 7 BREAST FEEDING AM) SERUM IgA IN THE NEONATE
7.1 INTRODUCTION
A major function of the breast is the transfer of immunity from
mother to neonate (Chandra 1978, McClelland et al.. 1978). Colostrum
and milk are rich in IgA and the breast fed infant ingests large
amounts of this immunoglobulin. Neonatal serum, in contrast to
maternal milk, is deficient in IgA, reflecting the immaturity of the
IgA synthesising system at birth (Tomasi and Grey, 1972). As described
previously, IgA in colostrum and milk consists largely of 11S IgA
(Newcomb et al., 1968; Hurlimann, Waldesbuhl and Zuber, 1969) which
is more resistant to digestion by intestinal proteolytic enzymes in
the neonatal gut than 7S IgA, due to the presence of secretory
component (Brown, Newcomb and Ishizaka, 1970). Although it is known
that the majority of IgA in feeds of colostrum and milk is not
absorbed by the infant (Ammann and Stiehm, 1966; Kenny, Boesman and
Michaels, 19675 Ogra, Weingraub and Ogra, 1977), it has been suggested
that the gut in early neonatal life is capable of absorbing small
quantities of IgA (Iyengar and Selveraj, 1972; Ogra et al. 1977).
However, the assay techniques which have been used have been relatively
insensitive and it was considered desirable to examine this question
using RIA, with its greater sensitivity, in a study of normally
breast-fed infants.
The purpose of the study described in this chapter was to determine
if exclusive breast feeding for one week altered IgA levels in the
serum of neonates. IgA concentrations in the serum of exclusively
breast-fed neonates were therefore compared with IgA levels in the
serum of exclusively artificially fed neonates. In addition, the
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metabolism of IgA in early life was studied by analysing cord blood
samples and comparing IgA concentrations present at birth with those
found in the same infant six days later. . The molecular size of IgA
in the neonate was also estimated by gel filtration.
7.2 MATERIALS AND METHODS
Sera: Forty-eight healthy, full term neonates were studied: 23 of
the neonates were exclusively artificially fed and 25 were exclusively
breast fed. Cord blood was collected from 2k.
On the sixth day after delivery, a heel prick blood sample is
routinely taken for Guthrie testing, and a further- 0.5 ml blood sample
was taken from the same site into a polythene capillary tube
(Sarstedt). The blood was allowed to clot, the serum separated by
centrifugation and stored at -20°C till analysis. All blood samples
were collected by Dr. P.J. Latham, whose assistance is gratefully
acknowledged.
Quantitation of serum IgA concentrations
IgA concentrations were determined by RIA as described in
Chapter J4..
Gel filtration
Gel filtration studies were carried out using a Sepharose I4B
(Pharmacia) column as described in Chapter 1;. Immunoassay was performed
on unconcentrated fractions.
Statistical methods
Student's t-test was used to compare the arithmetic means of
serum IgA concentrations in the breast-fed and artificially fed
neonates. A paired Student's t-test was used to compare cord blood
samples with further serum samples taken from the same baby 6 days
later.
168
•o
<N
90*
70-
o
CD
m
o
V-*
Q
Z
3
O
CO
<
S 30
50-
SERUM ADDED (jJl)
0-13 0-50 20 4-0
10-
5 20 80 320
1gA CONCENTRATION ( jjg/l)
Fig. 7.1 :
Inhibition curves for serum IgA standard (»—■ ), cord blood
(a—A and **—*), six-day heel prick serum from an exclusively
artificially-fed neonate (o—o ) and six-day heel prick serum from
an exclusively breast-fed neonate (• • ).
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7.3 RESULTS
Standard inhibition curve for IgA
1
The binding of PI-11S IgA to rabbit anti-7S IgA was inhibited
in a parallel manner by the 7S IgA standard, two samples of cord
blood, one sample of heel prick blood from a 6-day old neonate that
had been artificially fed, and one sample of heel-prick blood from a
6-day old neonate that had been breast fed (Fig. 7..1). This indicated
that immunoassayable IgA was present in cord blood and day 6 heel
prick blood.
Characterisation of IgA in cord blood and day 6 serum
A single peak of immunoassayable IgA on Sepharose 1|B gel
filtration was found in cord blood, pooled sera from k artificially
fed and k breast fed six-day old neonates, human colostrum, human
i|..8 and U.9) •
milk and from adult serum (Fig. 7.2// Cord blood and heel prick
serum IgA eluted at the same volume as adult 7S IgA and at a different
volume from 11S IgA present in milk and colostrum, indicating that
the predominant form of IgA in both cord blood and day 6 sera is the
7S monomeric norm. The trace of immunoassayable material found in
infants' serum at the elution volume of secretory IgA was at most 2.$%
of the 7S peak, suggesting that there is very little IIS IgA in day
6 serum. The 7S IgA standard was therefore used for all subsequent
measurements of IgA in cord blood and serum.
IgA concentration in cord blood
The concentrations of IgA in 2k cord blood samples ranged
from 0.52-^16.0 mg/1. Four neonates had cord blood levels that were
greater than 10 mg/1 and in two of these neonates, IgA levels decreased
from 516 mg/1 to 0.33 mg/1 and from 329 mg/1 to 3.08 mg/1 in 6 days
(Fig. 7-3).
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A significant decrease in IgA concentrations occurred during
the first 6 days of life in 20 neonates from -whom both cord and day 6
sera were tested^ this was found in both artificially and breast-fed
neonates (paired t-test, t-= 3.09, P<0.01, Fig. ,7.3). The four
neonates with cord blood levels greater than 10 mg/l were excluded
from statistical analysis because their cord sera were probably
contaminated with maternal blood.
IgA concentrations in day 6 serum
Serum IgA levels in 23 exclusively artificially fed and 23
exclusively breast-fed babies on the sixth day of life were 2.71 -
0.23 mg/l and 2.38 - 0.33 mg/l (arithmetic,/ 'mean - SE) respectively
(Fig. 7.3). There was no significant difference between mean IgA
concentrations in the two groups showing that exclusive breast feeding
had no detectable influence on serum IgA levels after 6 days. One
baby had less than 0.1k mg/l of IgA in its serum suggesting that it
might be deficient in IgA. This baby also had the lowest IgA
concentration in its cord blood.
7.1* DISCUSSION
In this chapter, the influence of breast feeding on IgA
concentrations in the serum of neonates was studied as the neonate
is IgA deficient at birth and breast feeding might therefore be able
to compensate for this. In comparison, IgG concentrations in neonatal
serum are equal to or greater than maternal serum IgG concentrations
due to transplacental transfer of IgG but not IgA (McClelland and
Samson, personal communication) . The properties of IgA antibodies in
serum have not been clearly delineated, due to the difficulties of
obtaining IgA preparations devoid of contaminating antibodies of
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Fig. 7-3: —
Serum IgA concentration in the cord blood of 2l± newborn infants and heel
prick sera of 23 artificially-fed and 2f> exclusively breast-fed six-day old
neonates. The solid lines indicate cord blood and heel prick sera that
were collected from the same baby, and the broken line the limit of
detection for serum IgA. in this particular assay.
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other immunoglobulin classes. Although IgA immunoglobulins cannot
fix complement by the classical pathway, 7S IgA and IIS IgA have
been reported to be effective activators of the alternative pathway
if artificially aggregated (Gotze and Muller-Eberhard, 1971j Colten
and Bienenstock, 197U)• The ability of IgA antibodies to opsinize
is controversial (for references, see Lamm, 1976), and it is thought
that the most important function of IgA antibodies is not in serum but
in external secretions e.g. gastrointestinal fluids, where IIS IgA.
antibodies can prevent bacteria from adhering to epithelial cells,
thus limiting bacterial colonisation and penetration of mucous .
surfaces (Williams and Gibbons, 1972). In addition, it is likely
that 11 S IgA antibodies can prevent the absorption of foreign
proteins by the formation of antigen-antibody complexes which are not
absorbed (Walker, Isselbacher and Bloch, 19725 Andre, Bazin and
Heremans, 1973).
In view of the IgA deficiency that exists at birth, breast
feeding might be an important mechanism for the transfer of immunity
to the serum compartment of the human neonate. In animal species where
immunoglobulin transfer via the placenta does not occur (horses, pigs,
cows, goats),absorption of colostral immunoglobulins (mainly IgG)
•
from the gut of the newborn takes place (Brambell, 1970). In human
neonates, the evidence for absorption of immunoglobulins from the
neonatal gut is conflicting. Although large amounts of IgA are
present in colostrum and breast milk (e.g. 3.£2 gm/2k hr and 1.31
gm/2k hr of IIS IgA is produced on the second and fifth day post¬
partum, McClelland et al.. 1978), Ammann and Stiehm (1966) found no
difference in immune globulin levels between artificially-fed and
breast-fed infants after days of breast feeding. In contrast,
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Iyengar and Selveraj (1972) reported significantly higher immuno¬
globulins on the fifth day of life in colostrum-fed infants compared
with artificially-fed infants. Ogra et al. (1977) reported a rise
in serum IgA levels in 3 infants who were fed colostrum 18 to 2k
hours after birth and suggested that the gut is capable of absorbing
IgA at this stage. In these studies IgA levels were determined by
the relative^ insensitive technique of single radial immunodiffusion
which has a lower limit of detection of approximately 10 mg/1$ Ogra
et al. (1977) used the slightly more sensitive technique of radio-
immunodiffusion.
In the studies described in this chapter, low concentrations
of IgA (a thousand-fold less than the IgA concentrations seen in
adult serum) were found in all the neonates studied by RIA, and these
levels were not influenced by breast feeding. Furthermore, it was
found that in infants' sera, less than 2.%% of the imrnunoreactive
IgA-like material behaves like IIS IgA on gel filtration. Breast
feeding would have been expected to produce an immunoreactive peak at
the IIS position in neonatal sera if the IIS molecule was absorbed in
the intact form by the neonatal gut.
The data demonstrates firstly, that IgA absorption had ceased
by the time of sampling at the sixth day, and secondly, that if there
was a period of IgA absorption before the sixth day, IgA entering the
circulation must have been cleared,with a half-life value considerably
less than the adult serum IgA half-life value of approximately 5
days (Waldmann and Strober, 1969). The collection of blood was
delayed till the sixth day post-partum because it was considered
unethical to obtain samples earlier, as no routine samples were being
taken at that time.
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The values for cord blood concentrations of IgA observed are
consistent with the concentrations found by other workers using
techniques of similar sensitivity (Faulkner and Borella, 19705
Schuurman, Haagenars and Zegers, 1977). However, I4. neonates were
found to have cord blood concentrations that were greater than 10 mg/l.
When these U neonates were studied 6 days later, their respective
serum IgA. levels had decreased much more than would be expected if
the half-life of serum IgA in the infant is similar to that in the
adult. It is therefore likely that these high values may be due to
contamination of cord blood with maternal blood at the time of
collection. Earlier reports of raised IgA in cord blood serum
(Stiehm, Ammann and Cherry, 1966) may therefore have been due to
contamination of cord blood by maternal blood (with thousand fold
higher IgA concentrations) at the time of collection.
In the remaining 20 neonates in whom paired cord and day 6
sera were collected, a significant decrease in serum IgA was observed
in the first 6 days of life. It is possible that this may have been
due to transplacental transfer of maternal IgA or to minimal contam¬
ination with maternal blood at the time of cord blood collection.
It was unfortunately not possible to distinguish between these two
possibilities with the methodology available. It is unlikely that
this decrease is due to cord material interfering with a sensitive
inhibition test • as parallelism in an inhibition curve was observed
between IgA in adult serum and IgA in cord blood. In addition, only
a single peak of immunoreactivity (at the elution volume of adult 7S
IgA) was found in cord blood on examination by gel filtration. Any
substance that interfered with cord blood IgA determinations would have
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been expected to elute at a different volume on gel filtration to
7S IgA, and therefore would have been detected on immunoassay of the
gel filtration fractions.
It was not possible to detect IgA at the assay dilution used
in one neonate, indicating a level less than OJI4. mg/l. This neonate
also had the lowest cord blood value among all neonates studied.
Unfortunately, there was insufficient serum for further analysis
using more sensitive conditions for IgA detection but it is possible
that this infant may be selectively deficient in IgA. This condition
has not been previously reported in neonates, but further studies of
this neonate when he is older are required for confirmation.
In conclusion, it is likely that the principle physiological
of colostrum and breast milk IgA in the neonate is at the level of
the intestinal lumen or mucosal surfaces (Brambell, 1970) as no
detectable transfer of IgA into the circulation of infants occurs.
17?
CHAPTER 8
GENERAL DISCUSSION
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CHAPTER 8 GENERAL DISCUSSION
The aim of the experiments described in this thesis was to
study the human mammary secretory immune system in different repro¬
ductive states by measuring 11S IgA secretion. Most of the studies
this subject have been concerned only with the post-partum lactating
breast, and the experiments described in this thesis have extended
knowledge about mammary secretory immunity to the neonate and the
non-lactating woman, and have also demonstrated the influence of pro¬
lactin on the development and maintenance of secretory immunity in
the breast. In this final chapter, the experimental observations
described in this thesis are related to current views of the develop¬
ment and control of secretory immunity outwith the breast. The
relevance of these observations to the aetiology of carcinoma of the
breast is also discussed.
The origin of the precursors of IgA secreting lymphocytes
In the human, the precursor lymphocytes destined to differen¬
tiate into the antibody synthesizing cells of the secretory immune
system probably originate in the foetal liver (Lawton, Self, Royal
and Cooper, 1972) or bone marrow (Abdou and Abdou, 1972). From there
these lymphocytes then migrate to gut-associated lymphoid tissue
(GAIT) consisting mainly of collections of lymphoid tissue in the
submucosa of the small intestine known as Peyer's patches. While in
the liver or bone marrow, these lymphocytes are influenced in an
unknown manner, so that they become committed to antibody synthesis
(Lamm, 1976). In the chicken, this committment takes place in the
Bursa of Fabricius, and these lymphocytes destined to synthesize anti
body are therefore called B lymphocytes (bursa equivalent derived
lymphocytes).
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Other lymphocytes migrate from the foetal liver or bone
marrow instead to the thymus where their development is influenced in
a different manner, so that they subsequently participate in cell
mediated immunity, or in the control of antibody synthesis by B
lymphocytes. Some thymus derived lymphocytes (T lymphocyte^) may
either suppress antibody synthesis (T suppressor lymphocytes) or
stimulate it (T helper lymphocytes).
The role of antigen in the development of the secretory immune
system
The access of GALT to antigens within the intestinal lumen is
thought to be important in the activation of IgA precursor lymphocytes
in the secretory immune system. Cellular proliferation and the
attainment of the full size of Peyer's patches is highly antigen
dependent, and in germ-free mice, both IgA. plasma cells in the
intestines and IgA. production are decreased (Stecher and Thorbecke,
1967; Crabbe, Bazin, Eyssen and Heremans, 1968; Vitetta, Grundke-Iqbal,
Holmes and Uhr, 1971+).
The access of GAIT to intestinal antigen is thought to be
assisted by a specialised epithelium overlying the lymphoid tissues
(Bookman and Cooper, 1973). The cells of this epithelium were reported
by Owen (1977) to preferentially take up horseradish peroxidase after
exposure to small quantities of this antigen, and then to release
the antigen into the underlying interstitial space for processing by
the lymphoid cells within Peyer's patches. Interestingly, in the
same experiments, a generalised uptake by other non-specialised
epithelial cells was noted at higher concentrations of horseradish,
peroxidase, suggesting that the mode of access to GALT may be dependant
upon antigen concentration within the intestinal lumen.
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The role of the thymus
Although B lymphocytes are responsible for the synthesis of
the large quantities of IgA appearing in external secretions, a number
of studies have emphasised the importance of the thymus, or of T
lymphocytes in the development of the secretory immune system. Firstly,
Peyer's patches in congenitally athymic ('nude') mice do not contain
germinal centres, and although IgA bearing lymphocytes are observed
in the peripheral blood of such animals, IgA plasma cells in the lamina
propria of the gut (considered to be part of the secretory immune
system) are markedly reduced. Furthermore, these mice do not respond
to antigenic challenge with a normal rise of IgA antibody (Hauptman
and Tomasi, 1978).
Secondly, in humans, thymic abnormalities are often associated
with deficiencies of IgA. In ataxia-teleangiectasia, there is a
reduction in salivary IIS IgA as well as serum IgA despite the fact
that these patients have normal numbers of circulating B lymphocytes
bearing IgA (Peterson, Kelly and Good, I96I4.). This suggests that
there is either a lack of specific IgA T helper lymphocyte activity,
or alternatively, a relative excess of T suppressor lymphocytes
specific for IgA. _ . .1 . J.:; , ' .;;
The latter defect has been demonstrated in IgA deficient patients,
many of whom have associated defects in secretory IgA (Waldman et al., .
197k).
Thirdly, the elegant experiments of Elson, Heck and Strober
(1979) have demonstrated variations in regulatory T lymphocyte
activity among various murine lymphoid tissues for IgA, but not IgG
or IgM. Peyer's patches were found to contain a high level of IgA
T lymphocyte helper activity in contrast to peripheral or mesenteric
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Intestine GALT
Fig. 8.1 :
A diagrammatic representation of the movement of lymphocytes from Peyer's
patches to sites of secretory immunity.
Antigen from the intestinal lumen activates B lymphocytes in Peyer's patches'
(part of the gut-associated lymphoid tissue, GALT), and IgA precursor
lymphocytes pass sequentially through the mesenteric lymph nodes to sites of
secretory immunity (e.g. the breast, lung, salivary gland and the lamina
propria of the gut), where they differentiate into IgA secreting plasma
cells. It is thought that IgA precursor lymphocytes do not return to
Peyer's patches but 'home' to the adjacent lamina propria.
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lymph nodes and the spleen. In all the above lymphoid tissues, T
lymphocyte suppressor activity was found for IgG and IgM leading this
group to propose that in the mouse, a specific subset of helper T
lymphocytes is involved in the regulation of IgA synthesis.
Further indirect evidence supporting the above concept arises
from the observation that GAIT cells, when isolated and incubated
in vitro, do not mature spontaneously into plasma cells capable of
synthesizing antibody, suggesting that helper T lymphocytes and
perhaps other factors like bacterial mitogens (e.g. lipopoly-
saccharide) may be.required for maturation of precursor lymphocytes
into IgA plasma cells (Walker and Isselbacher, 1977) -
The entero-mammary lymphocyte cycle
Extensive evidence for the circulation of IgA precursor
lymphocytes from GALT to the mammary gland exists, as described in
Chapter 1 . It is currently thought that following activation by
intestinal antigen, precursor lymphocytes pass sequentially through
the mesenteric lymph nodes, the thoracic duct, the blood vessels,
finally reaching the mammary gland and other sites of secretory
immunity (reviewed by Lamm, 1976; Fig. 8.1).
This movement of lymphocytes from GALT to sites of secretory
immunity has been described as 'homing' a term which implies that a
directed migration of precursor IgA lymphocytes exists. The exact
factor(s) that control homing are unknown, but one factor that has
been proposed is secretory component. This protein is synthesized by
epithelial cells, and binds preferentially to polymeric rather than
monomeric IgA (Radl, Klein, van den Berg, de Bruyn and Hijmans, 1971).
Furthermore, it has been demonstrated that a tendency exists for IgA
plasma cells in different locations to bind secretory component
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(Brandtzaeg, 1973)* However, it should be noted that no direct
evidence for the interaction of plasma cell surface IgA and locally
produced secretory component exists. Furthermore, IgA precursor
plasma cells arriving in a mucous membrane do not directly impinge
on the epithelial cells, making such an interaction less likely, and
experiments conducted by McWilliams, Philips-Quagliata and Lamm
(1975) in mice consisting of passively raising IgA levels or injecting
antiserum to secretory component failed to disrupt this hypothetical
interaction.
Another possibility, first proposed by Gowans and Knight (1961*),
is that homing (to the lamina propria of the gut) might reflect a
specific attraction or retention of cells that had been previously
sensitised to intestinal antigens. In support of this, IgA
producing plasma cells (presumably capable of synthesizing cholera
antitoxin) were demonstrated to home to the small intestine after oral
challenge with the toxin (Pierce and Gowans, 1975)* However, against
this hypothesis, Griscelli, Vassali and McCluskey (1969) demonstrated
that homing of mesenteric node lymphoblasts to the gut occurs in
germ free animals which are antigen deficient. Similar homing of
thoracic lymphoblasts to the small intestine of unsuckled neonatal
animals delivered by Caesarian section also occurs (Halstead and
Hall, 1972) as does lymphocyte homing to grafts of foetal intestine
explanted to sites free of antigen exposure (Moore and Hall, 1972;
Parrott and Ferguson, 1975) • In the latter study, the homing lympho¬
cytes were capable of differentiating into plasma cells, secreting
IgA into the lumen of the gut explant. Thus it is likely that
lymphocyte homing is independant of antigens and it is difficult to
see how such a mechanism might operate in the mammary gland.
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The requirement for IgA precursor lymphocytes to be specifically
involved in homing has recently been questioned by Brandtzaeg <4t al<. (1979)»
In IgA. deficient individuals, it is known, that there are compensatory
increases of IgM B lymphocytes in the intestine, and of IgD B
lymphocytes in the upper aero-digestive tract. Elson et al. (1979)
proposed an alternative hypothesis to homing, based on their studies
of murine IgA synthesis described above. This group proposed that
IgA B lymphocytes randomly distribute throughout the body after
activation by intestinal antigen, but lodge and terminally differentiate
only in sites where there is sufficient IgA T helper lymphocyte
activity. This proposal, although attractive, raises the problem of
how a differential distribution of T helper and suppressor activity
in the different lymphoid tissues is achieved, and perhaps the homing
of T lymphocytes to the gut described by various workers (Sprent
and Miller, 19725 Guy-Grand, Griscelli and Vasalli, 197i|-J
McWilliams et al., 1975) is of significance in understanding the control
of secretory immunity.
In view of the concepts discussed above, the observations des¬
cribed in this thesis on the neonatal mammary gland would be consistent
with activation of neonatal GALT by intestinal antigen following
parturition, followed by a rapid (within days) influx of IgA pre¬
cursor lymphocytes into the neonatal mammary gland, or alternatively,
an alteration in the secretory activity of the IgA lymphocytes present
in the mammary gland. Current evidence (as described above) would
favour the former, but further experiments might be indicated to
assess the number and class of lymphocytes present in the neonatal
mammary gland pre- and post-partum, and to determine the specificity
of the IgA antibody present in neonatal milk to see if it is directed
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against intestinal antigens.
The Entero-Mammary Cycle and Immunological Protection of the Neonate
o
The ente^-mammary circulation of lymphocytes described in the
preceding pages is of great significance to the immunity of the
neonate, since it results in the IIS IgA antibody content of colostrum
and milk reflecting the antigenic exposure of the maternal gut. The
gut of the breast fed neonate is therefore provided with colostrum
or milk antibodies against microorganisms harboured by, or passing
through the maternal intestine, and also against micro-organisms
present in the environment and likely to reach the neonate. It is
worth noting that in some animals, coprophagia by the mother of the
newborn's faeces can be observed e.g. the rat, and in other animals
licking of the hindquarters of the newborn by the mother is seen
e.g. the deer. If gastro-intestinal infection in the newborn animal
occurs, this behaviour is thought to allow the rapid production of
specific colostral and milk antibodies to the offending organism via
the ingestion of the organism, activation of GALT, seeding of the
mammary gland with IgA precursor lymphocytes and local (intra-
mammary) synthesis of the 11S IgA antibody. Although this newborn/
maternal cycle is unlikely to operate in humans, these observations
may suggest that the current concern with sterility in the care of
the neonate may not be warranted, at least in the case of the breast
fed neonate.
It may be possible to utilise the entero-mammary cycle for
therapeutic benefit by specifically immunising the lactating mother
by intestinal exposure to the relevant antigens. This possibility
has been demonstrated by Svennerholm,Holmgren, Hanson, Lindblad,
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Quereshi and Rahimtoola (19w) who showed that in lactating
Pakistani mothers, a rise in the 11S IgA antibodies in milk against
V. cholerae could be achieved by parenteral immunisation (vaccination)
following natural intestinal exposure to V. chqlerae. This manipu¬
lation of the secretory immune system coupled with breast feeding
may be of great value in countries with high infant mortality rates
due to gasteroenteritis.
The role of prolactin
It has previously been suggested that the ability to transport
secretory immunoglobulins e.g. 11S IgA from the sub-mucosal tissue
fluid to the luminal side of mucosae is a general property of
epithelium developmentally derived from the gut (Hall, Orlans,
Peppard and Reynolds, 1977). This would include all the known sites
of secretory immunity (the alimentary tract, its associated glands,
the liver, the nasopharynx, the upper respiratory tract and part of
aX. (frtirivwdt JI
the genitourinary tract) except the mammary glan<^ which arises as
an appendage of the skin,'jvcvw
The studies of Weisz-Carrington et al. (1978) clearly demon¬
strate that prolactin is the main hormone influencing the transit
of IgA secreting lymphocytes to the murine mammary gland, and the
studies in this thesis indicate that prolactin probably has a similar
role in humans, in view of the high concentrations of IIS IgA in
the mammary secretions of women with hyperprolactinaemic
galactorrhoea.
In Chapter 1 of this thesis, the origin of the entire epi¬
thelium of the mammary gland from the small number of epithelial
cells that represent the embyrological milk line in the foetus is
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described. If it is assumed that mammary epithelial cells possess
some (unknown) property that influences the 'homing' of IgA precursor
lymphocytes (Lamm, 1976), "Uien it might be reasonable to suggest
that the sensitivity of mammary epithelial cells to the action of
prolactin (McNeilly, 1977) allows the mammary gland to possess a
fully functional secretory immune system at the time of parturition,
and shortly after, when prolactin levels are highest (Hwang et al.,
1971). Thus the difference in ontogeny between the mammary gland
and other sites of secretory immunity (Hall et al., 1977) might
reflect the fact that the mammary secretory immune system is normally
only functional post-parturn, unlike other sites of secretory
immunity which are functional continuously e.g. the gut.
In this thesis, high concentrations of 11S IgA. were demon¬
strated in normal breast secretions, although the total quantity of
11S IgA present is much less than the amount present in normal post¬
partum milk or colostrum, or in galactorrhoeic mammary secretions,
since the volume of normal breast secretions was much less. The high
concentrations of 11S IgA in the normal breast secretions of premeno¬
pausal as well as postmenopausal women is consistent with the
proposal that prolactin is the hormone indirectly responsible for
the development and maintenance of the mammary secretory immune
system, by the stimulation of epithelial proliferation. This is
because peripheral blood levels of prolactin in non-lactating women
during the menstrual cycle, and in postmenopausal women, are probably
well in excess of threshold requirements for its action (McNeilly and
Chard, 197il)• Furthermore, prolactin concentrations in neonatal
blood are very similar to the prolactin concentrations in maternal
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blood post-partum, and decline in the same manner (Hiba et al.,
1977) lending weight to the suggestion that prolactin might be
influencing the neonatal mammary gland in the same way that it
influences the post-partum maternal mammary gland.
The Mammary Turnover of IgA secreting lymphocytes
In discussing the mammary secretory immune system, the life
span of IgA secreting plasma cells in the breast needs to be con¬
sidered. Unfortunately, in the human, this is not known, but in the
mouse, a value of 7 to 8 weeks for intestinal IgA plasma cells, and
splenic IgG, IgA and IgM plasma cells has been reported (Mattioli
and Tomasi, 1973)- As the IgA secreting lymphocytes of the mammary
gland originate from the gut, this would indicate that a regular
replenishment of these lymphocytes must occur, and this concept is
in agreement with the observation that immunological memory does not
exist in the secretory immune system (Ogra and Karzon, 1969; Clough,
Zaccari and Strober, 1970$ Andre, Bazin and Heremans, 1973).
The presence of 11S IgA in normal breast secretions would
therefore also indicate that an influx of IgA precursor lymphocytes
must be occurring continuously into the non-lactating breast. This
would be in agreement with the data of Drife et al. (1977), who
demonstrated a significance difference in mammary IgA synthesis bet¬
ween the luteal and proliferative phase of the menstrual cycle of
parous women, indicating that there must have been an increased
influx of plasma cells into the breast at around the beginning of the
luteal phase. The alternative possibility that this difference
reflects an alteration in the IgA synthetic rate due to a change in
the hormonal environment is less likely, since no such difference was
detected in the biopsies from nulliparous women.
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It is not possible to comment about the significance of the
results of the cyst, fluid analysis as the results were heterogenous
and indicate that the hypothesis that cyst fluid might exclusively
reflect the synthetic activity of the surrounding mammary tissue is
probably too simplistic.
The Relevance of Experimental Data to Carcinoma of the Breast
To assess the relevance of the studies described in this
thesis to carcinoma of the breast, one has to consider whether the
observations described explain the protective effect of an early
first pregnancy and, in addition, whether the 11S IgA antibodies
detected have any functional role in the mammary gland.
It is clear that no quaditative changes are present in the
mammary secretory immune system prior to the first pregnancy, since
IIS IgA. could be detected in the mammary secretions of the neonate
and the nulliparous woman. In particular, assay methods were
developed to confirm that it was the complete 11S IgA molecule that
was being detected, and not the 7S IgA or 10S IgA molecule. There
was therefore no evidence of defective IgA synthesis prior to the
first pregnancy. However, it is possible that a quantitative alter¬
ation in IgA synthesis might occur following the first full-term
pregnancy. Unfortunately, this hypothesis could not be tested
because of the small number of normal breast secretions available
for study, but it might be of value to carry out IIS IgA estimations
on the breast secretions of a larger group of premenopausal women. It
might also be worthwhile to confirm that a.~11 the normal breast
secretions contained 11S IgA in view of the finding that cyst fluids
contained 7S IgA, IIS IgA or both.
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One disadvantage of the present method of studying breast
the
secretions is the fact thai/ sample obtained is indicative only of
immunoglobulin at or near the nipple, and may not reflect synthetic
activity at the alveolar level. In order to study this problem
further, it might be necessary to immunise a non-lactating woman
orally to an appropriate antigen, and to assess the time interval
before the appearance of specific IIS IgA antibody in the breast
secretion.
In considering the relevance of these studies to carcinoma
of the breast, it must be emphasised that IIS IgA in this thesis was
measured as class-specific antibody, and no attempts were made to
determine the nature of the antigens that the IIS IgA was directed
against. Human colostrum and milk contain antibody activity against
ABO blood group antigens, E. coli, Staph, aureus, a host of viruses
(Coxsackie B5, Herpes simplex, poliovirus, rotavirus), cholera toxin
and pneumococcus (reviewed by Butler, 1979), but it is not known
what antibody activities are present in normal breast secretions in
non-lactating women. Such information might be helpful in under¬
standing the mode of formation of the secretions, and for formulating
a role (if any) for breast secretions in the non-lactating breast.
It is conceivable that the presence of immunoglobulins in
breast secretions outwith post-partum lactation simply reflects a low
level of mammary epithelial proliferation resulting from low levels
of serum prolactin, 'attracting' IgA precursor lymphocytes into
the breast.
If immunotherapy for breast cancer consisting of the delivery
of tumour specific IgA antibodies to the breast is ever considered,
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then it may be appropriate to carry out oral immunisation with tumour
antigen (to activate the appropriate GALT) at the same time as
raising serum prolactin levels to stimulate mammary epithelial pro¬
liferation and the 'attraction' of the maximum number of IgA precursor
lymphocytes into the breast.
Finally, it is possible that immunosurveillance (Burnet, 1965)
of the mammary gland for carcinoma may not exist, and it is interest¬
ing to note that the most recent study of patients treated with
immunosuppressive drugs demonstrated a striking excess of non-
Hodgkin's lymphomas and to a lesser extent skin cancer, but no excess
of breast cancers (Kinlen, Shiel, Peto and Doll, 1979)• However, the
studies in this thesis demonstrate that IgA B lymphocytes enter the
mammary gland throughout life and further studies are required to
assign a role to this process.
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